<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006224.pub2" GROUP_ID="MENSTR" ID="464705121821490996" MERGED_FROM="" MODIFIED="2011-05-30 23:13:21 +0200" MODIFIED_BY="Jane Clarke" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;edits completed to dicsussion&lt;/p&gt;" NOTES_MODIFIED="2011-05-19 14:22:15 +1000" NOTES_MODIFIED_BY="Liz Dooley" REVIEW_NO="TW1311" REVMAN_SUB_VERSION="5.1.1" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.13">
<COVER_SHEET MODIFIED="2011-05-30 23:13:21 +0200" MODIFIED_BY="Jane Clarke">
<TITLE MODIFIED="2010-08-02 13:20:57 +1000" MODIFIED_BY="[Empty name]">Chinese herbal medicine in the treatment of ectopic pregnancy</TITLE>
<CONTACT MODIFIED="2011-05-30 23:13:21 +0200" MODIFIED_BY="Jane Clarke"><PERSON ID="92605682878437085130100802044418" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lina</FIRST_NAME><LAST_NAME>Hu</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Professor</POSITION><EMAIL_1>cqhulina@126.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>The second Affiliated Hospital of Chongqing Medical University</ORGANISATION><ADDRESS_1>No. 76 Linjiang Road</ADDRESS_1><CITY>Chongqing</CITY><ZIP>400010</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 13983930077</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-05-30 23:13:21 +0200" MODIFIED_BY="Jane Clarke"><PERSON ID="61507014901496224124101123220014" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Hai Bo</FIRST_NAME><LAST_NAME>Qu</LAST_NAME><EMAIL_1>windowsqhb@126.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Radiology</DEPARTMENT><ORGANISATION>West China Second University Hospital Sichuan University</ORGANISATION><ADDRESS_1>No. 20, Section there, Ren Min Nan Lu Avenue</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+8615982222717</PHONE_1><FAX_1>+86 28 85501339</FAX_1></ADDRESS></PERSON><PERSON ID="F1795C5D82E26AA201D6C2750F94CE1E" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Wang</FIRST_NAME><LAST_NAME>Dengfeng</LAST_NAME><SUFFIX>PhD</SUFFIX><EMAIL_1>wonderful_96@163.com</EMAIL_1><MOBILE_PHONE>+8615982222707</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Gynecological Oncology</DEPARTMENT><ORGANISATION>Second People's Hospital of Sichuan (Sichuan Cancer Hospital)</ORGANISATION><ADDRESS_1>No. 55, Section Four, Ren Min Nan Lu Avenue</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+8615982222707</PHONE_1></ADDRESS></PERSON><PERSON ID="12346" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Taixiang</FIRST_NAME><LAST_NAME>Wu</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>txwutx@hotmail.com</EMAIL_1><URL>http://www.chictr.org</URL><MOBILE_PHONE>+86 18980601801</MOBILE_PHONE><ADDRESS><DEPARTMENT>Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 28 8542 2081</PHONE_1><PHONE_2>+86 28 8650 7920</PHONE_2><FAX_1>+86 28 8542 2253</FAX_1></ADDRESS></PERSON><PERSON ID="12773" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Jane</FIRST_NAME><LAST_NAME>Marjoribanks</LAST_NAME><POSITION>Systematic Reviewer</POSITION><EMAIL_1>j.marjoribanks@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Cochrane Menstrual Disorders and Subfertility Group</ORGANISATION><ADDRESS_1>Park Rd</ADDRESS_1><ADDRESS_2>Grafton</ADDRESS_2><CITY>Auckland</CITY><ZIP>1003</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 373 7599 ext: 89490</PHONE_1><FAX_1>+64 9 303 5969</FAX_1></ADDRESS></PERSON><PERSON ID="B382003282E26AA200F0756D7D049A53" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Sun</FIRST_NAME><LAST_NAME>Ying</LAST_NAME><EMAIL_1>iamxiaosunying@163.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Gynecology</DEPARTMENT><ORGANISATION>West China Second University Hospital, West China Women's and Children's Hospital</ORGANISATION><ADDRESS_1>No. 17, Section Three, Ren Min Nan Lu Avenue</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 28 134 0846 2284</PHONE_1></ADDRESS></PERSON><PERSON ID="B381FD6382E26AA200F0756D40831D33" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Jia</FIRST_NAME><LAST_NAME>Haijun</LAST_NAME><SUFFIX>MSc</SUFFIX><EMAIL_1>jianavy@qq.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Gynecology</DEPARTMENT><ORGANISATION>Zhuhai Maternity and Child Health Hospital</ORGANISATION><ADDRESS_1>543 Ningxi Road, Xiangzhou District</ADDRESS_1><CITY>Zhuhai City</CITY><ZIP>519000</ZIP><REGION>Guangdong Province</REGION><COUNTRY CODE="CN">China</COUNTRY></ADDRESS></PERSON><PERSON ID="17737" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Jing</FIRST_NAME><LAST_NAME>Zhang</LAST_NAME><POSITION>Resident</POSITION><EMAIL_1>moureen123@yahoo.com.cn</EMAIL_1><EMAIL_2>moureen123@yahoo.com.cn</EMAIL_2><ADDRESS><DEPARTMENT>Evidence-Based Medicine Center, School of Basic Medical Sciences</DEPARTMENT><ORGANISATION>Lanzhou University</ORGANISATION><ADDRESS_1>No. 199, Donggang West Road</ADDRESS_1><CITY>Lanzhou City</CITY><ZIP>730000</ZIP><REGION>Gansu</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 28 8542 2082</PHONE_1><FAX_1>+86 28 8554 2774</FAX_1></ADDRESS></PERSON><PERSON ID="92605682878437085130100802044418" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lina</FIRST_NAME><LAST_NAME>Hu</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Professor</POSITION><EMAIL_1>cqhulina@126.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>The second Affiliated Hospital of Chongqing Medical University</ORGANISATION><ADDRESS_1>No. 76 Linjiang Road</ADDRESS_1><CITY>Chongqing</CITY><ZIP>400010</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 13983930077</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-05-02 07:45:30 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 7/22/07&lt;/p&gt;" NOTES_MODIFIED="2011-05-02 07:45:30 +1000" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="30" MONTH="11" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="11" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="2" MONTH="11" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2011-05-02 07:45:09 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-05-02 07:45:09 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="5" YEAR="2011"/>
<DESCRIPTION>
<P>Search re run and methods confirmed as current.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2011-05-02 07:44:13 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="11" YEAR="2010"/>
<DESCRIPTION>
<P>1st updated and converted to new review format as well.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-01-19 23:31:56 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_MINOR" MODIFIED="2011-01-19 23:31:56 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="7" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2010-11-18 11:15:39 +1000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2010-11-18 11:15:39 +1000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2010-11-18 11:15:39 +1000" MODIFIED_BY="[Empty name]">
<NAME>MDSG</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-05-11 10:50:20 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-05-11 10:48:44 +1000" MODIFIED_BY="[Empty name]">
<TITLE>Chinese herbal medicine (CHM) in the treatment of ectopic pregnancy.</TITLE>
<SUMMARY_BODY MODIFIED="2011-05-11 10:48:44 +1000" MODIFIED_BY="[Empty name]">
<P>Ectopic pregnancy is the leading cause of pregnancy-related deaths in the first trimester of pregnancy. Its incidence has increased to between one and two percent of pregnancies. Chinese herbal medicines have been used to treat this condition in China and other countries. The review authors investigated 281 studies that claimed to be randomised controlled trials and that used Chinese herbal medicines in the treatment of ectopic pregnancy.Only two of these studies were confirmed to be randomised controlled trials. Both trials were of poor quality in terms of design and how they were conducted.These studies did not provide clear evidence that CHM is beneficial in the treatment of ectopic pregnancy.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-04-29 10:13:48 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-04-29 10:13:33 +1000" MODIFIED_BY="[Empty name]">
<P>Traditionally Chinese herbal medicine (CHM) has been used widely in Chinese hospitals to treat ectopic pregnancy. Many studies have been published supporting its use but the evidence has not been systematically reviewed. This is and update of the review published in 2007.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To determine the effectiveness and safety of CHM in the treatment of ectopic pregnancy. </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-04-23 00:56:10 +1000" MODIFIED_BY="[Empty name]">
<P>Computerised databases (CENTRAL (<I>The Cochrane Library</I>), MEDLINE, EMBASE, Chinese Biomedical Database, China National Knowledge Infrastructure, VIP, Traditional Chinese Medicine Database System) were searched from their inception to November 2010 for relevant trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised controlled trials (RCT) on the use of CHM for the treatment of ectopic pregnancy. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Original authors of the identified studies were contacted to determine the trial design and identify authentic RCTs. Two review authors extracted and analysed the data. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-04-29 10:13:48 +1000" MODIFIED_BY="[Empty name]">
<P>The search identified 281 trials. Only two studies involving a total of 157 participants were confirmed to be authentic RCTs (<A HREF="Li 2004c">Li 2004c</A>; <A HREF="Zhao 2000">Zhao 2000</A>). Both were of poor methodological quality with a high risk of conflicted interest and potential for bias in favour of the intervention. We could not reach a definitive conclusion from the results. The pooled result showed that adding a Western medicine to CHM resulted in a significantly higher treatment success rate than with CHM alone (RR 1.33, 95% CI 1.08 to 1.63). When CHM plus Western medicine was compared to CHM alone for the time to disappearance of abdominal pain, again the results favoured the arm that included Western medicine (RR -2.09, 95% CI -4.14 to -0.04). Results were inconsistent for the time required for human chorionic gonadotropin (beta-hCG) to return to normal. One study favoured CHM plus Western medicine over Western medicine (with or without placebo) (MD -6.68, 95% CI -11.49 to -1.87); when CHM plus Western medicine was compared to CHM alone the results favoured the arm that included Western medicine (MD -8.12, 95% CI -10.89 to -5.53).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-04-23 00:56:39 +1000" MODIFIED_BY="[Empty name]">
<P>We have not found any well-designed trials investigating Chinese herbal medicines in the treatment of ectopic pregnancy. We cannot support or refute any CHM preparation for clinical use on the basis of evidence from randomised controlled trials.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-05-11 10:50:20 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2011-04-29 10:05:06 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2010-12-06 22:23:10 +1000" MODIFIED_BY="[Empty name]">
<P>Ectopic pregnancy is defined as implantation of the blastocyst anywhere other than in the endometrial cavity (<LINK REF="REF-Bankowski-2002" TYPE="REFERENCE">Bankowski 2002</LINK>). It can occur in sexually active women who are of reproductive age both without contraception (where it is a reproductive failure) and with contraception (and contraceptive failure). Ninety-seven per cent of ectopic pregnancies occur in the fallopian tube, 80% in the ampulla region of the tube, about 10% in the isthmus region, about 5% in the infundibulum region and only about 3% in the interstitial portion. Rarely do ectopic pregnancies occur in the ovary, the cervix or the abdomen. Although non-tubal and interstitial ectopic pregnancies are rare, they represent nearly 20% of deaths due to ectopic pregnancy. Unlike the uterus these structures cannot expand enough to fit the growing embryo. If they eventually rupture it may cause life-threatening bleeding.</P>
<P>Ectopic pregnancy is a life- and fertility-threatening condition that is commonly seen in emergency departments. It is the leading cause of pregnancy-related deaths in the first trimester of pregnancy. The classic symptom triad of ectopic pregnancy is pain, amenorrhoea and vaginal bleeding. However, these symptoms are present in only about 50% of ectopic pregnancies and most typically in women with a ruptured ectopic pregnancy. Abdominal pain is the most common presenting complaint but the severity and nature of the pain vary widely. There is no specific type of pain that is typical and allows diagnosis of ectopic pregnancy (<LINK REF="REF-Stovall-2002" TYPE="REFERENCE">Stovall 2002</LINK>).</P>
<P>Epidemiological findings indicate that the two principal risk factors for ectopic pregnancy associated with reproductive rather than contraceptive failure are smoking and a history of genital infection or tubal surgery. Quantitatively their roles in the risk of ectopic pregnancy are similar: each explains approximately one-third of ectopic pregnancies. Both have a causal association with ectopic pregnancy. In eleven case-control studies, ten found a relationship between tobacco smoking and ectopic pregnancy (increased relative risk) (<LINK REF="REF-Dekeyser-2005" TYPE="REFERENCE">Dekeyser 2005</LINK>). Other risk factors are a woman's age and a history of spontaneous or elective abortion. These risk factors explain about 76% of ectopic pregnancies (<LINK REF="REF-Fernandez-2004" TYPE="REFERENCE">Fernandez 2004</LINK>). In addition, ectopic pregnancy is associated with: the use of assisted reproductive technologies such as in vitro fertilisation (IVF) or gamete intrafallopian transfer (GIFT); a history of ectopic pregnancy, the use of an intrauterine device (IUD), non-infectious pelvic inflammation (for example endometriosis or a foreign body) and sexually transmitted disease (STD). Although IUD use only marginally increases a woman's risk of ectopic pregnancy, if pregnancy should occur despite IUD use then the likelihood of ectopic presentation is substantially higher than normal.</P>
<P>The reported worldwide incidence of ectopic pregnancy has increased over time to between one and two per cent of pregnancies (<LINK REF="REF-Lehner-2000" TYPE="REFERENCE">Lehner 2000</LINK>). This may in part be explained by earlier diagnosis, which would also explain falling mortality rates over the same timeframe. Early diagnosis also allows the possibility of medical alternatives to surgical treatment (<LINK REF="REF-Luciano-2001" TYPE="REFERENCE">Luciano 2001</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2011-04-23 01:55:24 +1000" MODIFIED_BY="[Empty name]">
<P>At present there are various types of treatment available for ectopic pregnancy: surgical, medical and expectant. In expectant management no active treatment is given and women are observed in the expectation that they will recover without intervention. Medical treatment includes Chinese herbal medicine and Western medicines such as E Zhu, Hong Hua, Tian Hua, Fenmethotrexate, Mifepristone and Prostaglandin. Methotrexate (MTX) is an antimetabolite that interferes with the production and maintenance of DNA and causes the necrosis, exfoliation and absorption of the embryonic tissue. Thus methotrexate is used to treat early unruptured ectopic pregnancy. Mifepristone is a progestogen antagonist that blocks the actions of the naturally occurring hormone progesterone which is necessary to maintain pregnancy. Prostaglandin is a contraceptive agent that is used in early pregnancy to stimulate contractions of the uterus, enlarge the cervix and induce abortion of the ectopic pregnancy. A Cochrane systematic review (<LINK REF="REF-Hajenius-2000" TYPE="REFERENCE">Hajenius 2000</LINK>) indicated that administration of methotrexate as a one-off intramuscular injection was less effective than laparoscopic salpingostomy. Methotrexate given in multiple intramuscular doses had similar efficacy but was associated with greater impairment of health-related quality of life. Methotrexate is also more expensive because of the need for surgical interventions if tubal rupture occurs, with associated prolonged hospitalisation and loss of productivity.</P>
</INTERVENTION>
<THEORY MODIFIED="2011-04-23 01:55:24 +1000" MODIFIED_BY="[Empty name]">
<P>Chinese herbal medicine (CHM) follows a specific theoretical and methodological pathway as to the cause and treatment of ectopic pregnancy. The principle of Chinese herbal medicines in the treatment of ectopic pregnancy is to promote blood flow. E Zhu (Rhizoma curcumae) (<LINK REF="REF-Chu-1998" TYPE="REFERENCE">Chu 1998</LINK>) and Hong Hua (Flos carthami) (<LINK REF="REF-Liu-1998a" TYPE="REFERENCE">Liu 1998a</LINK>) have anti-implantation and abortifacient functions; Tian Hua Fen (Radix trichosanthis) can also induce abortion (<LINK REF="REF-Dai-1998" TYPE="REFERENCE">Dai 1998</LINK>). Tao Ren (semen Persicae) contains amygdalin which hydrolyses to produce hydrocyanic acid that can paralyse the central nervous system of the embryo and prevent its development (<LINK REF="REF-Gong-1998" TYPE="REFERENCE">Gong 1998</LINK>; <LINK REF="REF-Li-2005" TYPE="REFERENCE">Li 2005</LINK>). Dang Gui (radix Angelicae sinensis), San Qi (radix notoginseng) and Wu Gong (Scolopendra) have the effect of enhancing immune function (<LINK REF="REF-Huang-1998a" TYPE="REFERENCE">Huang 1998a</LINK>; <LINK REF="REF-Huang-1998b" TYPE="REFERENCE">Huang 1998b</LINK>; <LINK REF="REF-Liu-1998b" TYPE="REFERENCE">Liu 1998b</LINK>); Dan Shen (Radix salviae miltiorrhiae) can reduce the level of serum progesterone, inhibit specific binding of the human chorionic gonadotropin (beta-hCG) and luteinising hormone (LH) receptor and promote blood circulation (<LINK REF="REF-Liu-1998c" TYPE="REFERENCE">Liu 1998c</LINK>). Chinese herbal medicines may comprise of a single Chinese herb or a herbal formula that is either fixed or tailored for the individual. Chinese herbal medicines may also be combined with Western medicines in the treatment of ectopic pregnancy. Herbal decoctions are taken orally once a day for 7 to 14 days but for ectopic pregnancy the medicines are also used externally, for example by spreading on the abdomen.</P>
</THEORY>
<IMPORTANCE MODIFIED="2011-04-29 10:05:06 +1000" MODIFIED_BY="[Empty name]">
<P>Chinese herbal medicines have been used for centuries to treat disease in China. They are commonly used for ectopic pregnancy in Chinese hospitals extending from large tertiary and university college hospitals to rural hospitals and traditional Chinese medical hospitals. Many studies have been published on their beneficial effects for ectopic pregnancy. The interest in CHM is not confined to China. There is increasing public interest in, and use of, a wide range of therapies that lie outside the mainstream of traditional Western medicine. For example, in the UK the House of Lords Select Committee report of 2000 on Complementary and Alternative Medicine (CAM) stated that "we are now experiencing a rapid increase in the use of CAM across the Western World" (<LINK REF="REF-HLSC-2000" TYPE="REFERENCE">HLSC 2000</LINK>).<BR/>There is evidence to indicate that not all Chinese herbal medicines are risk free. Adverse events such as allergic reactions and Chinese herbal nephropathy (CHN) have raised concerns (<LINK REF="REF-Lampert-2002" TYPE="REFERENCE">Lampert 2002</LINK>; <LINK REF="REF-Lord-2001" TYPE="REFERENCE">Lord 2001</LINK>; <LINK REF="REF-Nortier-2000" TYPE="REFERENCE">Nortier 2000</LINK>). However, some published randomised trials report that CHM combined with Western medicine for ectopic pregnancy can increase the benefits and reduce the side effects of the latter, with a shortening of the time taken for beta-hCG to return to normal and promotion of absorption of the ectopic pregnancy mass. As there is currently insufficient evidence about the safety and efficacy of CHM in the treatment of ectopic pregnancy there is a need for this systematic review.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To determine the effectiveness and safety of CHM used alone or in combination with Western medicine in the treatment of ectopic pregnancy. </P>
</OBJECTIVES>
<METHODS MODIFIED="2011-05-02 07:43:22 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-04-29 10:08:30 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-11-10 13:08:24 +1000" MODIFIED_BY="jane clarke">
<P>Only truly randomised controlled trials were included. We excluded quasi-randomised trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-02-01 13:45:53 +1000" MODIFIED_BY="[Empty name]">
<P>Women needed to meet all of the following diagnostic criteria:<BR/>1. The characteristic symptoms of ectopic pregnancy : amenorrhoea, abdominal pain and vaginal bleeding<BR/>2. Positive serum beta-hCG assay<BR/>3. Empty uterine cavity and a pelvic mass or extrauterine sac visualised by ultrasound examination.</P>
<P>Medical management is considered inappropriate for women with abnormal liver function or significant haemoperitoneum, for pregnancies that have already ruptured or gone beyond eight-weeks of gestation or where the beta-hCG levels are higher than 10000 IU/L. If studies included such women we planned to include the study, note the inclusion criteria and apply a sensitivity analysis.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-02-01 13:46:06 +1000" MODIFIED_BY="[Empty name]">
<P>1. CHM versus placebo or expectant management<BR/>2. CHM versus Western medicine<BR/>3. One type of CHM versus another type of CHM<BR/>4. CHM versus acupuncture or massage for ectopic pregnancy<BR/>5. CHM plus Western medicine versus acupuncture or massage<BR/>6. CHM plus Western medicine versus placebo plus Western medicine or Western medicine alone<BR/>7. CHM plus Western medicine versus CHM</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-04-29 10:08:30 +1000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-11-10 12:54:29 +1000" MODIFIED_BY="jane clarke">
<P>Primary treatment success as defined by the disappearance of symptoms, a negative serum beta-hCG level and diminution or disappearance of the ectopic pregnancy mass as measured by ultrasound after initial medical treatment. Accordingly, treatment failure was defined as one or a combination of the following after initial medical treatment: a need for surgical intervention for worsening of symptoms, a rise or inadequate decline of the serum beta-hCG level, an increase of the ectopic pregnancy mass and appearance of signs of active bleeding .</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2011-04-29 10:08:30 +1000" MODIFIED_BY="[Empty name]">
<P>1. Patency of fallopian tubes as determined by salpingo graphy<BR/>2. Fertility as measured by the rate of subsequent intrauterine pregnancies<BR/>3. Cost<BR/>4. Quality of life, as measured by instruments such as the SF-36 or WHOQOL-BREF<BR/>5. Length of hospitalisation</P>
<P>
<B>
<I>Adverse events<BR/>
</I>
</B>
<BR/>Both serious and non-serious adverse events, where serious adverse events were defined by the ICH Guidelines (<LINK REF="REF-CFR-_x0026_-ICH-1997" TYPE="REFERENCE">CFR &amp; ICH 1997</LINK>).</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-04-29 10:14:12 +1000" MODIFIED_BY="[Empty name]">
<P>We formulated a comprehensive search strategy in order to identify all randomised controlled trials (RCTs) regardless of language or publication status (published, unpublished, in press or in progress). Where necessary, non-English language papers were translated so that they could be fully assessed for potential inclusion.<BR/>
</P>
<ELECTRONIC_SEARCHES MODIFIED="2011-04-29 10:12:49 +1000" MODIFIED_BY="[Empty name]">
<P>We identified relevant trials from The Cochrane Library (issue 4, 2010 ), MEDLINE (1966 to November 2010), EMBASE (1980 to November 2010); and the Chinese Biomedical Database (CBM) (1975 to November 2010), China National Knowledge Infrastructure (CNKI) (1979 to November 2010), VIP (1989 to November 2010), and the Chinese herbal medicine Database System. The following search strategy was constructed by using a combination of subject headings and text words relating to the use of Chinese herbal medicines in the treatment of ectopic pregnancy see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> . We also conducted the searches in Chinese databases.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2011-04-29 10:12:40 +1000" MODIFIED_BY="[Empty name]">
<P>We also searched for ongoing trials in<BR/>National Research Register<BR/>Meta-register of Controlled Trials<BR/>Medical Research Council Clinical Trials Directory<BR/>
<BR/>We hand searched the following Chinese Journals<BR/>
</P>
<UL>
<LI>Chinese Journal of Obstetrics and Gynecology;</LI>
<LI>Chinese Journal of Integrated Traditional and Western Medicine;</LI>
<LI>Progress in Obstetrics and Gynecology;</LI>
<LI>Chinese Journal of Practical Gynecology and Obstetrics;</LI>
<LI>Journal of Practical Obstetrics and Gynecology;</LI>
<LI>New Journal of traditional Chinese herbal medicine;</LI>
<LI>Modern traditional Chinese herbal medicine;</LI>
<LI>Journal of traditional Chinese herbal medicine.</LI>
</UL>
<P>For hand searching, we concentrated on journals which are not indexed in electronic databases. We contacted authors, as required, to obtain full details and if these could not be obtained we designated the trial as 'awaiting assessment'.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-05-02 07:43:22 +1000" MODIFIED_BY="[Empty name]">
<P>
<U>
<BR/>
</U>
</P>
<STUDY_SELECTION MODIFIED="2011-01-24 00:34:47 +1000" MODIFIED_BY="[Empty name]">
<P>We interviewed the original authors of the identified RCTs by telephone to determine whether the randomisation procedure was sufficiently rigorous. Only those studies that used an acceptable method to generate allocation sequence (see below) were included in the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-04-23 01:00:14 +1000" MODIFIED_BY="[Empty name]">
<P>By using data extraction forms, WD and WT independently extracted data published before March 2006; QH and WD independently extracted data published between April 2006 and November 2010. We extracted data on study characteristics including methods, participants, interventions and outcomes. We listed the contents of all of the Chinese herbal medicine formulations (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and listed the Ping Yin, Latin and English names of the Chinese herbal medicines in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>. <U>
<BR/>
</U>
</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-01-24 00:33:30 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed the methodological quality according to the criteria outlined in <LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>; <LINK REF="REF-Juni-2001" TYPE="REFERENCE">Juni 2001</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK> and <LINK REF="REF-Wu-2007" TYPE="REFERENCE">Wu 2007</LINK>.<BR/>1. Generation of the allocation sequence: adequate (computer-generated random numbers, table of random numbers or similar) or inadequate (other methods or not described).<BR/>2. Allocation concealment: adequate (central independent unit, sealed envelopes or similar) or inadequate (not described, open table of random numbers or similar).<BR/>3. Double blinding: adequate (identical placebo tablets or similar) or inadequate (not performed or tablets versus injections or similar).<BR/>4. Follow up: adequate (number and reasons for dropouts and withdrawals described) or inadequate (number or reasons for dropouts and withdrawals not described).</P>
<P>We described each of our criteria separately for the included studies. Additionally, we planned to explore the influence of individual quality criteria using sensitivity analysis.Three review authors (WD, WT and QH) assessed each trial and extracted data independently. No disagreement was recorded.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-02-01 01:24:02 +1000" MODIFIED_BY="[Empty name]">
<P>Dichotomous data: risk ratio (RR) with 95% confidence intervals (CI).</P>
<P>Continuous date: mean difference with 95% CI.</P>
<P>Intention-to-treat (ITT) analysis was conducted to measure the treatment effect.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2011-02-01 01:29:20 +1000" MODIFIED_BY="[Empty name]">
<P>No unit of analysis in review now, because the two included studies were standard designed. If non-standard designed studies will be included in the future, the assessment will be conducted to avoid unit of analysis errors.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2011-05-02 07:43:22 +1000" MODIFIED_BY="[Empty name]">
<P>All authors were contacted by phone to provide missing information and data. We were successful in making contact some authors,but there were no further available data. An intention to treat analysis was conducted in the following way: assuming that there was a treatment failure in those patients who failed to attend follow (drop-outs) in treatment group and that there was treatment success for those patients who failed to attend follow up (drop-outs) in control group.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-02-01 01:29:37 +1000" MODIFIED_BY="[Empty name]">
<P>We planned to conduct an assessment of heterogeneity amongst trials by inspecting the forest plots and using the Chi-squared test for heterogeneity; we also planned to use the I<SUP>2</SUP> statistics to estimate total variation across studies due to heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2011-01-31 01:41:06 +1000" MODIFIED_BY="[Empty name]">
<P>Test for potential publication bias by using the funnel plot or another corrective analytical method depending on the number of clinical trials included. As there were less 10 included study, there were insufficient included studies to conduct assessment.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-04-29 10:14:54 +1000" MODIFIED_BY="[Empty name]">
<P>We analysed the data using Review Manager (version 5.0.25). We compared outcome measures for binary data using risk ratios (RR). For continuous data, we used the mean difference (MD). We planned to conduct an assessment of heterogeneity amongst trials by inspecting the forest plots and using the Chi-squared test for heterogeneity, with a 10% level of significance. We also planned to use the I<SUP>2</SUP> statistics to estimate total variation across studies due to heterogeneity: less than 25% would have been considered as low-level heterogeneity; 25% to 50% as moderate level; and higher than 50% as high-level heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). Where it was appropriate to pool data and heterogeneity was detected, we planned to use the random-effects model. We did not plan to combine results of trials using different Chinese herbal medicine formulations or different comparator drugs. We planned to test for potential publication bias by using the funnel plot or another corrective analytical method depending on the number of clinical trials included in the systematic review (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).<BR/>
</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-04-23 01:00:32 +1000" MODIFIED_BY="[Empty name]">
<P>We planned to use subgroup analyses to explore the following potential sources of heterogeneity.<BR/>1. The Chinese herbal medicines used in the experimental group.<BR/>2. The intervention used in the experimental group (only Chinese herbal medicines or combination of CHM with Western medicine).<BR/>3. The degree of severity of disease by stratifying ectopic pregnancies as: beta-hCG level &lt; 5000 IU/L, between 5000 IU/L and 10000 IU/L; and size &lt; 3 cm, and between 3 cm and 5 cm.<BR/>4. Different follow up times, for example short-term effects at &lt; 3 months, long-term effects at &gt; 3 months depending on the data.<BR/>However, there were insufficient included studies to conduct subgroup analyses.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-11-10 12:58:24 +1000" MODIFIED_BY="jane clarke">
<P>We planned to explore reasons for heterogeneity in studies and, if necessary, to use sensitivity analyses to examine the effects of excluding study subgroups, for example those studies with lower methodological quality.<BR/>However, there were insufficient included studies to conduct sensitivity analyses.</P>
<P>We will update the review three to four years after its publication.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-05-11 10:50:20 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2011-05-08 23:10:05 +1000" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>
</P>
<P>A total of 281 reports of studies were retrieved for further assessment. Seven were identified as second publications of other studies, leaving 274 original authors of studies to be contacted. We successfully communicated by telephone with the original authors of 243 studies. Of these studies, 243 were excluded due to the authors having misunderstood the principles of randomisation <I>(See</I> the table 'Characteristics of excluded studies'). Twenty-nine authors could not be contacted and their studies are listed as 'excluded studies'. Finally two studies fulfilled our inclusion criteria as RCTs (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>; <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>). This process is presented as a flow figure (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).<BR/>
<B>Design</B>
</P>
<P>Both of the included studies had a parallel group design.</P>
<P>
<B>Interventions<BR/>
</B>Study <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> compared three groups. Group A received a single dose (50 mg/m<SUP>2</SUP>) of MTX , either by intramuscular injection or two thirds by intramuscular injection and one third by injection to the uterine cavity or to the abdominal cavity via the posterior fornix of the vagina. Group B received oral CHM Yi wei ren shen fang decoction, once a day for seven to ten days, and group C received a combination of the above.</P>
<P>Study <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> compared oral CHM Yi wei fang decoction once a day for fourteen days plus MTX 20 mg by intramuscular injection once a day for five days versus Yi wei fang decoction alone.</P>
<P>Both the CHM formulations above were provided by authors themselves and the decoctions were prepared in their own hospitals.</P>
<P>
<B>Participants</B>
</P>
<P>A total of 157 participants were included in the two studies, 97 (<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) and 63 (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>) respectively.</P>
<P>The study by <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> used an unequal arms design: 32 in group A, 24 in group B and 38 in group C; a proportion of 4: 3: 4.75.<BR/>The baseline levels of beta-hCG in the three groups were: 0.255 +/- 0.085 mmol/L, 0.240 +/- 0.077 mmol/L and 0.270 +/- 0.096 mmol/L respectively. The age, diameter of the mass and the length of menolipsis of participants was not reported except to note that the groups were comparable. Although the study was described as an RCT by the original author when interviewed, the number of participants in each arm differed considerably.</P>
<P>The study by <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> had 32 versus 31 participants in the two arms. The mean age of the participants in the intervention group was 30 +/- 7 years (range 19 to 43), the mean length of menolipsis (temporary cessation of menstruation) was 44 +/- 11 days, the mean serum hCG level was 5.56 +/- 2.39 IU/L and the mean diameter of the mass was 50 +/- 22 mm. In the control group the mean age was 29 +/- 6 years (range 20 to 38), the length of menolipsis was 47 +/- 2 days, the serum hCG level was 6.75 +/- 3.60 IU/L and the mean diameter of the mass was 47 +/- 15 mm.</P>
<P>The power calculation for sample size was reported in both of the included studies (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>; <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>). <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> had only 24 participants in group B (Yi wei ren shen fang decoction) and an unequal distribution of participants. This was interpreted as an uncompleted study and the risk of selection bias was high.</P>
<P>
<B>Inclusion criteria for medical treatment</B>
</P>
<P>
<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>
<BR/>1. Stable vital signs and no obvious intra-abdominal haemorrhage<BR/>2. Diameter of ectopic pregnancy mass up to 5 cm</P>
<P>3. Normal liver and renal function, white blood count (WBC) &gt; 4 x 10<SUP>9</SUP>
<BR/>4. Serum beta-hCG &lt; 0.5 nmol/L (normal value &lt; 0.132 nmol/L)</P>
<P>
<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>
<BR/>1. Length of menolipsis &lt; two months except for intramural pregnancy<BR/>2. No obvious internal haemorrhage or no more than a small quantity of fluid in the pelvic cavity, measured by B-type ultrasonography<BR/>3. Serum beta-hCG &lt; 2000 IU/L<BR/>4. No fetal heartbeat, determined by B-type ultrasonography</P>
<P>
<B>Outcomes<BR/>
</B>Treatment success was the primary outcome in both studies. Inefficacy was reported in detail only in the study by <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>. The time for the beta-hCG levels to reduce to normal was reported in both studies (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>; <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>). In addition, the study by <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> reported the time to cessation of vaginal bleeding, time to cessation of abdominal pain and the diameter of the ectopic mass before and after treatment. The average duration of hospital stay and the occurrence of side effects were reported in <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>. Neither patency of fallopian tubes nor cost was mentioned in either study.</P>
<SEARCH_RESULTS MODIFIED="2011-01-24 03:04:09 +1000" MODIFIED_BY="[Empty name]">
<P>Two studies fulfilled our inclusion criteria as RCTs (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>; <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-11-10 13:06:12 +1000" MODIFIED_BY="jane clarke">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>
</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-11-10 13:05:54 +1000" MODIFIED_BY="jane clarke">
<P>See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>
</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-05-11 10:49:27 +1000" MODIFIED_BY="[Empty name]">
<P>See<B> </B>
<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK> ; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>
<BR/>
</P>
<ALLOCATION MODIFIED="2011-01-23 15:30:44 +1000" MODIFIED_BY="[Empty name]">
<P>Both of the studies (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>; <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) referred to random allocation but failed to report in the publication what methods were used. We interviewed the authors by telephone and ascertained that both used a random numbers table to generate the allocation sequence. Neither study provided any information about allocation concealment. We discovered by interviewing the authors that they did not know how to correctly conceal the allocation sequence.</P>
</ALLOCATION>
<BLINDING MODIFIED="2011-01-23 15:22:34 +1000" MODIFIED_BY="[Empty name]">
<P>Neither study mentioned the use of single blinding or double blinding. From our telephone interview we ascertained that the study by <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> used double blinding while <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> did not use blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2011-01-23 15:23:49 +1000" MODIFIED_BY="[Empty name]">
<P>Neither of the studies provided any information about losses to follow up or whether intention-to-treat or per-protocol analysis was used.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-05-11 10:49:27 +1000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>
</P>
<P>1. Subgroup: group A used MTX intramuscular injection; group B used only TCHM; group C used MTX intramuscular.</P>
<P>2. Outcome: the level of serum hCG (mmol/L); the success ratio of different group; the average period of hospitalisation.</P>
<P>3. Time-points: the size of the mass reduce 30% and Serum beta-hCG drop 30 to 50% half month after giving treatment.<BR/>
</P>
<P>
<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>
</P>
<P>1. Outcome: the time for the beta-hCG levels to reduce to normal.The time of treatment cases to cessation of vaginal bleeding were short, The time of treatment to cessation of abdominal pain were short. The diameter of the ectopic mass in treatment group reduced much.</P>
<P>2. Time-points: serum beta-hCG normal three consecutive times after treatment; cessation of vaginal bleeding and cessation of abdominal pain and ectopic mass reduce or disappear.</P>
<P>3. Subgroup: treatment (TCHM combined with MTX) and control group (TCHM).<BR/>
</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2011-01-31 01:51:36 +1000" MODIFIED_BY="[Empty name]">
<P>Unequal numbers on arms due to the discontinuation in <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> study, this might influence the outcomes.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-05-11 10:50:20 +1000" MODIFIED_BY="[Empty name]">
<P>We were not able to perform a pooled analysis because of the differing methodology employed in the included studies.</P>
<P>
<B>1. CHM versus placebo or expectant management</B>
</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>
<B>2. CHM versus Western medicine</B>
</P>
<P>1.1 Treatment success rate</P>
<P>One study ( <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) compared CHM (Yi wei ren shen fang decoction) with Western medicine (MTX, a single dose of 50 mg/m<SUP>2</SUP>). There was no statistically significant difference between the two groups in treatment success rate.</P>
<P>1.2 Time to cessation of abdominal pain</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.3 Time to cessation of vaginal bleeding</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.4. Time for serum beta-hCG levels to return to normal (days)</P>
<P>One study ( <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) compared CHM (Yi wei ren shen fang decoction) with Western medicine (MTX, a single dose of 50 mg/m2). There was no statistically significant difference between the two groups for this outcome.</P>
<P>1.5. Diminution of the ectopic pregnancy mass by ultrasound (mm)</P>
<P>No relevant studies were found.</P>
<P>1.6. Patency of fallopian tubes</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.7. Future fertility</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.8. Cost</P>
<P>No studies met the inclusion criteria for this outcome.</P>
<P>1.9. Quality of life</P>
<P>No studies met the inclusion criteria for this outcome.</P>
<P>1.10. Duration of hospital stay (days)</P>
<P>In the study by <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> there was a statistically significant difference in the duration of hospital stay between women receiving Yi wei ren shen fang decoction and MTX: this favoured MTX (MD 14.07, 95% CI 9.92 to 18.22).</P>
<P>1.11. Adverse event rate</P>
<P>One study (<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) compared CHM (Yi wei ren shen fang decoction) with Western medicine (MTX, a single dose of 50 mg/m2). There was no statistically significant difference between the two groups in the rate of adverse events.</P>
<P>
<B>3. One type of CHM versus another type of CHM</B>
</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>
<B>4. CHM versus acupuncture or massage for ectopic pregnancy</B>
</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>
<B>5. CHM plus Western medicine versus acupuncture or massage</B>
</P>
<P>No relevant studies were found.</P>
<P>
<B>6. CHM plus Western medicine versus placebo plus Western medicine or Western medicine alone</B>
</P>
<P>1.1 Treatment success rate</P>
<P>One study made this comparison (<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) and found no statistically significant difference between the groups.</P>
<P>1.2 Time to cessation of abdominal pain</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.3 Time to cessation of vaginal bleeding</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.4. Time for serum beta-hCG levels to return to normal (days)</P>
<P>One study (<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) compared a combination of Yi wei ren shen fang decoction with MTX versus MTX alone. There was a statistically significant difference between the groups favouring Yi wei ren shen fang decoction plus MTX (MD -6.68, 95% CI -11.49 to -1.87).</P>
<P>1.5. Diminution of the ectopic pregnancy mass by ultrasound (mm)</P>
<P>No relevant studies were found.</P>
<P>1.6. Patency of fallopian tubes</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.7. Future fertility</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.8. Cost</P>
<P>No studies met the inclusion criteria for this outcome.</P>
<P>1.9. Quality of life</P>
<P>No studies met the inclusion criteria for this outcome.</P>
<P>1.10. Duration of hospital stay (days)</P>
<P>In the study by <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> there was a statistically difference in the duration of hospital stay between participants receiving Yi wei ren shen fang decoction plus MTX and MTX alone. This favoured Yi wei ren shen fang plus MTX (MD -7.30, 95% CI -9.72 to -4.88).</P>
<P>1.11. Adverse event rate</P>
<P>In <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> there was no statistically significant difference in the rate of adverse events between Yi wei ren shen fang decoction plus MTX and MTX alone.</P>
<P>
<B>7. CHM plus Western medicine versus CHM</B>
</P>
<P>1.1 Treatment success rate</P>
<P>Two studies made this comparison. One (<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>) compared a combination of Yi wei ren shen fang decoction and MTX with Yi wei ren shen fang decoction alone. The other (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>) compared Yi wei fang decoction plus MTX with Yi wei fang decoction alone. A meta-analysis of these two studies found a statistically significant difference in treatment success rate between the two groups, favouring CHM plus Western medicine (RR 1.33, 95% CI 1.08 to 1.63).</P>
<P>1.2 Time to cessation of abdominal pain</P>
<P>One study (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>) compared Yi wei fang decoction plus MTX with Yi wei fang decoction alone for this outcome. There was a statistically significant difference between the two groups favouring CHM plus Western medicine (RR -2.09, 95% CI -4.14 to -0.04).</P>
<P>1.3 Time to cessation of vaginal bleeding</P>
<P>The study by <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> compared Yi wei fang decoction plus MTX with Yi wei fang decoction alone and found no statistically significant difference between the two groups.</P>
<P>1.4. Time for serum beta-hCG levels to return to normal (days)</P>
<P>Two studies made this comparison (<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>; <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>). A meta-analysis of these two studies found a statistically significant difference between the two groups favouring CHM plus Western medicine (MD -8.12, 95% CI -10.89 to -5.53). There was a high level of heterogeneity in this result (I<SUP>2</SUP> 74.4%).</P>
<P>1.5. Diminution of the ectopic pregnancy mass by ultrasound (mm)</P>
<P>
<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> found no statistically significant difference between the groups in the diameter of the mass before treatment but found a statistically significant difference after treatment. This favoured the group that received Yi wei fang decoction plus MTX (20 mg/day intramuscularly for five days) over the group that received Yi wei fang decoction alone (MD -10.87, 95% CI -17.10 to -4.64).</P>
<P>1.6. Patency of fallopian tubes</P>
<P>No relevant studies were found that met the inclusion criteria. However, <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> reported that among 16 patients in group C (Yi wei ren shen fang decoction plus MTX) who requested fertility treatment, 13 received hysterosalpingography four to six months after treatment and nine had tubal patency.</P>
<P>1.7. Future fertility</P>
<P>No relevant studies were found that met the inclusion criteria.</P>
<P>1.8. Cost</P>
<P>No studies met the inclusion criteria for this outcome.</P>
<P>1.9. Quality of life</P>
<P>No studies met the inclusion criteria for this outcome.</P>
<P>1.10. Duration of hospital stay (days)</P>
<P>In the study by <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> there was a statistically significant difference in the number of days of hospitalisation between women receiving Yi wei ren shen fang decoction plus MTX and Yi wei ren shen fang alone, favouring Yi wei ren shen fang plus MTX (MD -21.37, 95% CI -25.24 to -17.50).</P>
<P>1.11. Adverse event rate</P>
<P>In the study by <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> there was no statistically significant difference in the rate of adverse events between Yi wei ren shen fang decoction plus MTX and Yi wei ren shen fang alone.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-04-23 03:01:30 +1000" MODIFIED_BY="[Empty name]">
<P>We found that many different formulations of Chinese herbal medicines are widely used for treating ectopic pregnancy. Although 243 relevant trials claimed to be RCTs none of them were well designed.The limitations of these studies are summarised as follows:</P>
<P>1. There were a large number of trials on the treatment of ectopic pregnancy that claimed to be randomised and controlled. We interviewed the original authors by telephone about the method of randomisation they used and found that more than 67% of them misunderstood the concepts of randomisation and allocation concealment.</P>
<P>2. Both included studies used CHM as the control and the experimental group used CHM combined with MTX. This means that any treatment benefit should be attributed to MTX rather than CHM. It seems that CHM plus MTX produced a combined effect greater than either CHM or MTX individually. This was particularly evident for treatment success, reduction in the level of beta&#8722;hCG hormone, time to cessation of abdominal pain and duration of hospital stay.</P>
<P>We suggest that the best methodology would be a 'double dummy' design, with a placebo in each arm: a CHM placebo in one arm and a Western Medicine placebo in the other.</P>
<P>3. There was high heterogeneity in the pooled result for time to resolution of serum beta-hCG levels, presumably due to the small number of included studies.</P>
<P>4. We found that the intervention formulations used in both studies (<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>; <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>) were prepared by the authors themselves or by colleagues in their hospitals. Thus in these two studies the trialistic had three roles: as formulation designer, trial designer and trialistic. This creates high potential for selection and detection bias in favour of the intervention.</P>
<P>Furthermore, the overall treatment concept for CHM is different to that used in Western medicine. When a study uses a self-prepared Chinese herbal medicine formulation the quality of the Chinese herbal medicines and methods of preparation should be stated in detail in order to achieve consistent effects.</P>
<SUMMARY_OF_RESULTS MODIFIED="2011-01-31 01:59:47 +1000" MODIFIED_BY="[Empty name]">
<P>Although the methods of manufacture and use of CHM in the treatment of ectopic pregnancy are widely accepted in China, most of the constituents of the pharmacologically-prepared CHM drugs used in trials cannot be clearly specified. This is in marked contrast to pharmacological agents used in Western medicine, where the chemical constituents, their quantities and the percentage of any impurities or contaminants are precisely known, and the variation between different production batches is kept within specified limits. Variation between formulations and batches of treatments are inevitable consequences of Chinese herbal medicines, even though the Chinese Government specifies the limits of variation that are acceptable. This variation is a factor that may contribute to heterogeneity between different study results.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2011-01-31 04:41:57 +1000" MODIFIED_BY="[Empty name]">
<P>Exact conclusions could not be assessed for limited studies. The difference of the CHM formulations in included studies might decrease the generalizability of the results regarding the effectiveness of CHM for ectopic pregnancy patients.</P>
<P>The applicability of included two studies was limited, since their Inclusion criterion, interventions and durations were different, furthermore their formulations of CHM were different, and the outcome measures were not all the same. More related studies are expected in future.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2011-04-23 03:01:30 +1000" MODIFIED_BY="[Empty name]">
<P>Two RCTs were included in present review, but the quality of them was inadequate. Neither of them reported adequate methodology in their original publications, only randomisation methods were reported. Neither study provided any information about the use of single blinding or double blinding in their report. By telephone interview we found that study <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> did not use any blinding: this study reported a recovery rate that was almost 50% higher in the group receiving Yi wei ren shen fang decoction (RR 1.42). <LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK> was a double blinded study, and reported a similar recovery rate in both the intervention group and the control group. For a disease like ectopic pregnancy some mild cases spontaneously remit without any treatment (expectant treatment), so it is very difficult to prove the superiority of one active treatment over another. Above inadequate aspects of methodological quality should be avoided in future studies.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2011-01-31 04:21:41 +1000" MODIFIED_BY="[Empty name]">
<P>Neither of them reported adequate methodology in their original publications, so we obtained information by telephone communication with the authors. The studies were conducted several years ago and may be influenced by recall bias. In addition, we have to point out that the possibility of selection bias and/or detection bias in <LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK> may be the reason for the high relative risk.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2011-02-01 13:55:00 +1000" MODIFIED_BY="[Empty name]">
<P>The results of well-designed RCTs with large sample size in the future may confirm or refute current conclusion here. There is no other known systematic review on CHM for ectopic pregnancy by now.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-01-31 02:40:46 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE>
<P>We have not found any well-designed trials investigating Chinese herbal medicines in the treatment of ectopic pregnancy. We cannot support or refute any preparation for clinical use on the basis of evidence from randomised controlled trials.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-01-31 02:40:46 +1000" MODIFIED_BY="[Empty name]">
<P>Based on the studies included in this review, there is some evidence that CHM may strengthen the effect of MTX in the treatment of ectopic pregnancy. However we cannot draw a firm conclusion due to the poor methodological quality of the evidence available. We suggest that high quality clinical trials are needed to investigate the potential use of CHM for ectopic pregnancy.</P>
<P>Further trials of CHM for ectopic pregnancy should use a methodologically sound randomisation technique to generate allocation sequence, and be conducted by a person who is not involved in participant recruitment or enrolment . Knowledge of the randomised allocation sequence should be protected in such a way as to provide assurance that the allocations are not known until, at least, the point of allocation: for example by utilising sequentially numbered, sealed, opaque envelopes prepared remotely. Planned trials should use a placebo plus Western medicine as control versus CHM plus Western medicine or plus a placebo. Only treatment which has a demonstrated effect for ectopic pregnancy should be used as the control. Blinding for participants, trialistic and outcome assessors is necessary. The trialistic should not know about which test (for example 'equivalence effect test ' or 'non-inferiority effect test' ) is used. The power calculation for sample size should be reported and the trial methodology should be reported in detail according to the CONSORT statement (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>). It may be helpful to conduct clinical trials comparing the effect of CHM for ectopic pregnancy on women with differing levels of beta-hCG or differing sizes of ectopic pregnancy mass. Finally, in clinical trials international units of measurement should be used in order to increase the generalis ability of findings.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-01-31 03:44:03 +1000" MODIFIED_BY="[Empty name]">
<P>We thank Jane Clarke, Michelle Proctor, Roger Hart, Andy Vail and Andrew Prentice from the Menstrual Disorders and Subfertility Review Group editorial board and Phil Wiffen from the UK Cochrane Center, for advice on writing the review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-01-17 00:27:01 +1000" MODIFIED_BY="[Empty name]">
<P>Qu Haibo, Dengfeng Wang and Taixiang Wu: searched for and selected studies; they developed the review.<BR/>Lina Hu: provided clinical expertise, co-drafted both the protocol and the review.<BR/>Haijun Jia, Ying Sun and Jing Zhang: interviewed the original study authors by telephone.<BR/>Guanjian Liu: provided assistance with statistics, data analysis and data presentation.<BR/>Jane Marjoribanks edited the review and provided methodological support<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-02-01 13:55:24 +1000" MODIFIED_BY="[Empty name]">
<P>According to the contributions of authors, the first author has been changed to Qu Haibo.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-05-08 23:03:53 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2011-05-08 23:03:53 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004c" NAME="Li 2004c" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li WL, Li DJ, Lu Y, Zhou J, Liu CL, Pan TH</AU>
<TI>The clinical observation of ectopic recipe combined with methotrexate in the treatment for 32 cases of ectopic pregnancy</TI>
<SO>Journal of Anhui TCM College</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>2</NO>
<PG>19-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2000" NAME="Zhao 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao X, Huang GY</AU>
<TI>The comparison of three kinds of drug treatments for ectopic pregnancy</TI>
<SO>Chinese Journal of Practical Gynecology and Obstetrics</SO>
<YR>2000</YR>
<VL>16</VL>
<NO>4</NO>
<PG>221-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-05-08 23:03:53 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-An-2003" NAME="An 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>An FJ, Liu M, Xu H</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Medical Journal of Communication</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>3</NO>
<PG>300-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bai-2010" MODIFIED="2011-01-17 01:25:17 +1000" MODIFIED_BY="[Empty name]" NAME="Bai 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-01-17 01:25:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bai XY,Dong YY</AU>
<TI>The clinical observation of methotrexate and mifepristone combined with traditional Chinese medicine in the treatment for 96 cases of early ectopic pregnancy</TI>
<SO>Journal of Clinical and Experimental Medicine</SO>
<YR>2010</YR>
<VL>9</VL>
<NO>8</NO>
<PG>627-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bao-2007a" MODIFIED="2011-01-24 04:05:26 +1000" MODIFIED_BY="[Empty name]" NAME="Bao 2007a" YEAR="2007">
<REFERENCE MODIFIED="2011-01-24 04:05:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bao LH</AU>
<TI>The clinical effect of traditional Chinese medicine conservative treatment for cured ectopic pregnancy</TI>
<SO>Acta Medicinae Sinica</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>3</NO>
<PG>480-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bao-2007b" MODIFIED="2011-01-17 01:27:27 +1000" MODIFIED_BY="[Empty name]" NAME="Bao 2007b" YEAR="">
<REFERENCE MODIFIED="2011-01-17 01:27:27 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bao LH</AU>
<TI>The clinical observation of traditional Chinese medicine treatment for fallopian tube recanalization of cured ectopic pregnancy</TI>
<SO>Yunnan Journal of Traditional Chinese Medicine and Materia Medica</SO>
<YR>2007</YR>
<VL>28</VL>
<NO>7</NO>
<PG>4-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bi-2001" MODIFIED="2011-02-01 02:32:21 +1000" MODIFIED_BY="[Empty name]" NAME="Bi 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-12-24 01:24:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bi BF, Qiu XS</AU>
<TI>The clinical observation of three drug treatments for ectopic pregnancy</TI>
<SO>Zhejiang Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2001</YR>
<VL>11</VL>
<NO>10</NO>
<PG>635-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bu-2004" MODIFIED="2010-12-30 00:09:04 +1000" MODIFIED_BY="[Empty name]" NAME="Bu 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-12-30 00:09:04 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bu YG, Zhu BL</AU>
<TI>Combined use of single-dose methotrexate intramuscular injection and mifepristone in treating ectopic pregnancy</TI>
<SO>Acta University Medicinalis Anhui</SO>
<YR>2004</YR>
<VL>39</VL>
<NO>1</NO>
<PG>71-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cai-1998a" NAME="Cai 1998a" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cai CR, Pu YQ, Zheng XL</AU>
<TI>The effect comparison of methotrexate used alone or combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Current Advances in Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>7</VL>
<NO>3</NO>
<PG>280-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cai-1998b" NAME="Cai 1998b" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cai M, Yang ZW</AU>
<TI>The clinical observation of mifepristone combined with traditional Chinese medicine in the treatment of ectopic pregnancy</TI>
<SO>Hunan Guiding Journal of TCMP</SO>
<YR>1998</YR>
<VL>4</VL>
<NO>5</NO>
<PG>20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cao-2003" NAME="Cao 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cao YM, Li JX, Qin XN</AU>
<TI>Observation of curative effect of integrated Chinese traditional and Western medicine herbs in treating the ectopic pregnancy in 30 cases</TI>
<SO>Modern Medicine Health</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>7</NO>
<PG>815-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chang-2009" MODIFIED="2011-01-17 03:02:08 +1000" MODIFIED_BY="[Empty name]" NAME="Chang 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-17 03:02:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chang XM</AU>
<TI>The clinical observation of traditional Chinese medicine combined with western medicine in the treatment for 40 cases ectopic pregnancy</TI>
<SO>Chinese Journal Modern Drug Apply</SO>
<YR>2009</YR>
<VL>3</VL>
<NO>7</NO>
<PG>95-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Che-2007" MODIFIED="2010-12-13 01:44:02 +1000" MODIFIED_BY="[Empty name]" NAME="Che 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-12-13 01:44:02 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Che CY,Yang XF</AU>
<TI>The effect observation of combined traditional Chinese medicine with methotrexate in the treatment for 34 cases of ectopic pregnancy</TI>
<SO>Central Plains Medical Journal</SO>
<YR>2006</YR>
<VL>33</VL>
<NO>14</NO>
<PG>79</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-1999" NAME="Chen 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen JF</AU>
<TI>The comparison of four kinds of non-surgical conservative treatments for ectopic pregnancy</TI>
<SO>Central Plains Medical Journal</SO>
<YR>1999</YR>
<VL>26</VL>
<NO>3</NO>
<PG>7-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2003a" NAME="Chen 2003a" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen P, Xie TQ, Wu ZB, Wu J, Yan EL, Wu FQ</AU>
<TI>The report of methotrexate and mifepristone combined with tradition Chinese medicine in the treatment for 38 cases of tubal pregnancy</TI>
<SO>Medical Journal of Casc</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>6</NO>
<PG>53-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2003b" NAME="Chen 2003b" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen JX</AU>
<TI>The clinical observation of mifepristone combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>Acta Academiae Medicinae Xuzhou</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>6</NO>
<PG>569-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2004" MODIFIED="2010-12-30 00:15:00 +1000" MODIFIED_BY="[Empty name]" NAME="Chen 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-12-30 00:15:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen H, Zhang CY</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine for treating ectopic pregnancy</TI>
<SO>Journal of Practical Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>10</NO>
<PG>567</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2008" MODIFIED="2011-01-17 03:02:37 +1000" MODIFIED_BY="[Empty name]" NAME="Chen 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 03:02:37 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen AZ</AU>
<TI>The application of mifepristone and Chinese herb in ectopic pregnancy</TI>
<SO>China Practical Medicine</SO>
<YR>2008</YR>
<VL>3</VL>
<NO>18</NO>
<PG>123-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2003" NAME="Cheng 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheng L</AU>
<TI>The observation of drug conservative treatment for 38 cases of ectopic pregnancy</TI>
<SO>Journal of Practical Traditional Chinese Medicine</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>9</NO>
<PG>458</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2007a" MODIFIED="2010-12-26 22:10:16 +1000" MODIFIED_BY="[Empty name]" NAME="Cheng 2007a" YEAR="2007">
<REFERENCE MODIFIED="2010-12-08 01:49:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen FR</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the conservative treatment for ectopic pregnancy in 41 cases</TI>
<SO>Modern Journal of Integ rated Traditional Chinese and Western Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>35</NO>
<PG>5264-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2007b" MODIFIED="2011-01-17 01:29:38 +1000" MODIFIED_BY="[Empty name]" NAME="Cheng 2007b" YEAR="">
<REFERENCE MODIFIED="2011-01-17 01:29:38 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen LM,Zhao L,Gu X</AU>
<TI>Traditional Chinese medicine combined with western medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Occupational Health and Damage</SO>
<YR>2007</YR>
<VL>22</VL>
<NO>3</NO>
<PG>233-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2009" MODIFIED="2011-05-08 21:43:10 +1000" MODIFIED_BY="[Empty name]" NAME="Cheng 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-05-08 21:43:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen BH,Wei M,Cao LY</AU>
<TI>Evaluation on the contribution of Chinese herbs in conservative therapy of unruptured tubal pregnancy</TI>
<SO>Chinese Hospital Pharmacy Journal</SO>
<YR>2009</YR>
<VL>29</VL>
<NO>10</NO>
<PG>835-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cui-2003a" MODIFIED="2010-12-24 00:22:07 +1000" MODIFIED_BY="[Empty name]" NAME="Cui 2003a" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cui TT</AU>
<TI>The clinical summarization of traditional Chinese medicine combined with Western medicine in the treatment for 20 cases of early ectopic pregnancy</TI>
<TO>Clinic summarization on combined TCM and West medicine to treating 20 cases of early ectopic pregnancy</TO>
<SO>Hunan Guiding Journal of TCM</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>5</NO>
<PG>38-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cui-2003b" MODIFIED="2010-12-24 00:22:14 +1000" MODIFIED_BY="[Empty name]" NAME="Cui 2003b" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cui LN</AU>
<TI>The analysis of traditional Chinese medicine combined with Western medicine in the treatment for 230 cases of early ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>15</NO>
<PG>1604-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dai-2000" NAME="Dai 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dai HP</AU>
<TI>The effective of methotrexate combined Chinese herb medicine in the treatment of unruptured ectopic pregnancy</TI>
<SO>Clinical Medical Journal of China</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>2</NO>
<PG>172-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dai-2007" MODIFIED="2011-01-17 01:30:05 +1000" MODIFIED_BY="[Empty name]" NAME="Dai 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 01:30:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dai JD</AU>
<TI>The clinical analysis of traditional Chinese medicine combined with western medicine in the treatment for 35 cases ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>17</NO>
<PG>2369-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dai-2010" MODIFIED="2011-05-08 21:48:02 +1000" MODIFIED_BY="[Empty name]" NAME="Dai 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-05-08 21:48:02 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dai J,Cui JL,Chen YF</AU>
<TI>The clinical analysis about of two kinds of methods influence &#946; - hCG plateau in the treatment of ectopic pregnancy</TI>
<SO>Chinese Journal of Ethnomedicine and Ethnopharmacy</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>11</NO>
<PG>188-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dan-2001" NAME="Dan 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dan SF, Han XS, Cai ZY, San P</AU>
<TI>The comparison of three kinds of conservative treatments for ectopic pregnancy</TI>
<SO>Aerospace Medicine</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>4</NO>
<PG>201-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deng-2008" MODIFIED="2010-12-12 12:59:40 +1000" MODIFIED_BY="[Empty name]" NAME="Deng 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 12:59:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deng HQ</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>Maternal and Child Health Care of China</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>14</NO>
<PG>1924-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ding-2005" MODIFIED="2011-05-08 21:48:46 +1000" MODIFIED_BY="[Empty name]" NAME="Ding 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-05-08 21:48:46 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ding XL</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>14</NO>
<PG>1847</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fan-2001" NAME="Fan 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fan LL</AU>
<TI>The effect observation of three drugs for ectopic pregnancy</TI>
<SO>Qinghai Medical Journal</SO>
<YR>2001</YR>
<VL>31</VL>
<NO>6</NO>
<PG>24-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fang-2001" NAME="Fang 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fang X</AU>
<TI>Clinical observation of integration of traditional Chinese medicine and Western medicine on heterotopic pregnancy</TI>
<SO>Hebei Journal of Traditional Chinese Medicine</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>8</NO>
<PG>618-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feng-2007" MODIFIED="2010-12-11 19:19:12 +1000" MODIFIED_BY="[Empty name]" NAME="Feng 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-12-11 19:19:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feng XY</AU>
<TI>The effect comparison of three different conservation treatment for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>7</NO>
<PG>949-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fu-2009" MODIFIED="2011-01-17 01:30:29 +1000" MODIFIED_BY="[Empty name]" NAME="Fu 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-17 01:30:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fu Q, Li Y</AU>
<TI>The clinical observation of mifepristone combined with methotrexate and traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>6</NO>
<PG>1996-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gang-2004" NAME="Gang 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gang XF, Zhao XH, Zhang LX</AU>
<TI>The clinical analysis of conservative drug treatment for ectopic pregnancy</TI>
<SO>Journal of Practical Medical Techniques</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>5A</NO>
<PG>613-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gao-2003" NAME="Gao 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gao JZ</AU>
<TI>The effect observation of partner treatment of traditional Chinese medicine for unruptured ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>1</NO>
<PG>71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gao-2004" NAME="Gao 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gao HL, Gao F</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the conservative treatment for ectopic pregnancy in 85 cases</TI>
<SO>Journal of Practical Medical Techniques</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>5A</NO>
<PG>613-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gao-2006" MODIFIED="2010-12-30 00:58:02 +1000" MODIFIED_BY="[Empty name]" NAME="Gao 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-12-30 00:58:02 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gao MJ, Liu QY</AU>
<TI>The observation of traditional Chinese medicine combined with Western medicine in the treatment for 100 cases of ectopic pregnancy</TI>
<SO>Journal of Practical Traditional Chinese Internal Medicine</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>1</NO>
<PG>49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ge-2000" MODIFIED="2010-12-30 01:02:07 +1000" MODIFIED_BY="[Empty name]" NAME="Ge 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-12-30 01:02:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ge ZP</AU>
<TI>Methotrexate combined with traditional Chinese medicine in the treatment for 31 cases of ectopic pregnancy</TI>
<SO>Acta Academiae Medicinae Suzhou</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>2</NO>
<PG>162-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gu-2008a" MODIFIED="2011-01-17 01:34:31 +1000" MODIFIED_BY="[Empty name]" NAME="Gu 2008a" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 01:34:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gu JR</AU>
<TI>Observation of curative effects of three therapeutic schemes for unruptured ectopic pregnancy</TI>
<SO>China Modern Doctor</SO>
<YR>2008</YR>
<VL>46</VL>
<NO>32</NO>
<PG>90-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gu-2008b" MODIFIED="2011-01-17 03:03:09 +1000" MODIFIED_BY="[Empty name]" NAME="Gu 2008b" YEAR="">
<REFERENCE MODIFIED="2011-01-17 03:03:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gu JR</AU>
<TI>The effect observation of different medIcine in the treatment for unruptured ectopic pregnancy</TI>
<SO>Journal of Chinese Rural Physician</SO>
<YR>2008</YR>
<VL>10</VL>
<NO>199</NO>
<PG>91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2003" NAME="Guo 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo XY, Yang QS, Xia P</AU>
<TI>Methotrexate combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Information on TCM</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>2</NO>
<PG>46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2004" NAME="Guo 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo XJ</AU>
<TI>The clinical analysis of conservative treatment for early ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2004</YR>
<VL>13</VL>
<NO>12</NO>
<PG>1580-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2005" NAME="Guo 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo J</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy in 47 cases</TI>
<SO>Traditional Chinese Medicinal Research</SO>
<YR>2005</YR>
<VL>18</VL>
<NO>8</NO>
<PG>36-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2008" MODIFIED="2010-12-12 21:51:29 +1000" MODIFIED_BY="[Empty name]" NAME="Guo 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 21:51:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo R</AU>
<TI>Observation of curative effect of the four methods about conservative treatment of ectopic pregnancy</TI>
<SO>Modern Hospital</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>7</NO>
<PG>66-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2009a" MODIFIED="2011-01-17 01:35:36 +1000" MODIFIED_BY="[Empty name]" NAME="Guo 2009a" YEAR="2009">
<REFERENCE MODIFIED="2011-01-17 01:35:36 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo HM,Tian Y,Liang CF</AU>
<TI>The clinical study of MTX combined with shaofuzhuyu decoction in the treatment of ectopic pregnancy</TI>
<SO>He Bei Medcine</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>2</NO>
<PG>143-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2009b" MODIFIED="2010-12-25 01:17:13 +1000" MODIFIED_BY="[Empty name]" NAME="Guo 2009b" YEAR="">
<REFERENCE MODIFIED="2010-12-25 01:17:13 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo XZ</AU>
<TI>The observation of methotrexate and mifepristone combined with traditional Chinese medicine treating ectopic pregnancy</TI>
<SO>China Journal of Clinical Rational Drug Use</SO>
<YR>2009</YR>
<VL>2</VL>
<NO>2</NO>
<PG>40-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2004" MODIFIED="2010-12-30 01:03:56 +1000" MODIFIED_BY="[Empty name]" NAME="Han 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-12-30 01:03:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Han Y, Wang ZH</AU>
<TI>The effective of traditional Chinese medicine combined with Western medicine for 50 cases of ectopic pregnancy</TI>
<SO>The Journal of Medical Theory and Practice</SO>
<YR>2004</YR>
<VL>17</VL>
<NO>11</NO>
<PG>1307-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hao-2007" MODIFIED="2010-12-12 23:24:41 +1000" MODIFIED_BY="[Empty name]" NAME="Hao 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-12-12 23:24:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hao FX,Guo YY</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Traditional Chinese Medicine</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>4</NO>
<PG>32-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hao-2009" MODIFIED="2010-12-12 12:35:31 +1000" MODIFIED_BY="[Empty name]" NAME="Hao 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 12:35:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hao XH,G YH,WANG XX</AU>
<TI>The analysis of mifepristone combined with traditional Chinese medicine in the conservative treatments for ectopic pregnancy</TI>
<SO>Hebei Medical Journal</SO>
<YR>2009</YR>
<VL>31</VL>
<NO>15</NO>
<PG>1943-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-He-2005" NAME="He 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>He LP, Li QC</AU>
<TI>The clinical observation of methotrexate combined with traditional Chinese medicine in the treatment for 63 cases of ectopic pregnancy</TI>
<SO>Jiangxi Journal of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>36</VL>
<NO>267</NO>
<PG>32-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-He-2008" MODIFIED="2010-12-12 02:13:20 +1000" MODIFIED_BY="[Empty name]" NAME="He 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 02:13:20 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>He WM</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine conservative treatment for ectopic pregnancy.</TI>
<SO>Maternal and Child Health Care of China</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>31</NO>
<PG>4516-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-He-2009" MODIFIED="2010-12-25 01:15:18 +1000" MODIFIED_BY="[Empty name]" NAME="He 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-25 01:15:18 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>He YL,Zhou XL</AU>
<TI>The clinical research of methotrexate and mifepristone combined with traditional Chinese medicine treating ectopic pregnancy</TI>
<SO>China Foreign Medical Treatment</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>26</NO>
<PG>76-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-He-2010a" MODIFIED="2011-01-24 03:59:54 +1000" MODIFIED_BY="[Empty name]" NAME="He 2010a" YEAR="2010">
<REFERENCE MODIFIED="2011-01-24 03:59:54 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>He HJ,Lin SM,Liang MR</AU>
<TI>The effect of traditional Chinese medicine combined with Western medicine for treating ectopic pregnancy</TI>
<SO>Medical Information</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>8</NO>
<PG>2275-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-He-2010b" MODIFIED="2010-12-24 00:23:22 +1000" MODIFIED_BY="[Empty name]" NAME="He 2010b" YEAR="">
<REFERENCE MODIFIED="2010-12-14 01:38:27 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>He CQ,Tian Y,Li M</AU>
<TI>Clinical research on prevention of recurrent ectopic pregnancy with comprehensive traditional medicine therapy</TI>
<SO>Heilingjiang Medical Journal</SO>
<YR>2010</YR>
<VL>34</VL>
<NO>2</NO>
<PG>126-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hong-2004" NAME="Hong 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hong L, Liu YJ</AU>
<TI>The clinical observation of integrated traditional and Western medicine in the treatment for unruptured ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>11</NO>
<PG>1018-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hou-2005a" MODIFIED="2011-05-08 23:03:40 +1000" MODIFIED_BY="[Empty name]" NAME="Hou 2005a" YEAR="2005">
<REFERENCE MODIFIED="2011-05-08 21:51:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hou BP</AU>
<TI>Co-triplex drugs used in the treatment of unruptured tubal pregnancy</TI>
<SO>Maternal and Child Health Care of China</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>6</NO>
<PG>727-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hou-2008a" MODIFIED="2010-12-26 22:40:29 +1000" MODIFIED_BY="[Empty name]" NAME="Hou 2008a" YEAR="2008">
<REFERENCE MODIFIED="2010-12-08 01:17:36 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hou YM</AU>
<TI>The effect observation of conservative treatment for 102 cases ectopic pregnancy</TI>
<SO>Hebei Medical Journal</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>5</NO>
<PG>652-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-2000" MODIFIED="2010-12-30 01:28:46 +1000" MODIFIED_BY="[Empty name]" NAME="Hu 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-12-30 01:28:46 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hu XH, Li WH</AU>
<TI>The understanding of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Information on TCM</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>10</NO>
<PG>56-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-2001" NAME="Hu 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hu LQ, Yang JZ</AU>
<TI>The effect analysis of methotrexate combined with traditional Chinese medicine treating ectopic pregnancy</TI>
<SO>Journal of Gannan Medical College</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>3</NO>
<PG>331-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-2008" MODIFIED="2010-12-29 23:40:36 +1000" MODIFIED_BY="[Empty name]" NAME="Hu 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-12-29 23:40:36 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hu MH</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Proceeding of Clinical Medicine</SO>
<YR>2008</YR>
<VL>1</VL>
<NO>6</NO>
<PG>155-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hua-2009" MODIFIED="2011-01-17 01:35:58 +1000" MODIFIED_BY="[Empty name]" NAME="Hua 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-17 01:35:58 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hua XY,Li YX,Hu YG,Shang JW,Zhang JF</AU>
<TI>Traditional Chinese medicine combined with western medicine in the treatment for 36 cases of ectopic pregnancy</TI>
<SO>Journal GanSu College of Traditional Medicine</SO>
<YR>2009</YR>
<VL>26</VL>
<NO>2</NO>
<PG>33-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-1999" MODIFIED="2011-05-08 21:52:34 +1000" MODIFIED_BY="[Empty name]" NAME="Huang 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-05-08 21:52:34 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang AP</AU>
<TI>The effect observation of methotrexate intravenous injection combined with traditional Chinese medicine in the conservative treatment of ectopic pregnancy</TI>
<SO>Journal of Guangdong Medical College</SO>
<YR>1999</YR>
<VL>17</VL>
<NO>3</NO>
<PG>259-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2000" NAME="Huang 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Huang Y, Gu CW</AU>
<TI>Single dose of methotrexate combined with traditional Chinese medicine in the treatment for unruptured ectopic pregnancy</TI>
<SO>Journal of Sichuan Continuing Education College of Medical Science</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>3</NO>
<PG>175-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2004" NAME="Huang 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang JM</AU>
<TI>The clinical observation of traditional Chinese Medicine combined with methotrexate by intramuscular injection in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Clinical Medical Research</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>89</NO>
<PG>1079-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2006" MODIFIED="2011-01-17 01:41:56 +1000" MODIFIED_BY="[Empty name]" NAME="Huang 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-01-17 01:41:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang ZJ,Tan QW,Chen RQ</AU>
<TI>The study on the clinical effect of the method of partial injection of methotrexate with Chinese native medicine treatment for curing tubal pregnancy.</TI>
<SO>Journal of Clinical and Experimental Medicine</SO>
<YR>2006</YR>
<VL>5</VL>
<NO>8</NO>
<PG>1081-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2008" MODIFIED="2011-01-17 03:03:40 +1000" MODIFIED_BY="[Empty name]" NAME="Huang 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 03:03:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang PY</AU>
<TI>The clinical analysis of methotrexate intramuscular injection combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Community Doctor</SO>
<YR>2008</YR>
<VL>10</VL>
<NO>184</NO>
<PG>82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huo-2005b" MODIFIED="2011-05-08 23:03:53 +1000" MODIFIED_BY="[Empty name]" NAME="Huo 2005b" YEAR="2005">
<REFERENCE MODIFIED="2011-05-08 21:53:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huo J</AU>
<TI>The clinical observation of traditional Chinese medicine combined with Western medicine in the treatment for 140 cases of ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>10</NO>
<PG>1266</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huo-2008b" MODIFIED="2010-12-26 22:45:09 +1000" MODIFIED_BY="[Empty name]" NAME="Huo 2008b" YEAR="">
<REFERENCE MODIFIED="2010-12-26 22:45:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huo DZ,He JM</AU>
<TI>Mifepristone combined with TCD( Traditional Chinese Drug) treat tubal pregnancy</TI>
<SO>Journal of Zhejiang University of Traditional Chinese Medicine</SO>
<YR>2008</YR>
<VL>32</VL>
<NO>2</NO>
<PG>191-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ji-2001" MODIFIED="2010-12-30 02:03:10 +1000" MODIFIED_BY="[Empty name]" NAME="Ji 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-12-30 02:03:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ji LP, Xi YL</AU>
<TI>The clinical analysis of methotrexate combined with traditional Chinese medicine in the treatment for 30 cases of ectopic pregnancy</TI>
<SO>Journal of Shanxi Medical University</SO>
<YR>2001</YR>
<VL>32</VL>
<NO>1</NO>
<PG>66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ji-2002" NAME="Ji 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ji QX</AU>
<TI>The comparison of three kinds of drug treatments for ectopic pregnancy</TI>
<SO>Journal of Chinese Physician</SO>
<YR>2002</YR>
<VL>4</VL>
<NO>11</NO>
<PG>1274-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiang-2003" MODIFIED="2010-12-30 02:07:26 +1000" MODIFIED_BY="[Empty name]" NAME="Jiang 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-12-30 02:07:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiang FL</AU>
<TI>The clinical effective of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>American Journal Chinese Medicine</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>1</NO>
<PG>41-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiang-2004" MODIFIED="2011-01-02 00:05:47 +1000" MODIFIED_BY="[Empty name]" NAME="Jiang 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-02 00:05:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiang XX, Kong XL</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy in 20 cases</TI>
<SO>Shandong Journal of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>5</NO>
<PG>292-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiang-2007" MODIFIED="2010-12-12 13:33:11 +1000" MODIFIED_BY="[Empty name]" NAME="Jiang 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-12-12 13:33:11 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiang WH</AU>
<TI>The effect observation of mifepristone combined with methotrexate and traditional Chinese medicine in the conservative treatment for ectopic pregnancy</TI>
<SO>Anhui Medical and Pharmaceutical Journal</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>6</NO>
<PG>509</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jin-2007a" MODIFIED="2010-12-12 22:25:10 +1000" MODIFIED_BY="[Empty name]" NAME="Jin 2007a" YEAR="">
<REFERENCE MODIFIED="2010-12-12 22:25:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jin XX</AU>
<TI>Choice of different drug treatment and operation opportunity about heterotopic pregnancy</TI>
<SO>Journal North China Coal Medical College</SO>
<YR>2007</YR>
<VL>9</VL>
<NO>6</NO>
<PG>767-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jin-2007b" MODIFIED="2010-12-12 02:57:59 +1000" MODIFIED_BY="[Empty name]" NAME="Jin 2007b" YEAR="">
<REFERENCE MODIFIED="2010-12-12 02:57:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jin M</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine or methotrexate used alone in the treatment for ectopic pregnancy</TI>
<SO>China Healthcare Innovation</SO>
<YR>2007</YR>
<VL>1</VL>
<NO>2</NO>
<PG>83-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jin-2007c" MODIFIED="2011-01-17 01:42:25 +1000" MODIFIED_BY="[Empty name]" NAME="Jin 2007c" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 01:42:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jin XX</AU>
<TI>Observation on the curative effect of methotrexate combined with mifepristone and Chinese crude drug in the treatment of ectopic pregnancy</TI>
<SO>China Contemporary Medcine</SO>
<YR>2007</YR>
<NO>19</NO>
<PG>6-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuang-2008a" MODIFIED="2010-12-12 15:21:07 +1000" MODIFIED_BY="[Empty name]" NAME="Kuang 2008a" YEAR="">
<REFERENCE MODIFIED="2010-12-12 15:21:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuang FX</AU>
<TI>The effect observation of three drugs for ectopic pregnancy</TI>
<SO>Guiding Journal of Chinese Traditional Medicind</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>2</NO>
<PG>39-40,46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuang-2008b" MODIFIED="2010-12-24 00:24:42 +1000" MODIFIED_BY="[Empty name]" NAME="Kuang 2008b" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 13:11:28 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuang GR,Lei L,Xu Y</AU>
<TI>The clinical application of mifepristone combined with traditional Chinese medicine in the conservative treatment for ectopic pregnancy</TI>
<SO>Journal of Clinical and Experimental Medicine</SO>
<YR>2008</YR>
<VL>7</VL>
<NO>7</NO>
<PG>132</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lei-2005" NAME="Lei 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lei SX, Sha JF, Zhou Q</AU>
<TI>The clinical observation of traditional Chinese medicine combined with mifepristone in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2005</YR>
<VL>25</VL>
<NO>12</NO>
<PG>1073</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2001a" NAME="Li 2001a" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li P</AU>
<TI>The report of mifepristone combined with traditional Chinese medicine in the treatment for 40 cases of ectopic pregnancy</TI>
<SO>Guangxi Medical Journal</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>5</NO>
<PG>1296-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2001b" NAME="Li 2001b" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li SP</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 40 cases of ectopic pregnancy</TI>
<SO>Journal of Practical Traditional Chinese Medicine</SO>
<YR>2001</YR>
<VL>17</VL>
<NO>3</NO>
<PG>22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2003" MODIFIED="2011-05-08 21:53:59 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-05-08 21:53:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li Y, Xiang XH</AU>
<TI>The clinical observation of traditional Chinese medicine combined with Western medicine in the treatment for 42 cases of ectopic pregnancy</TI>
<SO>Yunan Journal of Traditional Chinese Medicine and Materia Medica</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>3</NO>
<PG>20-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004a" NAME="Li 2004a" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li SY</AU>
<TI>Mifepristone united traditional Chinese medicine treating ectopic pregnancy of clinical analysis</TI>
<SO>Chinese Journal of the Practical Chinese with Modern Medicine</SO>
<YR>2004</YR>
<VL>4</VL>
<NO>17</NO>
<PG>419-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004b" NAME="Li 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li J</AU>
<TI>The clinical research of traditional Chinese medicine combined with mifepristone in the treatment for ectopic pregnancy</TI>
<SO>Hebei Journal of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>26</VL>
<NO>11</NO>
<PG>857-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004d" MODIFIED="2011-02-01 02:37:32 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2004d" YEAR="2004">
<REFERENCE MODIFIED="2011-01-02 00:45:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li RH</AU>
<TI>The analysis of mifepristone combined with traditional Chinese medicine in the treatment for 30 cases of ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2004</YR>
<VL>13</VL>
<NO>17</NO>
<PG>2246</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004e" NAME="Li 2004e" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li P</AU>
<TI>The effect comparison of three kinds of conservative treatments for ectopic pregnancy</TI>
<SO>Journal of Guangxi Medical University</SO>
<YR>2004</YR>
<VL>21</VL>
<NO>1</NO>
<PG>59-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004f" NAME="Li 2004f" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li SF</AU>
<TI>The clinical comparison of two kinds of drug treatments for ectopic pregnancy</TI>
<SO>Clinical Medicine</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>12</NO>
<PG>43-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004g" MODIFIED="2011-05-08 21:55:53 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2004g" YEAR="2004">
<REFERENCE MODIFIED="2011-05-08 21:55:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li RL, Zhao J</AU>
<TI>The comparison of two kinds of treatments of traditional Chinese medicine combined with Western medicine for ectopic pregnancy</TI>
<SO>Acta Chinese Medicine and Pharmacology</SO>
<YR>2004</YR>
<VL>32</VL>
<NO>1</NO>
<PG>26-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2004h" NAME="Li 2004h" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li SH, Sun TX, Wang DL</AU>
<TI>Traditional Chinese medicine combined with methotrexate in the treatment for 44 cases of ectopic pregnancy</TI>
<SO>China's Naturopathy</SO>
<YR>2004</YR>
<VL>12</VL>
<NO>10</NO>
<PG>56-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2005a" MODIFIED="2011-05-08 21:56:40 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2005a" YEAR="2004">
<REFERENCE MODIFIED="2011-05-08 21:56:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li T, Shi L, Feng DL</AU>
<TI>The effect of combining traditional Chinese medicine and Western medicine to treat ectopic pregnancy</TI>
<SO>Study Journal of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>4</NO>
<PG>741-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2005b" MODIFIED="2011-01-02 02:02:01 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2005b" YEAR="2005">
<REFERENCE MODIFIED="2011-01-02 02:02:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li LL</AU>
<TI>The observation of traditional Chinese medicine combined with Western medicine in the treatment for 30 cases of ectopic pregnancy</TI>
<SO>Journal of Practical Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>12</NO>
<PG>737</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2006" MODIFIED="2010-12-24 00:18:46 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-12-24 00:18:46 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li XF,Wu J,Li H</AU>
<TI>The effect of traditional Chinese medicine on preserving fertility in laparoscopic surgery treated tubal pregnancy patients</TI>
<SO>Journal South Medicine University</SO>
<YR>2006</YR>
<VL>26</VL>
<NO>6</NO>
<PG>790-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2007" MODIFIED="2011-01-29 23:28:59 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-29 23:28:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li QM</AU>
<TI>The effect observation of two kinds of methods in the conservation treatment of ectopic pregnancy</TI>
<SO>China Foreign Medical Treatment</SO>
<YR>2007</YR>
<VL>24</VL>
<NO>24</NO>
<PG>4-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2008a" MODIFIED="2010-12-24 00:25:06 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2008a" YEAR="2008">
<REFERENCE MODIFIED="2010-12-11 19:40:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li MX</AU>
<TI>Methotrexate combined with traditional Chinese medicine in the treatment for 34 cases ectopic pregnancy</TI>
<SO>Henan Traditional Chinese Medicine</SO>
<YR>2008</YR>
<VL>28</VL>
<NO>9</NO>
<PG>70-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2008b" MODIFIED="2011-01-17 01:42:50 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2008b" YEAR="">
<REFERENCE MODIFIED="2011-01-17 01:42:50 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li L,Zhou ZX,Gao X</AU>
<TI>An analysis on the effectiveness of traditional Chinese Medicine in preventing persist ectopic pregnancy after laparoscopic operation</TI>
<SO>Journal of Minmially Invasive Medcine,</SO>
<YR>2008</YR>
<VL>3</VL>
<NO>5</NO>
<PG>443-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2008c" MODIFIED="2010-12-12 04:20:29 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2008c" YEAR="">
<REFERENCE MODIFIED="2010-12-12 04:20:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li P</AU>
<TI>The clinical observation of two kinds of methods in the conservation treatment for 102 cases of ectopic pregnancy</TI>
<SO>Guide of China Medicine</SO>
<YR>2008</YR>
<VL>6</VL>
<NO>24</NO>
<PG>88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2008d" MODIFIED="2010-12-12 12:55:33 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2008d" YEAR="">
<REFERENCE MODIFIED="2010-12-12 12:55:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li MQ</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine or methotrexate alone used in the treatment for ectopic pregnancy</TI>
<SO>Chinese Medicine of Factory and Mine</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>5</NO>
<PG>605</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2009" MODIFIED="2011-01-24 04:03:10 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2009" YEAR="">
<REFERENCE MODIFIED="2011-01-24 04:03:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li JE</AU>
<TI>The clinical observation of traditional Chinese medicine combined with Western medicine in the treatment for 50 cases of ectopic pregnancy</TI>
<SO>Chinese journal of ethnomedicine and ethnopharmacy</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>24</NO>
<PG>132</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2009b" MODIFIED="2011-05-08 21:57:07 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2009b" YEAR="2009">
<REFERENCE MODIFIED="2011-05-08 21:57:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li YH,Zhou XM,Ye ZG,Peng BL,Ren DJ,Huang HY</AU>
<TI>Effect of nursing and combination therapy with methotrexate and traditional Chinese medicine on ectopic re pregnancy after tubal pregnancy</TI>
<SO>Journal of Hainan Medical College</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>7</NO>
<PG>801-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2010" MODIFIED="2011-05-08 21:59:09 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-05-08 21:59:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li XF</AU>
<TI>The analysis of mifepristone combined with traditional Chinese medicine in the treatments for 32 cases ectopic pregnancy</TI>
<SO>China Practical Medicine</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>13</NO>
<PG>150-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang-2004" MODIFIED="2011-01-02 02:21:51 +1000" MODIFIED_BY="[Empty name]" NAME="Liang 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-02 02:21:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liang SL, Luo LP, Li YJ</AU>
<TI>The clinical analysis of mifepristone combined with traditional Chinese medicine in the treatment for 23 cases of ectopic pregnancy</TI>
<SO>Journal of Chinese Clinical Medicine Research</SO>
<YR>2004</YR>
<VL>124</VL>
<PG>136-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang-2009" MODIFIED="2010-12-08 01:41:29 +1000" MODIFIED_BY="[Empty name]" NAME="Liang 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-08 01:41:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liang XK, Zhang Y</AU>
<TI>Small dose of intramuscular methotrexate combined with traditional Chinese medicine in the course treatment for unruptured ectopic pregnancy</TI>
<SO>Journal of Liao Ning Medical</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>2</NO>
<PG>102-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liao-2001" MODIFIED="2011-01-02 02:23:41 +1000" MODIFIED_BY="[Empty name]" NAME="Liao 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-01-02 02:23:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liao XQ</AU>
<TI>The analysis of methotrexate intramuscular injection combined with traditional Chinese medicine in the treatment for 18 cases of ectopic pregnancy</TI>
<SO>Journal of Youjiang Medical College for Nationalities</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>4</NO>
<PG>590-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-2007" MODIFIED="2010-12-12 03:58:25 +1000" MODIFIED_BY="[Empty name]" NAME="Lin 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-12-12 03:58:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lin L</AU>
<TI>The effect observation of two kinds of methods in the conservation treatment of ectopic pregnancy</TI>
<SO>China Practial Medicine</SO>
<YR>2007</YR>
<VL>2</VL>
<NO>7</NO>
<PG>99-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ling-2003" NAME="Ling 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ling CB</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine for treating ectopic pregnancy</TI>
<SO>Guangxi Journal of Traditional Chinese Medicine</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>3</NO>
<PG>25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ling-2005" NAME="Ling 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ling WL, Wu XY</AU>
<TI>Clinical study of co-triplex drugs used in treatment of ectopic pregnancy</TI>
<SO>Maternal and Child Health Care of China</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>9</NO>
<PG>1120-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-1999a" NAME="Liu 1999a" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu YJ, Nong WZ</AU>
<TI>The clinical comparison of single-dose methotrexate intramuscular injection or combined with traditional Chinese medicine</TI>
<SO>Guangxi Medical Journal</SO>
<YR>1999</YR>
<VL>21</VL>
<NO>2</NO>
<PG>344-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-1999b" NAME="Liu 1999b" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu YH, Yang BL, Wang YH</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Critical Care Medicine</SO>
<YR>1999</YR>
<VL>7</VL>
<PG>415</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2001" NAME="Liu 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu ML, Xiong HJ</AU>
<TI>The effect observation of two kinds of drug conservative treatment for ectopic pregnancy</TI>
<SO>Journal of North China Coal Medical College</SO>
<YR>2001</YR>
<VL>3</VL>
<NO>1</NO>
<PG>83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2003" MODIFIED="2011-01-17 01:52:37 +1000" MODIFIED_BY="[Empty name]" NAME="Liu 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-01-17 01:52:37 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu YJ, Liu XH</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Medical Forum</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>13</NO>
<PG>43-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2004a" NAME="Liu 2004a" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu CF, Xia FY, Xing J</AU>
<TI>Cannula injection drug by hysteroscope combined with traditional Chinese medicine treating tubal pregnancy</TI>
<SO>Journal of Sichuan of Traditonal Chinese Medicine</SO>
<YR>2004</YR>
<VL>22</VL>
<NO>11</NO>
<PG>66-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2004b" NAME="Liu 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu M, Huang XQ</AU>
<TI>The analysis of mifepristone combined with methotrexate in the treatment for 42 cases of ectopic pregnancy</TI>
<SO>Qingdao Medical Journal</SO>
<YR>2004</YR>
<VL>36</VL>
<NO>4</NO>
<PG>263-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2004c" NAME="Liu 2004c" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu XF</AU>
<TI>The effect observation of treatment based on syndrome differentiation for ectopic pregnancy</TI>
<SO>Liaoning Journal of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>31</VL>
<NO>10</NO>
<PG>846</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2006" MODIFIED="2010-12-08 01:04:25 +1000" MODIFIED_BY="[Empty name]" NAME="Liu 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-12-08 01:04:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu XH, Xiao YL</AU>
<TI>The clinical effect observation of methotrexate combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>Chong Qing Medicine</SO>
<YR>2006</YR>
<VL>35</VL>
<NO>21</NO>
<PG>1988-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2009a" MODIFIED="2010-12-12 15:04:32 +1000" MODIFIED_BY="[Empty name]" NAME="Liu 2009a" YEAR="">
<REFERENCE MODIFIED="2010-12-12 15:04:32 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu YY</AU>
<TI>The clinical effect observation of mifepristone combined with traditional Chinese medicine and microwave in the treatment for 50 cases of ectopic pregnancy</TI>
<SO>Contemporary Medicine</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>19</NO>
<PG>68-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2009b" MODIFIED="2010-12-24 00:25:55 +1000" MODIFIED_BY="[Empty name]" NAME="Liu 2009b" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 02:47:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu HF</AU>
<TI>The clinical observation of methotrexate combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>International Medicine &amp; Health Guidance News</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>10</NO>
<PG>74-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2010" MODIFIED="2010-12-12 01:58:33 +1000" MODIFIED_BY="[Empty name]" NAME="Liu 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-12-12 01:58:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu FJ</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Journal of Practical Traditional Chinese Medicine</SO>
<YR>2010</YR>
<VL>26</VL>
<NO>4</NO>
<PG>249</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2000a" NAME="Lu 2000a" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu SH</AU>
<TI>The analysis of therapeutic effects of MTX and Chinese medicine No. 2 for the treatment of tubal pregnancy</TI>
<SO>Medical Journal of Casc Industry</SO>
<YR>2000</YR>
<VL>2</VL>
<NO>1</NO>
<PG>28-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2000b" MODIFIED="2011-05-08 21:59:27 +1000" MODIFIED_BY="[Empty name]" NAME="Lu 2000b" YEAR="2000">
<REFERENCE MODIFIED="2011-05-08 21:59:27 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu XF</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine treating 88 cases of ectopic pregnancy</TI>
<SO>Medical Journal of Casc industry</SO>
<YR>2000</YR>
<VL>2</VL>
<NO>4</NO>
<PG>60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2001" MODIFIED="2011-01-17 01:54:58 +1000" MODIFIED_BY="[Empty name]" NAME="Lu 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-01-17 01:54:58 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu GF</AU>
<TI>Protein of Trichosanthin combined with traditional Chinese medicine in the treatment for ectopic pregnancy (an analysis of 44 cases)</TI>
<SO>Journal Traditional of Chinese Medicine</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>92</NO>
<PG>57-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2002" MODIFIED="2011-01-02 02:42:51 +1000" MODIFIED_BY="[Empty name]" NAME="Lu 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-02 02:42:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu LJ, Jin XR</AU>
<TI>The effect observation of drug treatment for ectopic pregnancy</TI>
<SO>Zhejiang Medical Journal</SO>
<YR>2002</YR>
<VL>24</VL>
<NO>11</NO>
<PG>694-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2004" MODIFIED="2011-01-02 02:45:09 +1000" MODIFIED_BY="[Empty name]" NAME="Lu 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-02 02:45:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu JM</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 38 cases of ectopic pregnancy</TI>
<SO>Chinese Journal of Reproductive Health</SO>
<YR>2004</YR>
<VL>15</VL>
<NO>6</NO>
<PG>354-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luo-2000" MODIFIED="2011-01-02 02:47:54 +1000" MODIFIED_BY="[Empty name]" NAME="Luo 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-01-02 02:47:54 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luo L</AU>
<TI>The effect observation of traditional Chinese medicine combined with methotrexate in the treatment for ectopic pregnancy</TI>
<SO>Journal of Sichuan Continuing Education College of Medical Sciences</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>4</NO>
<PG>271,273</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luo-2003" NAME="Luo 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luo DF, Zhang JP, Chen YG</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine in the treatment for 33 cases of ectopic pregnancy</TI>
<SO>New Journal of Traditional Chinese Medicine</SO>
<YR>2003</YR>
<VL>35</VL>
<NO>12</NO>
<PG>39-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luo-2005" MODIFIED="2011-02-01 02:39:09 +1000" MODIFIED_BY="[Empty name]" NAME="Luo 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-02 02:49:23 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luo J, Liu L</AU>
<TI>The comparison of three conservative treatments for ectopic pregnancy</TI>
<SO>Journal of Clinical Research</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>3</NO>
<PG>356-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luo-2006" MODIFIED="2010-12-11 18:02:38 +1000" MODIFIED_BY="[Empty name]" NAME="Luo 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-12-11 18:02:38 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luo ZM</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Hainan Medical Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>1</NO>
<PG>93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2003" NAME="Ma 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ma SX</AU>
<TI>The observation and nursing of conservative treatment for ectopic pregnancy</TI>
<SO>Shandong Medical Journal</SO>
<YR>2003</YR>
<VL>43</VL>
<NO>26</NO>
<PG>64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2008" MODIFIED="2011-01-17 01:56:17 +1000" MODIFIED_BY="[Empty name]" NAME="Ma 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 01:56:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ma XL</AU>
<TI>Clinical observation on mifepristone combined with Chinese herbs in treating ectopic pregnancy</TI>
<SO>Shanghai Journal Traditional Chinese Medicine</SO>
<YR>2009</YR>
<VL>43</VL>
<NO>1</NO>
<PG>52-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mao-2004" MODIFIED="2011-01-02 02:54:32 +1000" MODIFIED_BY="[Empty name]" NAME="Mao 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-02 02:54:32 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mao LF, Liu LB, Yang HF</AU>
<TI>The observation of the conservative treatment for 114 cases of tubal pregnancy</TI>
<SO>Medicine and Pharmacy of Yunnan</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>1</NO>
<PG>50-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mei-2005" MODIFIED="2011-01-02 02:56:00 +1000" MODIFIED_BY="[Empty name]" NAME="Mei 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-02 02:56:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mei RS</AU>
<TI>The clinical analysis of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Study Journal of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>7</NO>
<PG>1345-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meng-2000" NAME="Meng 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meng XH, Sui XJ, Zhang JM</AU>
<TI>The clinical observation of traditional Chinese medicine combined with Western medicine in the conservative treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Coal Industry Medicine</SO>
<YR>2000</YR>
<VL>3</VL>
<NO>10</NO>
<PG>1071</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meng-2005" NAME="Meng 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meng QF, Sheng XY</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 20 cases of ectopic pregnancy</TI>
<SO>Chinese Journal of Surgery of Integrated Traditional and Western Medicine</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>4</NO>
<PG>321-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mo-2007" MODIFIED="2011-01-17 01:56:41 +1000" MODIFIED_BY="[Empty name]" NAME="Mo 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 01:56:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mo DM,Hai HL,Zhang H</AU>
<TI>The clinical observation of traditional Chinese medicine combined with western medicine in the treatment for 32 cases ectopic pregnancy</TI>
<SO>China Medical HeraldMEDICAL HERALD</SO>
<YR>2007</YR>
<VL>4</VL>
<NO>2</NO>
<PG>72,86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ni-2010" MODIFIED="2010-12-12 14:29:28 +1000" MODIFIED_BY="[Empty name]" NAME="Ni 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-12-12 14:29:28 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ni XR,Chen RD</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>China Practical Medcal</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>8</NO>
<PG>132-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pan-2007" MODIFIED="2011-01-02 03:00:08 +1000" MODIFIED_BY="[Empty name]" NAME="Pan 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-02 03:00:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pan YP</AU>
<TI>The clinical analysis of conservative treatment for 60 cases of ectopic pregnancy</TI>
<SO>China Practical Medicine</SO>
<YR>2007</YR>
<VL>12</VL>
<NO>32</NO>
<PG>114-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peng-1997" NAME="Peng 1997" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peng LX</AU>
<TI>Three expectant treatments for ectopic pregnancy (including the analysis of 97cases)</TI>
<SO>Guangxi Medical Journal</SO>
<YR>1997</YR>
<VL>19</VL>
<NO>5</NO>
<PG>752-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qi-2000" NAME="Qi 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qi XX, Xie ZQ, Zhao L, Zhen P</AU>
<TI>The initial approach of traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Sichuan Continuing Education College of Medical Sciences</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>2</NO>
<PG>110-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qian-2008" MODIFIED="2011-01-31 04:46:13 +1000" MODIFIED_BY="[Empty name]" NAME="Qian 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-31 04:46:13 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qian L</AU>
<TI>The effect observation of traditional Chinese medicine combined with western medicine in the conservation treatment for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>17</NO>
<PG>2641-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qin-2001" MODIFIED="2011-05-08 21:59:44 +1000" MODIFIED_BY="[Empty name]" NAME="Qin 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-05-08 21:59:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qin CY, Wang Y, Ding HY</AU>
<TI>The clinical observation of methotrexate combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Birth Health &amp; Heredity</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>6</NO>
<PG>37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qin-2008" MODIFIED="2011-05-08 22:00:03 +1000" MODIFIED_BY="[Empty name]" NAME="Qin 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-05-08 22:00:03 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qin LH,Shang JB</AU>
<TI>The effect comparison of different conservation treatment for early tubal pregnancy</TI>
<SO>Hebei Journal Traditional Chinese Medicine</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>3</NO>
<PG>253-254</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qiu-2006" MODIFIED="2011-01-17 01:57:45 +1000" MODIFIED_BY="[Empty name]" NAME="Qiu 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-01-17 01:57:45 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qiu CH,Zhu XY</AU>
<TI>The effect of traditional Chinese medicine on MTX in the treatment for unruptured ectopic pregnancy</TI>
<SO>Clinical Journal of Traditional Chinese Medicine</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>2</NO>
<PG>163-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qu-2004" MODIFIED="2011-01-02 03:11:19 +1000" MODIFIED_BY="[Empty name]" NAME="Qu 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-02 03:11:19 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qu LP, Guo YW</AU>
<TI>Comparison the three kinds of methods for the treatment of tubal pregnancy</TI>
<SO>Hunan Guiding Journal of TCM</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>4</NO>
<PG>26-7,45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ren-2009a" MODIFIED="2010-12-24 00:43:21 +1000" MODIFIED_BY="[Empty name]" NAME="Ren 2009a" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 01:41:32 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ren HW,Liu CL,Sun YP</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Journal of China-Japan Friendship Hospital</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>4</NO>
<PG>226-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ren-2009b" MODIFIED="2010-12-12 02:18:29 +1000" MODIFIED_BY="[Empty name]" NAME="Ren 2009b" YEAR="">
<REFERENCE MODIFIED="2010-12-12 02:18:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ren GX,Liu XX</AU>
<TI>The analysis of methotrexate combined with traditional Chinese medicine in the treatment for 85 cases of ectopic pregnancy</TI>
<SO>Medical Journal of Chinese People's Health</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>10</NO>
<PG>1133,1153</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shen-2008" MODIFIED="2010-12-12 02:51:17 +1000" MODIFIED_BY="[Empty name]" NAME="Shen 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 02:51:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shen Q</AU>
<TI>The clinical research of three drug methotrexate and mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Medicine of Factory and Mine</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>1</NO>
<PG>43-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-2000" MODIFIED="2011-01-02 03:13:51 +1000" MODIFIED_BY="[Empty name]" NAME="Shi 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-01-02 03:13:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi YQ</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine in the conservative treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Tradtional and Western Medicine</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>2</NO>
<PG>149-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-2004" MODIFIED="2011-05-08 22:00:28 +1000" MODIFIED_BY="[Empty name]" NAME="Shi 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-05-08 22:00:28 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi LL</AU>
<TI>The clinical observation of traditional Chinese medicine combined with Western medicine in the conservative treatment for ectopic pregnancy in 68 cases</TI>
<SO>Jiangsu Journal of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>11</NO>
<PG>35-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-2009" MODIFIED="2010-12-12 22:48:04 +1000" MODIFIED_BY="[Empty name]" NAME="Shi 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 22:48:04 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi F,Ye XP,Guo YL</AU>
<TI>The clinical observation of different methods using drug in the conservation treatment of ectopic pregnancy</TI>
<SO>Shan Xi Medical Journal</SO>
<YR>2009</YR>
<VL>38</VL>
<NO>7</NO>
<PG>895-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-2010" MODIFIED="2010-12-13 00:32:01 +1000" MODIFIED_BY="[Empty name]" NAME="Shi 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-12-13 00:32:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi XY</AU>
<TI>The effect observation of two methods in the conservative treatment for early ectopic pregnancy</TI>
<SO>Chinese Journal Modern Drug Apply</SO>
<YR>2010</YR>
<VL>4</VL>
<NO>11</NO>
<PG>63-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2000a" NAME="Song 2000a" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Song LX</AU>
<TI>The comparison of two kinds of drug treatments for ectopic pregnancy</TI>
<SO>Hebei Medical Journal</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>6</NO>
<PG>439-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2000b" MODIFIED="2011-05-08 22:00:48 +1000" MODIFIED_BY="[Empty name]" NAME="Song 2000b" YEAR="2000">
<REFERENCE MODIFIED="2011-05-08 22:00:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Song JR, Wang P, Tian JX</AU>
<TI>The observation of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy in 36 cases</TI>
<SO>Heilongjiang Medicine and Pharmacy</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>5</NO>
<PG>83-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2002" MODIFIED="2011-01-02 03:27:17 +1000" MODIFIED_BY="[Empty name]" NAME="Song 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-02 03:27:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Song HJ</AU>
<TI>The analysis of fours kinds of methods in the treatment of 183 cases of ectopic pregnancy</TI>
<SO>Medicine of Factory and Mine</SO>
<YR>2002</YR>
<VL>15</VL>
<NO>3</NO>
<PG>227-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2003" NAME="Song 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Song XL</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>Modern Medicine Health</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>3</NO>
<PG>310-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2004" NAME="Song 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Song XM</AU>
<TI>Traditional Chinese medicine combined with Western medicine treating 30 cases of ectopic pregnancy</TI>
<SO>Journal of Sichuan of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>22</VL>
<NO>8</NO>
<PG>66-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Su-2002" NAME="Su 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Su Y, Sun Y, Ma L, Zhang SX</AU>
<TI>Observation on treatment of ectopic pregnancy by combination therapy of Chinese herbal medicine with mifepristone or methotrexate</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>6</NO>
<PG>417-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Su-2005" MODIFIED="2011-01-17 01:58:29 +1000" MODIFIED_BY="[Empty name]" NAME="Su 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-17 01:58:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Su W</AU>
<TI>The clinical application of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Liaoning Journal of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>32</VL>
<NO>6</NO>
<PG>574-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Su-2006" MODIFIED="2011-01-31 04:46:52 +1000" MODIFIED_BY="[Empty name]" NAME="Su 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-01-31 04:46:52 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Su LY, Si XY, Ma GL</AU>
<TI>Research of Heterotopic Pregnancy Treated By TCM</TI>
<SO>Chinese Modern Traditional Chinese Medicine</SO>
<YR>2010</YR>
<VL>8</VL>
<NO>5</NO>
<PG>23,40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2003" MODIFIED="2011-01-03 19:42:47 +1000" MODIFIED_BY="[Empty name]" NAME="Sun 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-01-03 19:42:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun HJ, Zhang XY</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine in the treatment for 25 cases of ectopic pregnancy</TI>
<SO>Practical Journal of Rural Doctor</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>1</NO>
<PG>35-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2004" MODIFIED="2011-05-08 22:01:01 +1000" MODIFIED_BY="[Empty name]" NAME="Sun 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-05-08 22:01:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun JX, Wang HY, Liu JM</AU>
<TI>The clinical analysis of methotrexate combined with traditIonal Chinese medicine in the treatment for 32 cases of ectopic pregnancy</TI>
<SO>Journal of Linyi Medical College</SO>
<YR>2004</YR>
<VL>26</VL>
<NO>5</NO>
<PG>362-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2007a" MODIFIED="2011-01-17 03:04:33 +1000" MODIFIED_BY="[Empty name]" NAME="Sun 2007a" YEAR="">
<REFERENCE MODIFIED="2011-01-17 03:04:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun Y,Jin F</AU>
<TI>The clinical observation of traditional Chinese medicine combined with western medicine in the treatment for 57 cases ectopic pregnancy</TI>
<SO>Zhejiang Journal of Traditional Chinese Medicine</SO>
<YR>2007</YR>
<VL>42</VL>
<NO>9</NO>
<PG>527-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2007b" MODIFIED="2010-12-25 02:50:43 +1000" MODIFIED_BY="[Empty name]" NAME="Sun 2007b" YEAR="2007">
<REFERENCE MODIFIED="2010-12-25 02:50:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun FH</AU>
<TI>The use of mifepristone combined with traditional Chinese medicine in the conservative treatments for ectopic pregnancy</TI>
<SO>Chinese Community Doctors</SO>
<YR>2007</YR>
<VL>9</VL>
<NO>11</NO>
<PG>86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2009" MODIFIED="2010-12-11 19:33:17 +1000" MODIFIED_BY="[Empty name]" NAME="Tang 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-11 19:33:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tang J</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the conservative treatment for ectopic pregnancy</TI>
<SO>Journal of Guiyang College of Traditional Chinese Medicine</SO>
<YR>2009</YR>
<VL>31</VL>
<NO>1</NO>
<PG>45-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tian-2002a" MODIFIED="2011-05-08 22:01:47 +1000" MODIFIED_BY="[Empty name]" NAME="Tian 2002a" YEAR="2002">
<REFERENCE MODIFIED="2011-05-08 22:01:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tian XH, Song CG</AU>
<TI>The clinical observation of mifepristone combined with composition of traditional Chinese medicine for ectopic pregnancy in 45 cases</TI>
<SO>Medical Journal of Chinese Civil Administration</SO>
<YR>2002</YR>
<VL>14</VL>
<NO>4</NO>
<PG>211-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tian-2002b" MODIFIED="2011-01-03 20:14:48 +1000" MODIFIED_BY="[Empty name]" NAME="Tian 2002b" YEAR="2002">
<REFERENCE MODIFIED="2011-01-03 20:14:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tian JP</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Chinese Rural Physician</SO>
<YR>2002</YR>
<VL>18</VL>
<NO>19</NO>
<PG>28</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tian-2005" NAME="Tian 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tian XJ, Mi DH, Wang XR, Wei YH</AU>
<TI>The effective observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Academic Periodical of Changchun College of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>3</NO>
<PG>23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tian-2008" MODIFIED="2011-01-24 04:12:20 +1000" MODIFIED_BY="[Empty name]" NAME="Tian 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-24 04:12:20 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tian FY</AU>
<TI>Traditional Chinese medicine combined with methotrexate in the treatment for 33 cases of unruptured tubal pregnancy</TI>
<SO>Chinese Journal of Ethnomedicine and Ethnopharmacy</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>8</NO>
<PG>68-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2000a" NAME="Wang 2000a" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang FJ, Zhong WZ, Yu XY, Chen P</AU>
<TI>The clinical analysis of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Zhejiang Practical Medicine</SO>
<YR>2000</YR>
<VL>5</VL>
<NO>2</NO>
<PG>45-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2000b" MODIFIED="2011-01-17 01:59:48 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2000b" YEAR="2000">
<REFERENCE MODIFIED="2011-01-17 01:59:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang XM</AU>
<TI>Drug conservative treatment for ectopic pregnancy</TI>
<SO>Hebei Medicine</SO>
<YR>2000</YR>
<VL>6</VL>
<NO>7</NO>
<PG>592-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2001a" NAME="Wang 2001a" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang DX</AU>
<TI>The effective observation of mifepristone combined with traditional Chinese medicine in the treatment for 33 cases of ectopic pregnancy</TI>
<SO>Chinese Medical Therapy and Practice</SO>
<YR>2001</YR>
<VL>2001</VL>
<NO>7</NO>
<PG>854-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2001b" NAME="Wang 2001b" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang FG, Qi JP, Chen SL</AU>
<TI>The comparison of three kinds of drug treatments for ectopic pregnancy</TI>
<SO>Tianjin Journal of Traditional Chinese Medicine</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>6</NO>
<PG>9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2002" MODIFIED="2011-01-03 23:01:10 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-03 23:01:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang YJ</AU>
<TI>The clinical analysis of mifepristone combined with methotrexate in the treatment of 32 cases of ectopic pregnancy</TI>
<SO>Journal of Youjiang Medical College for Nationalities</SO>
<YR>2002</YR>
<VL>24</VL>
<NO>4</NO>
<PG>584-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2003a" MODIFIED="2011-02-01 02:41:35 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2003a" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang YL</AU>
<TI>The effective observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Traditional Chinese Medicine and Chinese Materia Medica of Jilin</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>11</NO>
<PG>27-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2003b" MODIFIED="2011-02-01 02:41:29 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2003b" YEAR="2003">
<REFERENCE MODIFIED="2011-01-03 23:04:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang ZY, Ni W</AU>
<TI>The clinical effective of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Chinese Medicine Research</SO>
<YR>2003</YR>
<VL>3</VL>
<NO>5</NO>
<PG>432-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2004a" MODIFIED="2011-01-03 22:11:16 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2004a" YEAR="2004">
<REFERENCE MODIFIED="2011-01-03 22:11:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang AL, Song RL</AU>
<TI>Combination of traditional Chinese medicine with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Birth Health &amp; Heredity</SO>
<YR>2004</YR>
<VL>12</VL>
<NO>3</NO>
<PG>91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2004b" MODIFIED="2011-05-08 22:02:02 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2004b" YEAR="2004">
<REFERENCE MODIFIED="2011-05-08 22:02:02 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang YF, Li MX, Gong Y</AU>
<TI>The analysis of methotrexate combined with tradItional Chinese medicine in the conservative treatment for 50 cases of ectopic pregnancy</TI>
<SO>Chinese General Practice</SO>
<YR>2004</YR>
<VL>7</VL>
<NO>4</NO>
<PG>269</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2004c" MODIFIED="2011-05-08 22:02:23 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2004c" YEAR="2004">
<REFERENCE MODIFIED="2011-05-08 22:02:23 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang SP, Wang JY, Sun Q, Xia CL</AU>
<TI>Methotrexate combined with traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Chinese Practice Journal of Rural Doctor</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>7</NO>
<PG>28</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2005a" MODIFIED="2011-01-03 22:58:20 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2005a" YEAR="2005">
<REFERENCE MODIFIED="2011-01-03 22:58:20 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang XG, Tao Y</AU>
<TI>Conservative treatment on stable tubal pregnancy by combining with traditional Chinese and Western medicine: an observation of 36 cases</TI>
<SO>Journal Gansu College of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>3</NO>
<PG>42-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2005b" MODIFIED="2011-01-03 23:26:13 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2005b" YEAR="2005">
<REFERENCE MODIFIED="2011-01-03 23:26:13 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang XY</AU>
<TI>Mifepristone combined with methotrexate and traditional Chinese medicine treating ectopic pregnancy</TI>
<SO>Jiangsu Medical Journal</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>12</NO>
<PG>951</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2005c" NAME="Wang 2005c" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang SX, Sun SY</AU>
<TI>The effect observation of traditional Chinese medicine combined with Western medicine in the treatment for 100 cases of ectopic pregnancy</TI>
<SO>Chinese Archives of Traditional Chinese Medicine</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>1</NO>
<PG>174</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006a" MODIFIED="2010-12-12 13:46:42 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2006a" YEAR="">
<REFERENCE MODIFIED="2010-12-12 13:46:42 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang LG</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Traditional Chinese Medicine</SO>
<YR>2006</YR>
<VL>26</VL>
<NO>3</NO>
<PG>27-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006b" MODIFIED="2010-12-24 02:27:22 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2006b" YEAR="2006">
<REFERENCE MODIFIED="2010-12-07 01:37:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang SM</AU>
<TI>The effective observation of conservation treatment 100 cases of ectopic pregnancy</TI>
<SO>China Practical Medcial</SO>
<YR>2006</YR>
<VL>1</VL>
<NO>4</NO>
<PG>101,08</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006c" MODIFIED="2010-12-26 23:17:28 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2006c" YEAR="">
<REFERENCE MODIFIED="2010-12-26 23:13:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang SM,Yang HM</AU>
<TI>The methotrexate and mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy.</TI>
<SO>Medical Information</SO>
<YR>2006</YR>
<VL>19</VL>
<NO>9</NO>
<PG>1647-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007a" MODIFIED="2010-12-12 14:24:44 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2007a" YEAR="">
<REFERENCE MODIFIED="2010-12-12 14:24:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang JC</AU>
<TI>The clinical observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>2</NO>
<PG>148-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007b" MODIFIED="2011-01-24 04:01:14 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2007b" YEAR="">
<REFERENCE MODIFIED="2011-01-24 04:01:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang LH</AU>
<TI>120 examples clinical analysis of two different medicine methods to treat tubal pregnancy</TI>
<SO>Contemporary Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>15</NO>
<PG>17-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007c" MODIFIED="2010-12-12 22:29:06 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2007c" YEAR="">
<REFERENCE MODIFIED="2010-12-12 22:29:06 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang RL</AU>
<TI>The clinical observation in treating ectopic pregnancy</TI>
<SO>Journal of Medical Forum</SO>
<YR>2007</YR>
<VL>28</VL>
<NO>9</NO>
<PG>48-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007d" MODIFIED="2011-01-17 02:00:33 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2007d" YEAR="">
<REFERENCE MODIFIED="2011-01-17 02:00:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang PP</AU>
<TI>The effect observation of Chinese medicine No.2 combined with methotrexate and mifepristone for the treatment of tubal pregnancy</TI>
<SO>Lishizhen Medicine and Materia Medica Research</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>9</NO>
<PG>2260</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007e" MODIFIED="2010-12-24 00:46:35 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2007e" YEAR="2007">
<REFERENCE MODIFIED="2010-12-11 18:08:45 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang LH</AU>
<TI>The clinical effect observation of methotrexate combined with traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>15</NO>
<PG>2068</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2008" MODIFIED="2011-01-17 02:01:26 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 02:01:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang QY,Dong SJ</AU>
<TI>The clinical observation of destroying embryo and resolving lump combined with methotrexate and mifepristone in treating ectopic pregnancy</TI>
<SO>Journal of Emergency in Traditional Chinese Medicine</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>5</NO>
<PG>618-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2009" MODIFIED="2010-12-12 03:11:38 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 03:11:38 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang YF</AU>
<TI>The Clinical observation of methotrexate combined with medicinal herbs in the treatment of ectopic pregnancy</TI>
<SO>China Modern Doctor</SO>
<YR>2009</YR>
<VL>47</VL>
<NO>3</NO>
<PG>21-2,24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2010a" MODIFIED="2011-01-17 02:01:41 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2010a" YEAR="">
<REFERENCE MODIFIED="2011-01-17 02:01:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang Q</AU>
<TI>Traditional Chinese medicine combined with western medicine in the treatment for 34 cases of ectopic pregnancy</TI>
<SO>Chinese Medicine Modern Distance Education of China</SO>
<YR>2010</YR>
<VL>8</VL>
<NO>11</NO>
<PG>55-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2010b" MODIFIED="2010-12-24 00:46:45 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2010b" YEAR="2010">
<REFERENCE MODIFIED="2010-12-07 02:08:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang CX, Wang XM, Jia GL</AU>
<TI>The clinical observation of methotrexate combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>8</NO>
<PG>942-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-1999" NAME="Wei 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wei X, Lin RF, Song M</AU>
<TI>Clinical study of Sanjie Shapei Heji applied in the treatment of early ectopic pregnancy</TI>
<SO>Henan Traditional Chinese Medicine</SO>
<YR>1999</YR>
<VL>19</VL>
<NO>2</NO>
<PG>21-3,72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2002" NAME="Wei 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wei LQ, Tang XH</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy in 53 cases</TI>
<SO>Shanxi Journal of Traditonal Chinese Medicine</SO>
<YR>2002</YR>
<VL>23</VL>
<NO>11</NO>
<PG>965-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2003" NAME="Wei 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wei FY, Chen HF</AU>
<TI>Clinical analysis of 82 cases of ectopic pregnancy treated by methotrexate combined with traditional Chinese recipe</TI>
<SO>Journal of Chinese Integrative Medicine</SO>
<YR>2003</YR>
<VL>1</VL>
<NO>4</NO>
<PG>267, 292</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wen-2005" MODIFIED="2011-05-08 22:02:34 +1000" MODIFIED_BY="[Empty name]" NAME="Wen 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-05-08 22:02:34 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wen WL, Wang H, Sun F</AU>
<TI>A gestation medicine cures three kinds of methods curative effect observation</TI>
<SO>International Medicine &amp; Health Guidance News</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>14</NO>
<PG>87-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2001" MODIFIED="2011-05-08 22:02:59 +1000" MODIFIED_BY="[Empty name]" NAME="Wu 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-05-08 22:02:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu YD, Liu B, Tang XX</AU>
<TI>The comparison of three kinds of drug treatments for ectopic pregnancy</TI>
<SO>Heilongjiang Medicine and Pharmacy</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>4</NO>
<PG>82-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2002" NAME="Wu 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu XF</AU>
<TI>Traditional Chinese medicine combined with methotrexate in the treatment for ectopic pregnancy</TI>
<SO>Primary Journal of Chinese Materia Medica</SO>
<YR>2002</YR>
<VL>16</VL>
<NO>5</NO>
<PG>60-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2004a" NAME="Wu 2004a" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wu J, Song YM</AU>
<TI>Combination of MTX and traditional Chinese medicine treating ectopic pregnancy</TI>
<TO>Combination of MAX and traditional Chinese medicine treating ectopic pregnancy</TO>
<SO>Chinese Journal of Family Planning</SO>
<YR>2004</YR>
<VL>104</VL>
<NO>6</NO>
<PG>361-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2004b" NAME="Wu 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu JX, Teng W, Zhao CL</AU>
<TI>Methotrexate combined with traditional Chinese medicine in the treatment for 18 cases of unruptured tubal pregnancy</TI>
<SO>Shanxi Journal of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>11</NO>
<PG>991-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2004c" NAME="Wu 2004c" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu YZ, Ye XC, Lin XE</AU>
<TI>The effect observation of conservative treatment for ectopic pregnancy</TI>
<SO>Strait Pharmaceutical Journal</SO>
<YR>2004</YR>
<VL>16</VL>
<NO>5</NO>
<PG>121-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2009" MODIFIED="2010-12-12 14:06:27 +1000" MODIFIED_BY="[Empty name]" NAME="Wu 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 14:06:27 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu FY</AU>
<TI>Comparative studies on ectopic pregnancy by mifepristone combined with herbal ectopic pregnancy II or MTX</TI>
<SO>Journal of Heze Medical College</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>1</NO>
<PG>20-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xiong-2001" MODIFIED="2011-01-04 23:46:15 +1000" MODIFIED_BY="[Empty name]" NAME="Xiong 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-01-04 23:46:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xiong DM, Li H</AU>
<TI>The clinical analysis of conservative treatment for 120 cases of ectopic pregnancy</TI>
<SO>Shenzhen Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2001</YR>
<VL>11</VL>
<NO>1</NO>
<PG>41-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xiong-2005" NAME="Xiong 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xiong JM, He M</AU>
<TI>Clinical analysis of traditional Chinese medicine combined with methotrexate in the treatment for 80 cases of ectopic pregnancy</TI>
<SO>Modern Medicine Health</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>17</NO>
<PG>2284</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xu-2001" MODIFIED="2011-01-17 02:41:35 +1000" MODIFIED_BY="[Empty name]" NAME="Xu 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-01-17 02:41:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xu CH, Lin JP, He DQ</AU>
<TI>The clinical observation of compound recipe for 40 cases of ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>17</NO>
<PG>1641-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xu-2005" NAME="Xu 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xu ZF, Liu XT</AU>
<TI>Traditional Chinese medicine in the treatment for 60 cases of ectopic pregnancy</TI>
<SO>Chinese Journal of Clinical Medicine Research</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>15</NO>
<PG>2171-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xu-2008" MODIFIED="2011-01-29 22:55:55 +1000" MODIFIED_BY="[Empty name]" NAME="Xu 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-29 22:55:55 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xu TH</AU>
<TI>The clinical observation of mifepristone combined with traditional Chinese medicine in the treatment for 40 cases ectopic pregnancy</TI>
<SO>Contemporary Medicine</SO>
<YR>2008</YR>
<VL>2</VL>
<NO>3</NO>
<PG>173-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xue-2000" MODIFIED="2011-01-17 02:42:34 +1000" MODIFIED_BY="[Empty name]" NAME="Xue 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-01-17 02:42:34 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xue P, Zhao SX</AU>
<TI>Clinical analysis of integration of TCM and Western Medicine on heteroptics pregnancy</TI>
<SO>Hebei Journal of Traditional Chinese Medicine</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>12</NO>
<PG>934-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Xun-1994" MODIFIED="2011-05-08 22:04:19 +1000" MODIFIED_BY="[Empty name]" NAME="Xun 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-05-08 22:04:19 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Xun AX, Liu SY, Ma HL, Zeng QL</AU>
<TI>The effective of 5-FU combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Jinning Medical College</SO>
<YR>1994</YR>
<VL>17</VL>
<NO>2</NO>
<PG>29-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yan-2007" MODIFIED="2011-01-17 02:42:49 +1000" MODIFIED_BY="[Empty name]" NAME="Yan 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 02:42:49 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yan Y,Chai HJ</AU>
<TI>The research of traditional Chinese medicine combine with laparoscopic conservative surgery for smooth tubal in treating tubal pregnancy</TI>
<SO>Liaoning Journal of Traditional Chinese Medicine</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>11</NO>
<PG>1609-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-1999" MODIFIED="2011-05-08 22:04:40 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-05-08 22:04:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang GP, Liu YF, Wang FY</AU>
<TI>Combination of methotrexate and traditional Chinese medicine in the treatment for unruptured ectopic pregnancy</TI>
<SO>Journal of Huaifang Medical College</SO>
<YR>1999</YR>
<VL>21</VL>
<NO>3</NO>
<PG>220</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2001" MODIFIED="2011-05-08 22:05:22 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-05-08 22:05:22 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang L, Yu GZ, Chen CY, Li M, He Y, Gong Y</AU>
<TI>Single-dose methotrexate intramuscular injection combined with tradItional Chinese medicine in the treatment for 22 cases of ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>9</NO>
<PG>666</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2002" MODIFIED="2011-01-05 00:50:51 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-05 00:50:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang QJ, Li MW</AU>
<TI>The clinical observation of drug treatment for ectopic pregnancy</TI>
<SO>Shandong Medical Journal</SO>
<YR>2002</YR>
<VL>42</VL>
<NO>30</NO>
<PG>76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2003" NAME="Yang 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Yang XL</AU>
<TI>Treatment of ectopic pregnancy with methotrexate combined with Chinese herbs, a report of 70 cases</TI>
<SO>Shanxi Journal of Traditional Chinese Medicine</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>5</NO>
<PG>31-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2005" NAME="Yang 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang AL, Zhou H</AU>
<TI>Experience in nursing care of pregnancy woman suffering ectopic pregnancy treated with traditional Chinese medicine combined with MTX</TI>
<SO>Journal of Qilu Nursing</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>12B</NO>
<PG>1843-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008a" MODIFIED="2011-01-17 02:43:25 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 2008a" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 02:43:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang YJ</AU>
<TI>Observations Conservative therapeutic of in ectopic pregnant case with MTX combined with RU486 and Chinese medicine</TI>
<SO>China Journal of Modern Medicine</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>19</NO>
<PG>2880-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008b" MODIFIED="2010-12-25 01:55:25 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 2008b" YEAR="">
<REFERENCE MODIFIED="2010-12-12 03:20:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang PZ</AU>
<TI>The clinical observation of methotrexate combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal of Practical Medical Techniques</SO>
<YR>2008</YR>
<VL>15</VL>
<NO>27</NO>
<PG>3703-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2008c" MODIFIED="2011-01-05 01:00:24 +1000" MODIFIED_BY="[Empty name]" NAME="Yang 2008c" YEAR="">
<REFERENCE MODIFIED="2011-01-05 01:00:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang WJ,Xu ZF,Peng XP</AU>
<TI>Preventing and treating the persistent ectopic pregnancy by the decoction of ectopic pregnancy</TI>
<SO>Anhui Medical and Pharmaceutical Journal</SO>
<YR>2008</YR>
<VL>12</VL>
<NO>3</NO>
<PG>243-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ye-1999" MODIFIED="2011-01-05 01:03:16 +1000" MODIFIED_BY="[Empty name]" NAME="Ye 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-01-05 01:03:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ye R</AU>
<TI>The clinical analysis of drug treatments for 70 cases of early ectopic pregnancy</TI>
<SO>Zhejiang Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>1999</YR>
<VL>9</VL>
<NO>3</NO>
<PG>206-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ye-2004" NAME="Ye 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ye CF, Chen XL, Deng WH</AU>
<TI>The clinical observation of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>The Journal of Practical Medicine</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>12</NO>
<PG>1434-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yi-1999" NAME="Yi 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yi NY, Deng W, Zhang SY</AU>
<TI>The analysis of Yi Wei Ting capsule treating 30 cases of stable ectopic pregnancy</TI>
<SO>Chinese Journal of Critical Care Medicine</SO>
<YR>1999</YR>
<VL>19</VL>
<NO>7</NO>
<PG>426</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2005a" NAME="Yu 2005a" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu XL</AU>
<TI>Mifepristone combined with methotrexate and traditional Chinese medicine treating 26 cases of ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>22</NO>
<PG>2958-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2005b" NAME="Yu 2005b" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu ZF</AU>
<TI>The effect comparison of four kinds of conservative treatments for ectopic pregnancy</TI>
<SO>Shanxi Medical Journal</SO>
<YR>2005</YR>
<VL>34</VL>
<NO>12</NO>
<PG>1053-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2009" MODIFIED="2010-12-12 13:34:48 +1000" MODIFIED_BY="[Empty name]" NAME="Yu 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 13:34:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu XF,Wang SY,Yan L</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Medical Journal West China</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>9</NO>
<PG>1507-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2010a" MODIFIED="2010-12-14 00:39:50 +1000" MODIFIED_BY="[Empty name]" NAME="Yu 2010a" YEAR="">
<REFERENCE MODIFIED="2010-12-14 00:39:50 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu DS</AU>
<TI>The clinical observation of mifepristone combined with traditional Chinese medicine in the conservation treatment for ectopic pregnancy</TI>
<SO>Hubei Journal of Traditional Chinese Medicine</SO>
<YR>2010</YR>
<VL>32</VL>
<NO>6</NO>
<PG>34-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2010b" MODIFIED="2010-12-24 00:47:14 +1000" MODIFIED_BY="[Empty name]" NAME="Yu 2010b" YEAR="2010">
<REFERENCE MODIFIED="2010-12-12 01:32:36 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu T,Yang Y</AU>
<TI>The clinical observation of methotrexate and mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Ethnomedicine and Ethnopharmacy</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>1</NO>
<PG>81-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yuan-2003" MODIFIED="2011-01-05 01:07:39 +1000" MODIFIED_BY="[Empty name]" NAME="Yuan 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-01-05 01:07:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yuan AY</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 46 cases of ectopic pregnancy</TI>
<SO>Applied Journal of General Practice</SO>
<YR>2003</YR>
<VL>1</VL>
<NO>4</NO>
<PG>278,280</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yuan-2005" MODIFIED="2011-05-08 22:05:40 +1000" MODIFIED_BY="[Empty name]" NAME="Yuan 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-05-08 22:05:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yun SH</AU>
<TI>The clinical effectiveness of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Medical Health</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>14</NO>
<PG>1822</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yuan-2008" MODIFIED="2011-01-17 02:43:53 +1000" MODIFIED_BY="[Empty name]" NAME="Yuan 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-01-17 02:43:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yuan SY,Wang L,Lin YZ,Wang L</AU>
<TI>Clinical effect and influence on cell factor of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Shandong Medical Journal</SO>
<YR>2008</YR>
<VL>48</VL>
<NO>27</NO>
<PG>96-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yuan-2009" MODIFIED="2010-12-12 14:10:51 +1000" MODIFIED_BY="[Empty name]" NAME="Yuan 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 14:10:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yuan LJ</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for 88 cases ectopic pregnancy</TI>
<SO>Aerospace Medicine</SO>
<YR>2009</YR>
<VL>20</VL>
<NO>1</NO>
<PG>39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeng-2003" NAME="Zeng 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeng GX</AU>
<TI>The effect observation of traditional Chinese medicine for ectopic pregnancy</TI>
<SO>Journal of Chenzhou Medical College</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>2</NO>
<PG>26-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeng-2004a" NAME="Zeng 2004a" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zeng L, Huang GZ, Bao XW</AU>
<TI>The effective observation of different conservative treatments for ectopic pregnancy</TI>
<TO>Explore the curative effect and side effect on the different conservative treatments of ectopic pregnancy</TO>
<SO>Liaoning Journal of Traditional Chinese Medicine</SO>
<YR>2004</YR>
<VL>31</VL>
<NO>10</NO>
<PG>843-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeng-2004b" NAME="Zeng 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeng GH, Ou XF, Bai XH, Yu ZH, Wen YF, Wen GJ</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine in the treatment for tubal pregnancy</TI>
<SO>New Chinese Medical of Journal</SO>
<YR>2004</YR>
<VL>5</VL>
<NO>5</NO>
<PG>426-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhai-2005" NAME="Zhai 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhai QZ, Jiang T, Sun HZ</AU>
<TI>The analysis of methotrexate combined with traditional Chinese medicine in the treatment for 100 cases of ectopic pregnancy</TI>
<SO>Journal of Jiangsu Clinical Medicine</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>1</NO>
<PG>81, 83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2000a" MODIFIED="2011-01-05 02:04:42 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2000a" YEAR="2000">
<REFERENCE MODIFIED="2011-01-05 02:04:42 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Y, Shen W</AU>
<TI>The primary approach of the condition of conservative treatment for ectopic pregnancy, an analysis of 76 cases</TI>
<SO>Chinese Journal of Information on TCM</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>2</NO>
<PG>46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2000b" MODIFIED="2011-05-08 22:06:15 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2000b" YEAR="2000">
<REFERENCE MODIFIED="2011-05-08 22:06:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang XJ</AU>
<TI>The effect observation of drug treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Birth Health &amp; Heredity</SO>
<YR>2000</YR>
<VL>8</VL>
<NO>6</NO>
<PG>52,51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2001" NAME="Zhang 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang QX</AU>
<TI>The comparison of two kinds of drug treatments for ectopic pregnancy</TI>
<SO>Shanxi Clinical Medicine Journal</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>10</NO>
<PG>740-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2003a" MODIFIED="2011-01-05 02:40:13 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2003a" YEAR="2003">
<REFERENCE MODIFIED="2011-01-05 02:40:13 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang L</AU>
<TI>The clinical observation of three drug treatments for ectopic pregnancy</TI>
<SO>Hainan Medical Journal</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>12</NO>
<PG>68-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2003b" NAME="Zhang 2003b" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang H, Li SH, Wang HQ, Shen LF, Ge HX</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 162 cases of ectopic pregnancy</TI>
<SO>China's Naturopathy</SO>
<YR>2003</YR>
<VL>11</VL>
<NO>6</NO>
<PG>7-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2004a" MODIFIED="2011-01-05 02:43:16 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2004a" YEAR="2004">
<REFERENCE MODIFIED="2011-01-05 02:43:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang B</AU>
<TI>The analysis of 31 cases of ectopic pregnancy treated by methotrexate combination with traditional Chinese medicine</TI>
<SO>Journal of Shanxi Medical College for Continuing Education</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>4</NO>
<PG>47-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2004b" NAME="Zhang 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang XM</AU>
<TI>The effective observation of integrated traditional and Western medicine treating 72 cases of ectopic pregnancy</TI>
<SO>Lishizhen Medicine and Materia Medica Research</SO>
<YR>2004</YR>
<VL>15</VL>
<NO>6</NO>
<PG>330</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2004c" MODIFIED="2011-01-05 02:45:21 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2004c" YEAR="2004">
<REFERENCE MODIFIED="2011-01-05 02:45:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang JH</AU>
<TI>The analysis of methotrexate combined with traditional Chinese medicine in the treatment for 108 cases of ectopic pregnancy</TI>
<SO>Shandong Medical Journal</SO>
<YR>2004</YR>
<VL>44</VL>
<NO>6</NO>
<PG>33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2005" NAME="Zhang 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Y, He JQ</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 32 cases of ectopic pregnancy</TI>
<SO>Chinese Journal of Information on TCM</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>2</NO>
<PG>74-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2006" MODIFIED="2010-12-11 18:00:06 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-12-11 18:00:06 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang QZ</AU>
<TI>The clinical analysis of methotrexate combined with traditional Chinese medicine in the treatment for 30 cases of ectopic pregnancy</TI>
<SO>Maternal and Child Health Care of China</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>19</NO>
<PG>2751-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2007a" MODIFIED="2011-02-01 02:43:13 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2007a" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 02:44:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang QH</AU>
<TI>The clinical observation of tradItional Chinese medicine combined with Western medicine in the treatment for 47 cases ectopic pregnancy</TI>
<SO>JOURNAL OF LIAONING UNIVERSITY OF TCM</SO>
<YR>2007</YR>
<VL>9</VL>
<NO>2</NO>
<PG>113</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2007b" MODIFIED="2011-01-17 02:44:53 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2007b" YEAR="">
<REFERENCE MODIFIED="2011-01-17 02:44:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang JN,Ke XH,Cheng QN,Yang JQ</AU>
<TI>Chinese medicine of activating blood and removing stasis, destroying embryo and resolving lump combined with mifepristone in treating 36 cases of ectopic pregnancy</TI>
<SO>Journal of Fujian College of Traditional Chinese Medcine</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>4</NO>
<PG>5-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008a" MODIFIED="2011-01-17 02:47:01 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2008a" YEAR="">
<REFERENCE MODIFIED="2011-01-17 02:47:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang XH,E ZM,Guo LJ</AU>
<TI>The observation and analysis of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal Modern Drug Apply</SO>
<YR>2008</YR>
<VL>2</VL>
<NO>6</NO>
<PG>68-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008b" MODIFIED="2010-12-12 13:38:44 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2008b" YEAR="">
<REFERENCE MODIFIED="2010-12-12 13:38:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang H</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>China Practical Medicine</SO>
<YR>2008</YR>
<VL>3</VL>
<NO>22</NO>
<PG>119-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2008c" MODIFIED="2010-12-24 00:47:42 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2008c" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 03:03:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang YL</AU>
<TI>The effect observation of methotrexate combined with traditional Chinese medicine for tubal pregnancy</TI>
<SO>GanSu Medical Journal</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>3</NO>
<PG>55-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2009" MODIFIED="2010-12-12 15:10:25 +1000" MODIFIED_BY="[Empty name]" NAME="Zhang 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 15:10:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang PQ</AU>
<TI>The clinical analysis of mifepristone and methotrexate combined with traditional Chinese medicine independently in the treatment for 50 cases of ectopic pregnancy</TI>
<SO>Medical Journal of Chinese People'health</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>19</NO>
<PG>2430-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2001" MODIFIED="2011-05-08 22:06:34 +1000" MODIFIED_BY="[Empty name]" NAME="Zhao 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-05-08 22:06:34 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao YH</AU>
<TI>The adjunctive therapy of traditional Chinese medicine for 24 cases of ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>6</NO>
<PG>466-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2002" MODIFIED="2011-05-08 22:06:56 +1000" MODIFIED_BY="[Empty name]" NAME="Zhao 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-05-08 22:06:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao FQ, Ma J</AU>
<TI>Traditional Chinese medicine combined with Western medicine in the treatment for 30 cases of ectopic pregnancy</TI>
<SO>Journal of Henan College of Traditional Chinese Medicine</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>5</NO>
<PG>56-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2003a" NAME="Zhao 2003a" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao XY, Zhu YP, Xie SR</AU>
<TI>Comparison of mifepristone combined Chinese herbs and a methopterin in the treatment of ectopic pregnancy</TI>
<SO>Journal of Xinxiang Medical College</SO>
<YR>2003</YR>
<VL>20</VL>
<NO>5</NO>
<PG>342-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2003b" MODIFIED="2011-01-06 01:53:33 +1000" MODIFIED_BY="[Empty name]" NAME="Zhao 2003b" YEAR="2003">
<REFERENCE MODIFIED="2011-01-06 01:53:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao W, Li M</AU>
<TI>The clinical observation of three drug treatments for ectopic pregnancy</TI>
<SO>Journal of Practical Countryside Doctor</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>2</NO>
<PG>35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2003c" NAME="Zhao 2003c" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao X</AU>
<TI>The effect observation of mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>New Chinese Medical Journal</SO>
<YR>2003</YR>
<VL>4</VL>
<NO>22</NO>
<PG>2058-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2006a" MODIFIED="2010-12-24 00:47:51 +1000" MODIFIED_BY="[Empty name]" NAME="Zhao 2006a" YEAR="2006">
<REFERENCE MODIFIED="2010-12-12 01:49:23 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao LH</AU>
<TI>The effect observation of methotrexate and mifepristone combined with traditional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Misdiagnostics</SO>
<YR>2006</YR>
<VL>6</VL>
<NO>18</NO>
<PG>3509-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2006b" MODIFIED="2010-12-12 13:06:05 +1000" MODIFIED_BY="[Empty name]" NAME="Zhao 2006b" YEAR="">
<REFERENCE MODIFIED="2010-12-12 13:06:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao CF</AU>
<TI>Analysis on 40 examples patients of Etopic gestation treated by Mifepristone Tablets with Chinese traditional medicine</TI>
<SO>Guangming Journal of Chinese Medicine</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>8</NO>
<PG>18-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhao-2009" MODIFIED="2011-01-17 02:47:23 +1000" MODIFIED_BY="[Empty name]" NAME="Zhao 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-17 02:47:23 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhao L,Zhang J,Fu WL,Liu YG</AU>
<TI>Comparative observation of Chinese Medicine and western medicine treatment for unruptured tubal pregnancy</TI>
<SO>Liaoning Journal of Traditional Chinese Medicine</SO>
<YR>2009</YR>
<VL>36</VL>
<NO>4</NO>
<PG>566-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zheng-2002" NAME="Zheng 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zheng WL, Lin J, He H</AU>
<TI>Methotrexate and mifepristone combined with traditional Chinese medicine in the treatment for unruptured tubal pregnancy</TI>
<SO>Guangdong Medical Journal</SO>
<YR>2002</YR>
<VL>23</VL>
<NO>Suppl.</NO>
<PG>183-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zheng-2010" MODIFIED="2010-12-07 01:22:30 +1000" MODIFIED_BY="[Empty name]" NAME="Zheng 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-12-07 01:22:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zheng XH</AU>
<TI>The clinical experience of conservative drug treatment for ectopic pregnancy</TI>
<SO>Journal of medical forum</SO>
<YR>2010</YR>
<VL>31</VL>
<NO>2</NO>
<PG>76-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-1999" NAME="Zhou 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhou YH</AU>
<TI>The clinical analysis of traditional Chinese medicine combined with Western medicine in the treatment for 34 cases of ectopic pregnancy</TI>
<SO>Shanxi Journal of Traditional Chinese Medicine</SO>
<YR>1999</YR>
<VL>15</VL>
<NO>5</NO>
<PG>28-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2001" NAME="Zhou 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhou ZH, Wang J</AU>
<TI>The comparison of different therapeutic regimens of methotrexate in the conservative treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Primary Medicine and Pharmacy</SO>
<YR>2001</YR>
<VL>8</VL>
<NO>3</NO>
<PG>266-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2006" NAME="Zhou 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhou M, Luo Y</AU>
<TI>The therapeutic effects of methotrexate and mifepristone combined with the traditional Chinese drug on ectopic pregnancy</TI>
<SO>West China Medical Journal</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>1</NO>
<PG>133</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2010a" MODIFIED="2010-12-24 00:48:02 +1000" MODIFIED_BY="[Empty name]" NAME="Zhou 2010a" YEAR="2010">
<REFERENCE MODIFIED="2010-12-11 19:55:45 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhou GZ,Gao YX,Zhou LW</AU>
<TI>The treatment of guizhifulintang for 60 cases of ectopic pregnancy</TI>
<SO>Chinese Medcine Modern Distance Education of China</SO>
<YR>2010</YR>
<VL>8</VL>
<NO>85</NO>
<PG>32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhou-2010b" MODIFIED="2011-01-17 02:48:07 +1000" MODIFIED_BY="[Empty name]" NAME="Zhou 2010b" YEAR="">
<REFERENCE MODIFIED="2011-01-17 02:48:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhou DX,Wang XM</AU>
<TI>Observation on the curative effect of MTX combined Chinese medicine in the treatment of ectopic pregnancy</TI>
<SO>National Medical Frontiers of China</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>5</NO>
<PG>24,53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2002" NAME="Zhu 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu YL, Tian DL</AU>
<TI>The primary approach of conservative treatment for ectopic pregnancy</TI>
<SO>Acta Academiae Medicine Suzhou</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>4</NO>
<PG>497,499</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2003" NAME="Zhu 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu XM</AU>
<TI>The effect analysis of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Hebei Medical Journal</SO>
<YR>2003</YR>
<VL>25</VL>
<NO>8</NO>
<PG>610</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2005" MODIFIED="2011-01-06 01:56:35 +1000" MODIFIED_BY="[Empty name]" NAME="Zhu 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-06 01:56:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu XB</AU>
<TI>The clinical analysis of traditional Chinese medicine combined with Western medicine in the treatment for ectopic pregnancy</TI>
<SO>Modern Journal of Integrated Traditional Chinese and Western Medicine</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>10</NO>
<PG>1264-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2007a" MODIFIED="2011-01-17 02:48:26 +1000" MODIFIED_BY="[Empty name]" NAME="Zhu 2007a" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 02:48:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu SQ</AU>
<TI>The clinical observation of different dose mifepristone combined with tradItional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Journal North China Coal Medical College</SO>
<YR>2007</YR>
<VL>9</VL>
<NO>5</NO>
<PG>681-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2007b" MODIFIED="2011-01-17 02:48:43 +1000" MODIFIED_BY="[Empty name]" NAME="Zhu 2007b" YEAR="2007">
<REFERENCE MODIFIED="2011-01-17 02:48:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu JW,Song JM,Wu XH</AU>
<TI>The clinical observation of single-dose methotrexate combined with tradItional Chinese medicine in the treatment for ectopic pregnancy</TI>
<SO>Chinese Journal of Integrated Traditional and Western Medicine</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>8</NO>
<PG>761-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2008" MODIFIED="2010-12-12 03:35:14 +1000" MODIFIED_BY="[Empty name]" NAME="Zhu 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-12-12 03:35:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu WZ</AU>
<TI>The effect observation of methotrexate combined with mifepristone for ectopic pregnancy</TI>
<SO>Public Medical Forum Magazine</SO>
<YR>2008</YR>
<VL>12</VL>
<NO>25</NO>
<PG>814-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2009" MODIFIED="2010-12-12 12:50:59 +1000" MODIFIED_BY="[Empty name]" NAME="Zhu 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-12-12 12:50:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu FF,Peng ML</AU>
<TI>The clinical observation of mifepristone combined with traditional Chinese medicine in the conservative treatment for 51cases of ectopic pregnancy</TI>
<SO>Clinical Education of General Practice</SO>
<YR>2009</YR>
<VL>7</VL>
<NO>3</NO>
<PG>308-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2010" MODIFIED="2011-01-17 02:49:08 +1000" MODIFIED_BY="[Empty name]" NAME="Zhu 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-01-17 02:49:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu JF,Li SH</AU>
<TI>The most favourable plan of methotrexate combined with traditional Chinese medicine conservative treatment for ectopic pregnancy</TI>
<SO>Sichuan Medical Journal</SO>
<YR>2010</YR>
<VL>31</VL>
<NO>6</NO>
<PG>828-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhuang-2006" MODIFIED="2011-01-17 02:49:19 +1000" MODIFIED_BY="[Empty name]" NAME="Zhuang 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-01-17 02:49:19 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhuang FN,Li YH</AU>
<TI>The analysis of Chinese medicine Shenghongqi capsule in the treatment of 30 cases ectopic pregnancy</TI>
<SO>Strait Pharmaceutical Journal</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>2</NO>
<PG>113-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2011-05-08 22:06:56 +1000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-04-29 10:16:27 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2011-04-29 10:16:27 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bankowski-2002" NAME="Bankowski 2002" TYPE="BOOK">
<AU>Bankowski BJ, Hearne AE, Lambrou NC, Fox HE, Wallach EE</AU>
<SO>The Johns Hopkins Manual of Gynecology and Obstetrics</SO>
<YR>2002</YR>
<EN>2nd</EN>
<PB>Lippincott Williams &amp; Wilkins Inc.</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CFR-_x0026_-ICH-1997" NAME="CFR &amp; ICH 1997" TYPE="BOOK_SECTION">
<AU>International Conference on Harmonisation Expert Working Group.</AU>
<TI>ICH harmonised tripartite guideline for good clinical practice.</TI>
<SO>CFR &amp; ICH Guidelines</SO>
<YR>1997</YR>
<VL>1</VL>
<PG>19063-2043</PG>
<EN>1</EN>
<PB>USA: Barnett International/PAREXEL</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chu-1998" NAME="Chu 1998" TYPE="BOOK">
<AU>Chu Yan</AU>
<TO>E Shu</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>895-9</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dai-1998" NAME="Dai 1998" TYPE="BOOK">
<AU>Dai Guangjun</AU>
<TO>Tian Hua Fen</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>148-60</PG>
<EN>2nd</EN>
<ED>Wang Yusheng,Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dekeyser-2005" NAME="Dekeyser 2005" TYPE="JOURNAL_ARTICLE">
<AU>Dekeyser BJ, Milliez J</AU>
<TI>Smoking and ectopic pregnancy: is there a causal relationship?</TI>
<SO>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction</SO>
<YR>2005</YR>
<VL>34</VL>
<NO>1</NO>
<PG>119-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Smith GD, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fernandez-2004" MODIFIED="2011-04-29 10:16:27 +1000" MODIFIED_BY="[Empty name]" NAME="Fernandez 2004" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez H, Gervaise A</AU>
<TI>Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy</TI>
<SO>Human Reproduction Update</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>6</NO>
<PG>503-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gong-1998" NAME="Gong 1998" TYPE="BOOK">
<AU>Gong Xuling</AU>
<TO>Ku Xing Ren</TO>
<SO>Pharmacology and Application of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>655-9</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hajenius-2000" MODIFIED="2011-01-29 23:35:21 +1000" MODIFIED_BY="[Empty name]" NAME="Hajenius 2000" TYPE="COCHRANE_REVIEW">
<AU>Hajenius PJ, Mol BWJ, Bossuyt PMM, Ankum WM, Van der Veen F</AU>
<TI>Interventions for tubal ectopic pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>1</NO>
<PB>Wiley</PB>
<CY>Chichester</CY>
<IDENTIFIERS MODIFIED="2011-01-29 23:35:21 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-01-29 23:35:21 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="CD000324"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-HLSC-2000" NAME="HLSC 2000" TYPE="OTHER">
<AU>House of Lords Select Committee</AU>
<TI>Science and Technology-Sixth Report: Complementary and alternative medicine</TI>
<SO>http://www.publications.parliament.uk/pa/ld199900/ldsctech/123/12303.htm#a3.2000</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huang-1998a" NAME="Huang 1998a" TYPE="BOOK">
<AU>Huang Bin, Wang Xiawen, Liu Guowei, Li Rui</AU>
<TO>Dang Gui</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>760-2</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huang-1998b" NAME="Huang 1998b" TYPE="BOOK">
<AU>Huang Xienan, Wang Xiawen</AU>
<TO>San QI</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>33-42</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" MODIFIED="2011-01-17 02:54:55 +1000" MODIFIED_BY="[Empty name]" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavahan DJ, McQuay HJ</AU>
<TI>Assessing the quality of reports of randomised clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<NO>1</NO>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juni-2001" NAME="Juni 2001" TYPE="JOURNAL_ARTICLE">
<AU>Juni P, Altman DG, Egger M</AU>
<TI>Systematic reviews in health care: Assessing the quality of controlled clinical trials</TI>
<SO>British Medical Journal</SO>
<YR>2001</YR>
<VL>323</VL>
<NO>7303</NO>
<PG>42-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" MODIFIED="2011-01-17 02:55:23 +1000" MODIFIED_BY="[Empty name]" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodologic quality and discrepancies between large and small randomised trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lampert-2002" NAME="Lampert 2002" TYPE="JOURNAL_ARTICLE">
<AU>Lampert N, Xu Y</AU>
<TI>Chinese herbal nephropathy</TI>
<SO>Lancet</SO>
<YR>2002</YR>
<VL>359</VL>
<NO>9308</NO>
<PG>796-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lehner-2000" NAME="Lehner 2000" TYPE="JOURNAL_ARTICLE">
<AU>Lehner R, Kucera E, Jirecek S, Egarter C, Husslein P</AU>
<TI>Ectopic pregnancy</TI>
<SO>Archives of Gynecology &amp; Obstetrics</SO>
<YR>2000</YR>
<VL>263</VL>
<NO>3</NO>
<PG>87-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Li-2005" NAME="Li 2005" TYPE="JOURNAL_ARTICLE">
<AU>Li Tao, Shi Li, Feng Dongling</AU>
<TI>Therapeutic effect observation of combination of traditional Chinese medicines with Western medicine for ectopic pregnancy</TI>
<SO>Zhong Yi Yao Xue Kan</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>4</NO>
<PG>741-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liu-1998a" NAME="Liu 1998a" TYPE="BOOK">
<AU>Liu Guoxiong</AU>
<TO>Xi Hong Hua</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>426-9</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liu-1998b" NAME="Liu 1998b" TYPE="BOOK">
<AU>Liu Changwu</AU>
<TO>Wu Gong</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>1195-120</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publishing House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liu-1998c" NAME="Liu 1998c" TYPE="BOOK">
<AU>Liu Changwu</AU>
<TO>Dan Shen</TO>
<SO>Pharmacology and Applications of Chinese Materia Medica</SO>
<YR>1998</YR>
<PG>190-218</PG>
<EN>2nd</EN>
<ED>Wang Yusheng, Deng Wenlong, Xue Chunsheng</ED>
<PB>People's Health Publish House</PB>
<CY>Beijing</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lord-2001" NAME="Lord 2001" TYPE="JOURNAL_ARTICLE">
<AU>Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD</AU>
<TI>Urothelial malignant disease and Chinese herbal nephropathy</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>358</VL>
<NO>9292</NO>
<PG>1515-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luciano-2001" NAME="Luciano 2001" TYPE="JOURNAL_ARTICLE">
<AU>Luciano AA, Roy G, Solima E</AU>
<TI>Ectopic pregnancy from surgical emergency to medical management</TI>
<SO>Annals of the New York Academy of Sciences</SO>
<YR>2001</YR>
<VL>943</VL>
<PG>235-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad A, Moher M</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2011-01-17 02:55:42 +1000" MODIFIED_BY="[Empty name]" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D; Schulz KF; Altman DG</AU>
<TI>The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials</TI>
<SO>Annals Of Internal Medicine</SO>
<YR>2001</YR>
<VL>134</VL>
<NO>8</NO>
<PG>657-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nortier-2000" NAME="Nortier 2000" TYPE="JOURNAL_ARTICLE">
<AU>Notier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M</AU>
<TI>Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)</TI>
<SO>New England Journal of Medicine</SO>
<YR>2000</YR>
<VL>342</VL>
<NO>23</NO>
<PG>1686-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stovall-2002" NAME="Stovall 2002" TYPE="BOOK">
<AU>Stovall TS</AU>
<TI>Early Pregnancy Loss and Ectopic Pregnancy</TI>
<SO>Novak's Gynecology</SO>
<YR>2002</YR>
<PG>507-42</PG>
<EN>13th</EN>
<ED>Berek JS, Adama Hillard PJ, Adashi EY, Hengst TC</ED>
<PB>Lippincott Williams and Wilkins</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wu-2007" NAME="Wu 2007" TYPE="JOURNAL_ARTICLE">
<AU>Taixiang Wu, Guanjian Liu</AU>
<TI>The concepts, design, practice and report of allocation concealment and blinding</TI>
<SO>Chinese Journal of Evidence-Based Medicine</SO>
<YR>2007</YR>
<VL>7</VL>
<NO>3</NO>
<PG>222-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-05-08 23:08:31 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-04-23 03:12:28 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-04-23 01:55:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2004c">
<CHAR_METHODS>
<P>Methods<BR/>"Random allocation" was mentioned, but lack of description about what methods were used. After telephone interviewing the author, we found that a random number table had been used to generate allocation sequence. <BR/>Blinding was not mentioned in the study, but the author claimed that they used double blinding when he was interviewed.<BR/>Withdrawals/drop-outs/loss to follow up and intention-to-treat analysis<BR/>No information provided. <BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>63 cases (32 in treatment group and 31 in control group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-04-23 01:55:24 +1000" MODIFIED_BY="[Empty name]">
<P>Treatment group: TCHM combined with MTX intramuscular 20 mg once a day for 5 days.<BR/>Control group: only TCHM.<BR/>The TCHM Yiweirenchengfang contains: Chi Shao10 g, Dan Shen 10 g, Tao Ren 10 g, San Ling 10 g, E Zhu 10 g, Tu Niu Xi 10 g, Tian Hua Fen 30 g, Wu Gong 3 g. If the patient had unstable ectopic pregnancy Sanling and E Zhu not used. Once a day, use 2 weeks.<BR/>MTX: 20mg, once a day for 5 days.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-11-18 11:16:28 +1000" MODIFIED_BY="[Empty name]">
<P>1. Level of HCG (uG/L).<BR/>2. The disappearance of symptoms.<BR/>3. The size of the mass (mm).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-02-01 15:32:57 +1000" MODIFIED_BY="[Empty name]">
<P>1. The TCHM Yiweirenchengfang was provided by the authors themselves;<BR/>2. The decoction was prepared by the authors' hospital.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-04-23 03:12:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2000">
<CHAR_METHODS>
<P>"Random allocation" was mentioned, but lack of description about what methods were used. After telephone interviewing the author, we found that a random number table had been used to generate allocation sequence <BR/>No blinding. <BR/>Withdrawal/drop-out/loss to follow up and intention-to-treat analysis<BR/>No information provided<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-02-01 15:33:03 +1000" MODIFIED_BY="[Empty name]">
<P>94 participants allocated to three groups (32 in group A, 24 in group B and 38 in group C)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-04-23 03:12:23 +1000" MODIFIED_BY="[Empty name]">
<P>Group A used MTX intramuscular injection single dose; group B used only TCHM; group C used MTX intramuscular single dose combined with TCHM.<BR/>The TCHM Yi wei fang contains: Chi Shao10-12 g, Dan Shen 12-15 g, Tao Ren 6-9 g, San Ling 6-9 g, Tian Hua Fen 20-30 g. If hCG&gt;0.25 nmol/L, added Zi Chao 20-30 g, Wu Gong 2 g. If vaginal bleeding for too long and low-grade fever, added Shuang Hua 15 g, Lian Qiao 12-15 g, Huang Bo 10-12 g, Xian He Chao 15-20 g. Once a day, use 7-10 days.<BR/>MTX: 50 mg/m<SUP>2</SUP>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-10 13:06:56 +1000" MODIFIED_BY="jane clarke">
<P>1. The size of the mass half a month after giving treatment (mm).<BR/>2. The level of serum hCG (mmol/L).<BR/>3. The disappearance of symptom.<BR/>4. The average period of hospitalisation (days).<BR/>5. Adverse effects.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-04-23 03:12:28 +1000" MODIFIED_BY="[Empty name]">
<P>1. The formulation of Yi wei fang was provided by authors themselves.<BR/>2. The decoction was prepared by the authors' hospital.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>MTX = methotrexate</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-05-08 23:08:31 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-An-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration", without an adequately random approach; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:16:17 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bai-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:16:17 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:25:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bao-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:25:44 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:29:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bao-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:29:06 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 01:28:10 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bi-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 01:28:10 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", no random number table or other adequate methods of randomisation were used.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 00:09:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bu-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 00:09:43 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cai-1998a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", an inadequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cai-1998b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cao-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was "according to the sequence of administration" only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:07:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chang-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:07:53 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:36:16 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Che-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:36:16 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chen-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", no random number table or other adequate methods of randomisation were used.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chen-2003a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chen-2003b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the medical group", no random number table or other adequate methods of randomisation were used.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 00:16:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 00:16:00 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:02:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:02:38 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cheng-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patients", without a random number table or other adequate methods; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:03:36 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:03:36 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:11:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:11:11 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:47:35 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:47:35 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cui-2003a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cui-2003b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patients", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dai-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:13:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dai-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:13:25 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:48:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dai-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:48:32 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dan-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:58:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deng-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:58:00 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:25:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ding-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:25:58 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fan-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition and the patients" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fang-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:05:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feng-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:05:02 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:26:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:26:03 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gang-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gao-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gao-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 00:59:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gao-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 00:59:11 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 01:02:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ge-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 01:02:26 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:09:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gu-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:09:30 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:58:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gu-2008b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:58:47 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guo-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guo-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guo-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:27:17 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guo-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:27:17 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:11:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guo-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:11:48 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:17:56 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guo-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:17:56 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 01:04:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 01:04:29 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 21:17:01 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hao-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 21:17:01 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 00:00:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hao-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 00:00:19 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-He-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patient's doctor", without a random number table or other adequate methods; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:49:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-He-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:49:20 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:06:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-He-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:06:11 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:06:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-He-2010a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:06:30 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:30:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-He-2010b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:30:04 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hong-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:52:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hou-2005a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:52:24 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:37:13 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hou-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:37:13 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 01:29:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hu-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 01:29:25 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hu-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-29 23:41:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-29 23:41:04 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:25:54 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hua-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:25:54 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:53:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:53:24 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Huang-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Huang-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:30:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:30:52 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:25:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:25:33 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the decision of the doctor" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:53:50 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huo-2005b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:53:50 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:47:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huo-2008b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:47:26 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 02:03:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ji-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 02:03:43 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ji-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-30 02:07:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiang-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-30 02:07:52 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 00:06:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiang-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 00:06:38 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:53:13 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiang-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:53:13 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:07:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jin-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:07:33 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:28:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jin-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:28:43 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:30:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jin-2007c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:30:18 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:21:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuang-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:21:24 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 19:49:59 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuang-2008b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 19:49:59 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lei-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2001a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patients", no random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2001b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:55:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:55:48 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2004a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2004b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 00:45:59 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2004d">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 00:45:59 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 13:07:04 +1000" MODIFIED_BY="jane clarke" STUDY_ID="STD-Li-2004e">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 13:07:04 +1000" MODIFIED_BY="jane clarke">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the voluntarily of patients" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2004f">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the decision of the doctor" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:56:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2004g">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:56:31 +1000" MODIFIED_BY="[Empty name]">
<P>Author refused to provide information.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2004h">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:56:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2005a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:56:52 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:02:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2005b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:02:21 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:26:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:26:18 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:39:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:39:09 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:42:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:42:02 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:26:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2008b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:26:33 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:43:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2008c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:43:52 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:56:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2008d">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:56:26 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:25:13 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:25:13 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through analysis the article we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:29:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:29:57 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:59:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:59:21 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:22:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:22:15 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:10:51 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:10:51 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:24:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liao-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:24:09 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:37:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:37:15 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ling-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ling-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-1999a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-1999b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the doctor" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenetic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-2004a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-2004b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Liu-2004c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequately methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 03:47:01 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 03:47:01 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patients", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:06:51 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:06:51 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:44:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:44:42 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:46:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:46:22 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lu-2000a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and actually it is a before-after study in different patients; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:59:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2000b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:59:39 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:52:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:52:32 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through analysis the article we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:45:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:45:39 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patients", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:48:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luo-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:48:19 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Luo-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:52:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luo-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:52:00 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through analysis the article we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Luo-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequately methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ma-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequately methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:05:23 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:05:23 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 02:55:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mao-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 02:55:25 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the patients and the sequence of administration", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 23:08:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mei-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 23:08:31 +1000" MODIFIED_BY="[Empty name]">
<P>The author refuse to answer any question through interviewing the author by phone</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meng-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meng-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:02:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mo-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:02:06 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:12:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ni-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:12:58 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 03:00:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pan-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 03:00:38 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Peng-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Qi-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:05:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qian-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:05:06 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 21:59:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qin-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 21:59:58 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:00:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qin-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:00:11 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:29:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qiu-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:29:22 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 03:11:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qu-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 03:11:38 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:35:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ren-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:35:03 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:51:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ren-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:51:06 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:19:07 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:19:07 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 03:14:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shi-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 03:14:15 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:00:41 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shi-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:00:41 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 21:08:49 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 21:08:49 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 21:13:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 21:13:20 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Song-2000a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:00:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Song-2000b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:00:58 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-02 03:28:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Song-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-02 03:28:24 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through analysis the article we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Song-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Song-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Su-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Su-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:26:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Su-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:26:15 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 19:43:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 19:43:22 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:01:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:01:42 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:07:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:07:37 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:51:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:51:19 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:10:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tang-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:10:40 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:01:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tian-2002a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:01:57 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 20:15:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tian-2002b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 20:15:26 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tian-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:30:46 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tian-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:30:46 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wang-2000a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wang-2000b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wang-2001a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wang-2001b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 23:01:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 23:01:37 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wang-2003a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 23:05:16 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2003b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 23:05:16 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 22:14:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 22:14:32 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:02:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2004b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:02:18 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:02:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2004c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:02:31 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 22:59:12 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2005a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 22:59:12 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-03 23:27:08 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2005b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-03 23:27:08 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the voluntarily of patients" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wang-2005c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:03:59 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:03:59 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:06:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:06:02 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understood that the method of allocation was thus described as "according to the patients" but without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:20:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:20:02 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:03:05 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:03:05 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the medical group" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:36:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:36:26 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:31:54 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:31:54 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:35:08 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007d">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:35:08 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 01:04:05 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007e">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 01:04:05 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:28:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:28:34 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:51:54 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:51:54 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-12 00:51:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2010a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-12 00:51:40 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; though the random number tablenot were mentioned, not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:33:12 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2010b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:33:12 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition and selection of patient" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wei-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wei-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understood that the method of allocation was thus described as "according to the patients" but without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wei-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:28:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wen-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:28:57 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:04:07 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wu-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:04:07 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wu-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wu-2004a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wu-2004b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wu-2004c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:08:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:08:43 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-04 23:47:16 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xiong-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-04 23:47:16 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Xiong-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-04 01:48:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xu-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-04 01:48:19 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Xu-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:23:56 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:23:56 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Xue-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:04:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Xun-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:04:34 +1000" MODIFIED_BY="[Empty name]">
<P>Authors could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:21:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yan-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:21:58 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:05:16 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:05:16 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:05:35 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:05:35 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 00:53:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 00:53:30 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yang-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yang-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:26:49 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:26:49 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:55:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2008b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:55:58 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 01:00:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2008c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 01:00:42 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 01:04:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ye-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 01:04:20 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ye-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yi-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yu-2005a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yu-2005b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and actually it is a before-after study in different patients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 19:54:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 19:54:43 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:23:05 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2010a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:23:05 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:18:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yu-2010b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:18:42 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 01:08:16 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yuan-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 01:08:16 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as " a retrospective clinical analysis" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:06:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yuan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:06:11 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:00:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yuan-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:00:03 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:09:41 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yuan-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:09:41 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zeng-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zeng-2004a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the date of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zeng-2004b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhai-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 02:07:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2000a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 02:07:28 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through analysis the article we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:06:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2000b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:06:30 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 13:07:06 +1000" MODIFIED_BY="jane clarke" STUDY_ID="STD-Zhang-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 13:07:06 +1000" MODIFIED_BY="jane clarke">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the voluntaries of patients" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 02:41:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2003a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 02:41:31 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhang-2003b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 02:44:08 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 02:44:08 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhang-2004b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 02:47:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2004c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 02:47:47 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the voluntaries of patients" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhang-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:18:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:18:02 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 22:15:46 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 22:15:46 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-05 02:50:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-05 02:50:15 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 21:58:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 21:58:33 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 19:59:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 19:59:09 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 01:43:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2008c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 01:43:27 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 20:19:59 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 20:19:59 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:06:50 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:06:50 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-08 22:07:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-08 22:07:00 +1000" MODIFIED_BY="[Empty name]">
<P>Author could not be contacted by phone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhao-2003a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of hospitalisation"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 01:55:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2003b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 01:55:11 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the voluntaries of patients" without random number table or other adequate methods; a retrospective clinical analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhao-2003c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:39:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:39:47 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 02:02:56 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2006b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 02:02:56 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:27:41 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhao-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:27:41 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition and the sequence of administration" without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zheng-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the medical group" only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:51:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zheng-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:51:00 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "dividing group freely" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 13:07:06 +1000" MODIFIED_BY="jane clarke" STUDY_ID="STD-Zhou-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 13:07:06 +1000" MODIFIED_BY="jane clarke">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the voluntaries of patients" without random number table or other adequate methods; a retrospective clinical analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhou-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the medical group" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhou-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:11:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhou-2010a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:11:27 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone it is a retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 00:48:05 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhou-2010b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 00:48:05 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that it was a retrospective clinical study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhu-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the admission number and pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zhu-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 01:57:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 01:57:09 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 02:56:01 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 02:56:01 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-24 03:00:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-24 03:00:52 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation, described as "according to the pathogenic condition", without a random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:00:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:00:47 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:54:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:54:48 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone and the method of allocation was described as "according to the pathogenic condition" without random number table or other adequate methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-25 02:09:23 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-25 02:09:23 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration"; not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-26 23:24:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhuang-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-26 23:24:48 +1000" MODIFIED_BY="[Empty name]">
<P>Stated as randomised but through interviewing the author by phone we understand that the method of allocation was described as "according to the sequence of administration" without any adequately random approach.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2011-05-08 22:06:56 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-02-01 01:21:05 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-01-17 00:35:33 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-27 18:26:14 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2004c">
<DESCRIPTION>
<P>A random number table had been used to generate allocation sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-17 00:35:33 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhao-2000">
<DESCRIPTION>
<P>A random number table had been used to generate allocation sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-01-17 00:36:49 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-27 18:33:44 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Li-2004c">
<DESCRIPTION>
<P>After interviewing the author by telephone, we found that no allocation concealment was used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-17 00:36:49 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhao-2000">
<DESCRIPTION>
<P>After interviewing the author by telephone, we found that no allocation concealment was used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-01-17 00:39:17 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-27 18:34:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Li-2004c">
<DESCRIPTION>
<P>Blinding was not mentioned in the study, but the author claimed that they used double blinding when he was interviewed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-17 00:39:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhao-2000">
<DESCRIPTION>
<P>Blinding was not mentioned in the study, the author claimed that they were not used it when he was interviewed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-02-01 01:21:05 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-02-01 01:21:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2004c">
<DESCRIPTION>
<P>The author did not mention it in the study, and did not provide relevant information in telephone interview.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-02-01 01:21:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2000">
<DESCRIPTION>
<P>The author did not mention it in the study, and did not provide relevant information in telephone interview.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-02-01 01:17:55 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-01 01:17:16 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2004c">
<DESCRIPTION>
<P>Protocol was unavailable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-01 01:17:55 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2000">
<DESCRIPTION>
<P>Protocol was unavailable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-11-18 11:14:41 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Li-2004c">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zhao-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2011-04-23 01:55:19 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2011-04-23 01:55:19 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Contents of the formulations used in included studies</TITLE>
<TABLE COLS="3" ROWS="3">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Content</P>
</TH>
<TH>
<P>Treating methods</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>
</P>
</TD>
<TD>
<P>Chi Shao10-12 g, Dan Shen 12-15 g, Tao Ren 6-9 g, Yuan Hu 10-12 g, San Leng 6-9 g, E Zhu 6-9 g, Tian Hua Fen 20-30 g.</P>
</TD>
<TD>
<P>Once a day for 7-10 days.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>
</P>
</TD>
<TD>
<P>Chi Shao 10 g, Tao Ren 10 g, Dan Shen 10 g, San Leng 10 g, E Zhu 10 g, Wu Gong 3 pieces, Tu Niu Xi 10 g, Tian Hua Fen 30 g, Yan Hu Suo 10 g, Hou Pu 10 g.</P>
</TD>
<TD>
<P>Once a day for 14 days.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2011-04-23 01:55:19 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>The names of Chinese herbs in different languages</TITLE>
<TABLE COLS="3" ROWS="19">
<TR>
<TH>
<P>Pingying name</P>
</TH>
<TH>
<P>Latin name</P>
</TH>
<TH>
<P>English name</P>
</TH>
</TR>
<TR>
<TD>
<P>E Zhu</P>
</TD>
<TD>
<P>Rhizoma curcumae</P>
</TD>
<TD>
<P>Zedoray rhizome</P>
</TD>
</TR>
<TR>
<TD>
<P>Chi Shao</P>
</TD>
<TD>
<P>Radix paeoniae</P>
</TD>
<TD>
<P>Rubra</P>
</TD>
</TR>
<TR>
<TD>
<P>Hong Hua</P>
</TD>
<TD>
<P>Flos carthami</P>
</TD>
<TD>
<P>Safflower</P>
</TD>
</TR>
<TR>
<TD>
<P>Tian Hua Fen</P>
</TD>
<TD>
<P>Radix trichosanthis</P>
</TD>
<TD>
<P>Trichosanthin</P>
</TD>
</TR>
<TR>
<TD>
<P>Tao Ren</P>
</TD>
<TD>
<P>Semen persicae</P>
</TD>
<TD>
<P>Peach seed</P>
</TD>
</TR>
<TR>
<TD>
<P>Dang Gui</P>
</TD>
<TD>
<P>Radix angelicae sinensis</P>
</TD>
<TD>
<P>Chinese angelica</P>
</TD>
</TR>
<TR>
<TD>
<P>San Qi</P>
</TD>
<TD>
<P>Radix notoginseng</P>
</TD>
<TD>
<P>Sanchi</P>
</TD>
</TR>
<TR>
<TD>
<P>Wu Gong</P>
</TD>
<TD>
<P>Scolopendra</P>
</TD>
<TD>
<P>Centipede</P>
</TD>
</TR>
<TR>
<TD>
<P>Dan Shen</P>
</TD>
<TD>
<P>Ridx salviae miltiorrhiae</P>
</TD>
<TD>
<P>Danshen root</P>
</TD>
</TR>
<TR>
<TD>
<P>Yuan Hu</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Corydalis tuber</P>
</TD>
</TR>
<TR>
<TD>
<P>San Leng</P>
</TD>
<TD>
<P>Rhizoma sparganii</P>
</TD>
<TD>
<P>Common burreed tuber</P>
</TD>
</TR>
<TR>
<TD>
<P>Lian Qiao</P>
</TD>
<TD>
<P>Fructus forsythiae</P>
</TD>
<TD>
<P>Weeping forsythia capsule</P>
</TD>
</TR>
<TR>
<TD>
<P>Zi Cao</P>
</TD>
<TD>
<P>Radix arnebiae</P>
</TD>
<TD>
<P>Arnebia root</P>
</TD>
</TR>
<TR>
<TD>
<P>Huang Bo</P>
</TD>
<TD>
<P>Cortex phellodendri</P>
</TD>
<TD>
<P>Amur cork-tree</P>
</TD>
</TR>
<TR>
<TD>
<P>Xian He Cao</P>
</TD>
<TD>
<P>Herba agrimoniae</P>
</TD>
<TD>
<P>Hairyvein agrimonia herd</P>
</TD>
</TR>
<TR>
<TD>
<P>Tu Niu Xi</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Twotooth achyranthes root</P>
</TD>
</TR>
<TR>
<TD>
<P>Yan Hu Suo</P>
</TD>
<TD>
<P>Rhizoma</P>
</TD>
<TD>
<P>Yan Hu Suo</P>
</TD>
</TR>
<TR>
<TD>
<P>Hou Pu</P>
</TD>
<TD>
<P>Magnoliae cortex</P>
</TD>
<TD>
<P>Magnolia bark</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2010-11-18 11:15:53 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2008-11-10 13:01:23 +1000" MODIFIED_BY="jane clarke">Risk of bias of the included studies</TITLE>
<TABLE COLS="8" ROWS="3">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Concealed allocation</P>
</TH>
<TH>
<P>Randomisation method</P>
</TH>
<TH>
<P>Complete follow up</P>
</TH>
<TH>
<P>Blinding</P>
</TH>
<TH>
<P>Prognosis balanced</P>
</TH>
<TH>
<P>Control group contamination</P>
</TH>
<TH>
<P>Any other bias</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zhao-2000" TYPE="STUDY">Zhao 2000</LINK>
</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Random number table</P>
</TD>
<TD>
<P>No?</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Unequal numbers on arms due to the discontinuation of the study</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-2004c" TYPE="STUDY">Li 2004c</LINK>
</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Random number table</P>
</TD>
<TD>
<P>Yes?</P>
</TD>
<TD>
<P>Double blinding.</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-01-31 03:22:30 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-11-10 13:04:35 +1000" MODIFIED_BY="jane clarke" NO="1">
<NAME>TCHM versus control</NAME>
<DICH_OUTCOME CHI2="6.3756656245214165" CI_END="1.3177256064645395" CI_START="1.0124746266359708" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1550600596565717" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="89" I2="52.94608944889276" I2_Q="66.62317979199013" ID="CMP-001.01" LOG_CI_END="0.11982498536819323" LOG_CI_START="0.0053841482817060336" LOG_EFFECT_SIZE="0.06260456682494965" METHOD="MH" NO="1" P_CHI2="0.09469716589233124" P_Q="0.049982174829955706" P_Z="0.032001926581297344" Q="5.992182561237613" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="132" TOTAL_2="119" WEIGHT="300.0" Z="2.1443865558568294">
<NAME>Treatment success rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1392858828388293" CI_START="0.5909327050979926" DF="0" EFFECT_SIZE="0.8205128205128205" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.056632715967222254" LOG_CI_START="-0.22846197338040872" LOG_EFFECT_SIZE="-0.08591462870659325" NO="1" P_CHI2="1.0" P_Z="0.23748804636254395" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="32" WEIGHT="100.0" Z="1.181288773883315">
<NAME>TCM versus WMD</NAME>
<DICH_DATA CI_END="1.1392858828388293" CI_START="0.5909327050979926" EFFECT_SIZE="0.8205128205128205" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="0.056632715967222254" LOG_CI_START="-0.22846197338040872" LOG_EFFECT_SIZE="-0.08591462870659325" ORDER="93306" O_E="0.0" SE="0.16746603176427094" STUDY_ID="STD-Zhao-2000" TOTAL_1="24" TOTAL_2="32" VAR="0.0280448717948718" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.399488846686248" CI_START="0.9714526276458894" DF="0" EFFECT_SIZE="1.165991902834008" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="26" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.14596944167898082" LOG_CI_START="-0.012578372679850604" LOG_EFFECT_SIZE="0.06669553449956508" NO="2" P_CHI2="1.0" P_Z="0.09915235732194141" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="100.0" Z="1.64897694840427">
<NAME>TCM + WMD versus placebo + WMD or WMD only</NAME>
<DICH_DATA CI_END="1.399488846686248" CI_START="0.9714526276458894" EFFECT_SIZE="1.165991902834008" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="26" LOG_CI_END="0.14596944167898082" LOG_CI_START="-0.012578372679850604" LOG_EFFECT_SIZE="0.06669553449956508" ORDER="93307" O_E="0.0" SE="0.09313177097871612" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="32" VAR="0.00867352676563203" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.40017502437781083" CI_END="1.630668672034449" CI_START="1.0841284845729584" DF="1" EFFECT_SIZE="1.3296068427370948" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="37" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.21236572773266382" LOG_CI_START="0.03508075529679761" LOG_EFFECT_SIZE="0.12372324151473071" NO="3" P_CHI2="0.5269993016829474" P_Z="0.006226087540786439" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="55" WEIGHT="100.0" Z="2.7356305961820455">
<NAME>TCM + WMD versus TCM</NAME>
<DICH_DATA CI_END="1.656307498541938" CI_START="0.9366371986644384" EFFECT_SIZE="1.2455357142857142" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="21" LOG_CI_END="0.2191409680301891" LOG_CI_START="-0.02842859815131969" LOG_EFFECT_SIZE="0.09535618493943472" ORDER="93308" O_E="0.0" SE="0.1454235886641353" STUDY_ID="STD-Li-2004c" TOTAL_1="32" TOTAL_2="31" VAR="0.02114802013995562" WEIGHT="52.10084033613445"/>
<DICH_DATA CI_END="1.9041814327293265" CI_START="1.060503241449525" EFFECT_SIZE="1.4210526315789473" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="16" LOG_CI_END="0.27970832612787305" LOG_CI_START="0.025512000284443618" LOG_EFFECT_SIZE="0.15261016320615833" ORDER="93309" O_E="0.0" SE="0.14931618009253686" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="24" VAR="0.022295321637426903" WEIGHT="47.899159663865554"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="32" TOTAL_2="31" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Time to cessation of abdominal pain (days)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>TCM + WMD versus TCM</NAME>
<CONT_DATA CI_END="-0.03610967297099732" CI_START="-4.143890327029002" EFFECT_SIZE="-2.09" ESTIMABLE="YES" MEAN_1="5.29" MEAN_2="7.38" ORDER="93310" SD_1="3.54" SD_2="4.68" SE="1.0479224838975754" STUDY_ID="STD-Li-2004c" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="32" TOTAL_2="31" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Time to cessation of vaginal bleeding (days)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>TCM + WMD versusTCM</NAME>
<CONT_DATA CI_END="0.3532728574052437" CI_START="-6.593272857405243" EFFECT_SIZE="-3.119999999999999" ESTIMABLE="YES" MEAN_1="9.23" MEAN_2="12.35" ORDER="93311" SD_1="5.56" SD_2="8.21" SE="1.7721105514192994" STUDY_ID="STD-Li-2004c" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.163611926826174" CI_END="-5.364116286053521" CI_START="-10.161340106918928" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.762728196486225" ESTIMABLE="YES" I2="51.96478357855618" I2_Q="0.0" ID="CMP-001.04" NO="4" P_CHI2="0.12470484404044746" P_Q="0.6112473377701381" P_Z="2.2516735456004444E-10" Q="0.2583626160258186" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="108" TOTAL_2="87" UNITS="" WEIGHT="200.0" Z="6.343113540256657">
<NAME>Time for serum beta-hCG levels to return to normal (days)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.3071174179006338E-31" CI_END="-1.8650585893551206" CI_START="-11.494941410644877" DF="0" EFFECT_SIZE="-6.679999999999999" ESTIMABLE="YES" I2="100.0" ID="CMP-001.04.01" NO="1" P_CHI2="0.0" P_Z="0.006544944825558887" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="100.0" Z="2.7191523842393">
<NAME>TCM + WMD versus placebo + WMD or WMD only</NAME>
<CONT_DATA CI_END="-1.8650585893551215" CI_START="-11.494941410644877" EFFECT_SIZE="-6.68" ESTIMABLE="YES" MEAN_1="16.97" MEAN_2="23.65" ORDER="93312" SD_1="8.98" SD_2="11.19" SE="2.456647902014793" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.905249310800356" CI_END="-5.35381757560099" CI_START="-10.886405024734986" DF="1" EFFECT_SIZE="-8.120111300167988" ESTIMABLE="YES" I2="74.39344020279576" ID="CMP-001.04.02" NO="2" P_CHI2="0.04813554455997637" P_Z="8.755392617012803E-9" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="55" WEIGHT="100.0" Z="5.753230597837956">
<NAME>TCM + WMD versus TCM</NAME>
<CONT_DATA CI_END="-2.919448970807424" CI_START="-9.580551029192577" EFFECT_SIZE="-6.250000000000001" ESTIMABLE="YES" MEAN_1="6.88" MEAN_2="13.13" ORDER="93313" SD_1="3.94" SD_2="8.63" SE="1.6992919540683087" STUDY_ID="STD-Li-2004c" TOTAL_1="32" TOTAL_2="31" WEIGHT="68.98654560252095"/>
<CONT_DATA CI_END="-7.312667627079088" CI_START="-17.247332372920916" EFFECT_SIZE="-12.280000000000001" ESTIMABLE="YES" MEAN_1="16.97" MEAN_2="29.25" ORDER="93314" SD_1="8.98" SD_2="10.16" SE="2.534399821681723" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="24" WEIGHT="31.013454397479055"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="64" TOTAL_2="62" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Diminution of the ectopic pregnancy mass by ultrasound (mm)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>Diameter of the mass before treatment</NAME>
<CONT_DATA CI_END="12.579607193114716" CI_START="-5.879607193114714" EFFECT_SIZE="3.3500000000000014" ESTIMABLE="YES" MEAN_1="50.0" MEAN_2="46.65" ORDER="93315" SD_1="21.82" SD_2="15.04" SE="4.70906979205571" STUDY_ID="STD-Li-2004c" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>Diameter of the mass after treatment</NAME>
<CONT_DATA CI_END="-4.6403010185775555" CI_START="-17.09969898142244" EFFECT_SIZE="-10.869999999999997" ESTIMABLE="YES" MEAN_1="32.7" MEAN_2="43.57" ORDER="93316" SD_1="15.72" SD_2="8.59" SE="3.1784762529115396" STUDY_ID="STD-Li-2004c" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2008-11-10 13:04:35 +1000" MODIFIED_BY="jane clarke" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="100" TOTAL_2="88" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Duration of hospital stay (days)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.06.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>TCM versus WMD</NAME>
<CONT_DATA CI_END="18.223156187304024" CI_START="9.916843812695976" EFFECT_SIZE="14.07" ESTIMABLE="YES" MEAN_1="34.29" MEAN_2="20.22" ORDER="93317" SD_1="9.08" SD_2="5.81" SE="2.118996175472402" STUDY_ID="STD-Zhao-2000" TOTAL_1="24" TOTAL_2="32" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.06.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>TCM + WMD versus placebo + WMD or WMD only</NAME>
<CONT_DATA CI_END="-4.877265010797795" CI_START="-9.722734989202202" EFFECT_SIZE="-7.299999999999999" ESTIMABLE="YES" MEAN_1="12.92" MEAN_2="20.22" ORDER="93318" SD_1="4.24" SD_2="5.81" SE="1.2361119940531704" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="24" WEIGHT="0.0" Z="0.0">
<NAME>TCM + WMD versus TCM</NAME>
<CONT_DATA CI_END="-17.49523427960228" CI_START="-25.244765720397716" EFFECT_SIZE="-21.369999999999997" ESTIMABLE="YES" MEAN_1="12.92" MEAN_2="34.29" ORDER="93319" SD_1="4.24" SD_2="9.08" SE="1.9769576129772666" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="24" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-11-10 13:04:35 +1000" MODIFIED_BY="jane clarke" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="100" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>Adverse events rate</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="9" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>TCM versus WMD</NAME>
<DICH_DATA CI_END="1.247907686187948" CI_START="0.07035095317593892" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.09618245965568527" LOG_CI_START="-1.1527300139897727" LOG_EFFECT_SIZE="-0.5282737771670437" ORDER="93320" O_E="0.0" SE="0.7336173692357921" STUDY_ID="STD-Zhao-2000" TOTAL_1="24" TOTAL_2="32" VAR="0.5381944444444445" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>TCM + WMD versus placebo + WMD or WMD only</NAME>
<DICH_DATA CI_END="1.8653740061149113" CI_START="0.3801603710106285" EFFECT_SIZE="0.8421052631578947" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2707659205990705" LOG_CI_START="-0.4200331571928789" LOG_EFFECT_SIZE="-0.07463361829690421" ORDER="93321" O_E="0.0" SE="0.40577879780557535" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="32" VAR="0.164656432748538" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="2" I2="0.0" ID="CMP-001.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="24" WEIGHT="0.0" Z="0.0">
<NAME>TCM + WMD versus TCM</NAME>
<DICH_DATA CI_END="12.049038649148489" CI_START="0.6703906064273972" EFFECT_SIZE="2.8421052631578947" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.0809523974482025" LOG_CI_START="-0.17367207970792356" LOG_EFFECT_SIZE="0.45364015887013953" ORDER="93322" O_E="0.0" SE="0.736972628372832" STUDY_ID="STD-Zhao-2000" TOTAL_1="38" TOTAL_2="24" VAR="0.5431286549707603" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-05-08 22:19:39 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Figure 1.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2011-05-08 22:19:39 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION/>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2011-02-01 01:21:06 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADAAMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdCQkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYAAJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkAmcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwzAP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8zzAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBmMzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNmzGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZM5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZzMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zMM//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP//2b//5n//8z///9BjlLGAAAJ2klEQVR42u2dCXbjKhBF6X+yAbZUC2dLbKBP8tu2BuZBg4Wc+zpp2xKICn4UhcxzKQVAGX+UphNACfY/+gBUAEcAHAFwBMARAEcAHAFwBHw6vuiCBCxd4NxbhSO41yS+6QzAgAFwBMARAEcAHAEfyhF5IllOrjJQcm1L/bXkq8kof98N4N8fMc/uMoPZmLSnxUrTfsoM91cPP9e83Imol1eZfIt7cHE3MheZS07jVzJXEadmstD0anoqKlUq2bZnRaGi+OapnOsEST/iDtLpd/oJDiozDeS1lFMye5WloFKpq5rg1b9f4zUzH1dxQd+YfMXoEtMDjqSRIzK5YRN6ZCO+mzZZv20k79djB59z/iYzUZjG6aRQLmUN9OiKR6Yx1hwryKuHpTXQlfIB6Qgj47b7Jg3xrgKa5xqzeOfmgFKaR33dExh/pupsu+u9nhswA4bp97g/Im1Lw2jcB2tLKa07pdKWtPiBZB1pqrUE16AvZjXPAM6NFaZXSac8HVwfppJxhcdB91iu0PxqtuE5xqO2JyujS85WZCvOZ0MDcCVZHK/T6+nsHW/M0e+pdz2kaep74YW9bo+R7FtPHLxWxY280498Atir6OxVtOxVLPYPUHzuC+AIgCMAjoDrQczKuqYWt8ORzC2B344f5hpAPALgCIAjAI4AOALgiEz/Sfb0nv1d0nAODdbgHBFT35F8ruGHa7DgQg5H3ENbtqeb+YU8SGTmM7JsD3TLLIfdY2rZWvg6G5cXhx1hHdeSrAmva66nFPviz+dIKLMqK6cioZV3bNVTOVIvr7xBg3WPuWbacJxw4FUNRUr5ZHJnTXXqQIM1rB+RTeFmwxWl45posIbmSFYf1aHeSg30dHVTsAIN1phzzaJcSQ5M6fZAUq9ekYWiwRo7ZvWUTzXllC+aio754q9gTvEZigbrXbitduJcDRb7R35W7cRt78UffNMLN/KBfuRUsFcRDVZz/wDF574AjgA4AuAIuB7ErKxranE7HBnTvf4MZABzDSAeAXAEwBEARwAcAZ/EkTkLliS+nbsjO9a2dDCl/ayFdvN7WdFgHQXv/siye6sxB0hy08W+nRiHbuMgD9aZc41E6au8A+7oDfJXrSmsplRUa9asclqsQn6qZFYu5efnctolD9aJfiRyCH5qq/CAGJWVVSWyZpXTYuW0USqTlUsFmbSMn40LDdZJfuQRjxTESsl8ViWZlFGulKp4mZI2qlDRtM4yaLAOj0e2hpzdZfLHjCfj7Y1g221Gg7Vjrjk61kzqq0y+nD/XNLWNBuuq+yPFFHhdg1gKy9CiNqqWKQsN1rv8iCQXhYFMYT3wDPMysqrEkI6Ta0V5r9xyUcasRPtewUecigbrBGzTToRLhA/AYHmwrt8/skc74TibD1ov4kaO9iOfDvYqosFq7h+g+NwXwBEARwAcAdeDmJV1TS1uhyMMnST+MtcA4hEARwAcAXAEwBHwuzki/QXlzKuJ80TcZ2iw8CPT25vY+uFvqFe5As5rSHI0R1JCKkdu5UieIoGUU35RSmUu41XJXs09Lsr/hwbrAHxtH7yRkGqVW4VCJ5PUVE0DOH8Zr4pUrhYcR4N1+VyTUzIZVfPyVd9v0vX9wzXpV/76aLDe5Uc2BLiyp3Llaju+qgAN1uUcMXsGq0mEpxI8i191xLposN6xrmn4YpLid4TUHIFkF60bPQkarPf6kZQAyzmhEgIpFeW8ep4yGblUpJdyqqxKMCf7lpP9Fw3WMThHO/HWDj+mMV+Dxf6Rvx+QB8v3NvdiNX7kA8BeRTRYzf0DFJ/7AjgC4AiAI+B6ELOyrqnF7XCEoZMEGixAPALgCIAjAI4AOALgSAHiaREas1OVrteVhKtaDw3W9TcCpJq8on+nRnsSruaWyIM1wlwTSq6c7FRz0j5ZBrXEya6cvFqFJFwb6qHButqPzKM0Ekm52amUc3x6ms2k5RVJJuHqqocG63o/YiQ/LldtXjBTZOVQZenUpnposK73I3M8UtdFHCCj2hVtosG6MmbNDOVi3Gh2cHKzpWiwrr4/ks1OtUz+sSuRDX6jqx4arMv9iJmGZlJy5S1Z07mzYj2WO8iDJFwb6qHB6sZo2omGt2pdsGyq13IWuYCrwbpZZ2xNwiW1wAU3ch8/MgbYq4gGq7l/gOJzXwBHABwBcARcD2JW1jW1uB2OsLCpDRPmGkA8AuAIgCMAjgA4AuDIiJhVEZldZhkdFkjjI++PiNkr0QIf7kfmL4qfE2GtnmURYqHD+u1+ZPYTSW3WxKKUDgv8zpg1KdBAh4UfyYapmePosOBIlgHosH7pXDOnO8q7EnRYv96PLFOHkyHWjz3SOiyQBNqJFCydYj8qDxZgrrlkFNEFcKQMpppPX9cAOALgCIAjAI4AOALgCABwBMCRvbAX1x/rAnAE4EcAHAFng/0jp8zmHwC+e7O1gzZybO/AG+ACzDWAeATAEUDMCsYJ4IlZsyGbfj7o9vhvqfN87Kq6xol6W9trnKmbLXidWq3ONQpHst337/f500yRuXf19Kq9qrec2tL2Wt2qVgts8JdmGyUeOXq9vH3VeYSqxzb7nvbW8COHv3N2M11seGOmv23dbIFu/oPhSNE12MePbY7r56nm32NvVbXU3Nh2dJ1NFqTqwJH6DK+7xrPeXFXvbnuvBek6xCMHTjV250yxf5rT+yOcuA4cOZpO2z8PPOqTxKM/keQeWjl8tPN9hq67E71VoxssWy+ge4xP3R9J1LFwBNSIx1wDaoAjAI4AOALgCIAjYHR8Bet7ACboBEe4UwJUymUw1wDiEQBHABwBcATcaO1bWAWPuuLB0Ms4EnqX77uY/3dYQ//4L3+YawDxCIAjTVNq5mxUztr16Dvu99tkS3Y84xdDc+0P0qlHaSdqqtKhQ7Wrjddjd2r/XGPtxPyFyfb5bzrjjpBXSRswfyq2lj7PocwtuabPD3Yc418XVp6xA3Vqtx9JCUqt9s+4r2eF8SLs8UXI55JErz9xy6thAxj/uKjX0kCdunGu0Xb6Fzg7HTnCyCHq9zlJnWxI+48XGm+DPo2tGaJTD9Ryauf7N+o9o+37o5NCjHeJ8Q2arRE69evYYftge0Vhap0vUXkzSbRnwD2MH8Cu/zY7Da2CLzNpXRw70e45vWoj12wrC+MhjLd77jic2alfnX+Dzruz9cyLPH5JbZeTrzPnzTXBpd2WH88mA8YyPmnUIJ3qaDnzmaG/h/2oLPy8ZlhDw89rdO2mx/Um60wng6veETXuZ8FwZAyMvFcgzZHvu3Tt37sY+nNj/n7djdQY+nawNwDAEQBHABwBcATAEXB3uGtfvlwCVDjCV0sA5hoARwAcAXAEwBEARwAcAQCABP4HckBx9AuHwYwAAAAASUVORK5CYII=</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2011-02-01 01:21:06 +1000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAQgAAAFWCAIAAAAaEJQvAAAOPklEQVR42u3dvW4c5RfH8ZWQEIULF74CrsEVsqig4p5ImSISKXMXiEtABMqQig4BCSIuUhjoeImGNf7rz8ae3R3vznl2fjufoy2ijX00fp7zPS/Py5nFghDSKx0hZEWAQQgwCAEGIcAgBBiEAIMQYBACDEKAQQgwSMPJc3wBGIxs9WmHfEmAMRcj2/xg2AAGIyPAIOu5NYnAYGQ9Dyy+AYORAQMYjAwYwGBku00eKoDByAgwCAEG2X3ynAoBBiNbVxeZRGAwsuAFA2AEg9FZrgUGMLrk5drVWWTNwGBkBBiEAIMMDG56EAODkRFgEAIMMsLkCXHAYGS3ksDN3xBgzM7IgAEMRrb9sU0iMOZuZF4ZBwxGRoBBCDAIAQYhwCAEGGRSKwfGBBhzNzKzBgxGBgxgMDJsAIORjZj7mUdgMDICDEKAQXYOdAYEGIzMfQxgMLLmzywWAQMYPQYx5EtgAGOi3nd0zV7uDIwW5sv7AoMclffVyRcYqcjVbUp6wQAwWrTojPO+wABGsJHVLRgAAxiRRtags4mXO0ulao2sZcQgwCiPGKMPMWsGBjkAz6Vbh2oMRhbj15vVRWoMVJQkV9XVS8SCATCA0c77Nth4AYZUipH1P7ZUitRa2Gy9LzBIU++7Gt9MIjBqU6nEbGesWOTlzsCIT3gkacDgfYEBDN73/unf9C/NAiO+xjAgGvMAIxi5BpuSwABGkvdtcx9jzlQAo919jAZ+ffqjAQzC+wKDHC7hsfMNjEZ23M1455sAI97I7L0Ag5EdwzNnNSwFBu87qEAacQXivv8LDCF+Wm6CPRiIdsglvnmjKDirMXjfWtIanDeZW8oKjFpP1sb7dsVtTWZ4VB4Y5RNW7X2DagNgAKOd980qmlMalgIjzJNtoC5Cc9iSiRpD6+X0WASMzCHO8b6JDUuBUW4E4xqEN4hvSFnVGDFJ1OYv51Yiz7lhKTAamcKc83VgkBbIRV9AdSSENC0GRkz83PkGxlEtG5hHYMQY7nH0H5lhu2hgqF6OpHoBRgsjm/OJJvYAjEJT4H3bRDlgRPrI6vsYFTeznQgGRnD+kDhrwIgvMKbfIDk3ykWwDYxgHxnERlzFBYxUMEorAQsGwChfLbEkBQx+3WgAgylMb81gbpUAMLJL5IoXDNTdhmMPwCivBEob81RrbrNgoNv5rGNRBBiHeu2lbufAqMqmQrdHJtsVQZeQ8nsClmuBQY6z4qp2E8AI82TSv9kOhVSqqtzM3RPwPlhgiA8HWDBwiJC0s+DRz3dVaA6yNGC0Kze7yp3vzm1yYASVm3EbfNVmnWJswMgz31LN1S2u1RjAaFTIVnhim5LAaFHI2vkGBiFr/Y5UKjVcRHo14QgYiWxU7wkEHdzQVyre9c52VarlCEulBKLI9a4GLTqlUsDIu6g059vkwLjtI7uaPYEgy2gDMzDm7teNRoNaDhgxplB37qjNddyKJC0vgwBGhY8sPXdEgNG0xnAkpE37OW9UIjEwV+822OAjwX69fV8pYMR438TbcJ4ZGOUTFvfYpXWRGgMYAT6yWSWgr5RUylvn1oLR6SulwJjzsbk2YEilyDHEz+q+Uopv4cg9O2Akm2/ntV2t2JBKzTerLh3b0WFusN6VsiABjBblZvQzW64FRtINhMSXUwIjvkSW/hWBUXdTEhikHOa4lzsDI9h8u9kvUgEj2/WOe8MhxRSAAYwtiXXFzW9rR1m1HDA2lZtTBsPaETCCwWhQyAaBoeFafJkRMZENVqW6gitQwCBK5O2LHMAQi1xUUmOQepMKOmzS4H2wwABGa+RG1DnkS2Bg4/ir2GYLBsConbAuqhWNiQNGZLlZmko16/6k+AZG0g2+xOoFGMBItTP2AIzyojA04WESwDiSKBexYBDUmhEY0r+m4aLoeD8wmk5YhXdMbIZQl6FN9mIjMDZNWFDQiDgDCwxgHM86RIP3YwAjxhqmX8gSYBxPiQw5YJDUEln8BEb5hB3T2tHEYQZGC1MoChrRa0fAAIYoVzU+miFgIzvKxZ0cA0YL1zv9/t5mDRjHEIgcaAcGaQFGdZQbF7//B0ypVGo2VeTUg3o0OSADjEYJT9ZdopbLtSLGfMFo6donC3PQ+1qBEZ/w5Db/lErl1Ril+9OhgcjON5l1Idsg4bHzTcrBSCzr1RjBeVSDO2tzi0WpJmEg4iystBJwBQoYqWw0ixilF5WAMV8w4pK0utGwwRdfY0w58rSfL2CQACOu7sXU0k0AAxu1tpsyj2qM7FRqrJlr0KKTAKORX5/5CcIgvw6M1kY2ZzYSd+uB0TGF9kmaVSllhoMbwACGJK15wpNSywHjGJK0UN6mXGwAo9zIqpO0rOu4YfZgFOKMDBjAYGTHA0ZK+geMciOrKzcTz4OkwAyMRpVAERtZfh0YJBiMBi+7AQZp99qulMTSkZDUMsOd78SyHhizLgrbJGmJTaXGdW3ACPaRcUflu/oTwWPNIDCCI0bd5aq6JC3l7bjA6O7G39kOSFxPcmAclbWVZiPV+mfi2oCRmlL3JjymcmR3ZiCywOiNRRWaZ5tYAiObDUsRRSkrMA5Qzs4ZjDansNQY0y2RjyDEBZ2Vsiol2zmAm5ghcsAILpHFonXKpVJTZ6PxLnLchv3UnxMYcc3LujVnpfbRn7vzDYywVKp987Lpu+GKER4dZmCk1hiJYNwaEBFj7my0RG6UP6RNHuV1xnkFhn2MOq9RNMIlLzYRMYrMK3rnu6IuSln9A8ZRBboKO5vnDXhgHKZEnnJRVLFo2yB+jgszMKrMt3pPwKyVjjMwUv16l3ygffp/AjDCJmyzp5xs9RK3pw6M2hqjCzzQ3vIcwNTtARjVppD13iMTB4ymYHTjdfFotsJTR92UH9gub6O1oznfn25Ty5UkwFx76etdVsd6zqlUUI9DYJR7stwol7XIIZWaOxgto5ziWyoV9sr3xNbLbWawcyRkzrHI2/1KFzmAEZykeWsrMA5Q0c7WfDt9pYCh1jxI+jf9114CIxiM0G04y7XYaJGWZNVFYU4HFXHe1zZcafwERmq+3iWe4s7ZrQdGcCGr5Q8wUgvZ3LQkLi45XVs4pnN+61yz9G/cnW/NENqB0U3+dG36gsH0xxkYVRMW3VI/d+d7LJiB0TNnBoQDAsYxrBOIRValmO9hHn6m08eCbw2CPYFoNwSMMY1gdbWndP7GhTnlFNatt9tMfBkNGIvRrXZgUBoR5tENuuhNeRXPvE6D4rtkwkbnoUG/+ykfNgEGMPq1BYHRcpyBIWIAo+qZ1RjlqxnVDc8n/sylo3H37bJTPqlpufYAHBqHGI9pIAgBBiHAIAQYhACDEGDs+RcScp9l6FmAQTPN99UMDJppBgbNNAODKdAMDKZAMzCYAs3AqB7Wq7+uHr54ePH84vTr08WXi5OnJ+fPzh/8+OD1n6/31PzX1dWLhw+fX1x8fXr65WLx9OTk2fn5jw8e/Pn69WSf+c2bq19/fXh5efHy5elPPy1evDh59er86urBmzfT1QyM8cF48suTs2/OlrZ197O0ucc/P95Z8y9PnnxzdtaneLHk5OfHjyf4zL///uTly7Ol1d79LK35t9+mqBkY4//xSxfba16rn+XP7KB5GRa2KV4sf2ZSz7x03r2Gu/pZ/sykNANj/D9+6Xe3WtjNZ50PXqd5GSuGKV6sixvtn3np0bfa7s1nnXdvrzkDjF4l677s7eM08Mv7DlbvTy5z9HXZSG9+cvnH5UDNy7piXQbVm1P9cXl58GdeZv+rec5XXy0+/HDx3nvXn08+WXz77e3M5++/D685G4zNP9bbwHTzl6sPvc+DLSvXgRa2ITnp1bystu+juD+havzMy5p41UDff/96eL/4YvH559f/+OCDQWlPY81HGDEqwNjwV/R+f/H8oseYbqTPyM6fnQ/U/Pzi4l5gPDs/P/gzX15e9OY2339/rfvdd29//+rV4TUDo//fW39l8zPcrHION7KTpycDNd+szA7/PD05Ofgz36yf3vp8993io4+udX/22e3/evHi8JqPFoyt/VR2AOMeD9ZrXqtyx84Gar5romdbFC8O/sy9Tv3jj69Vfvppf6F8cM3A6P9yTzBEjK1+/Z13rhX/8EOP7e4ZMUbRfJxgbOjStxWMu7dMdgBDjTGkElj32b/G2F/zcS7X7rxUNfxXrErtvCp187mR4ZtxjTUngXHXnfcadO/Fwj33Me67KmUfY8Nuw2bz3WcfY0TNMWBMVux8D9Fs5xsY/4mzUm9FJGelgLHqg/tXe/7NRh69fLSz5mXcWLdCtfz+5aNHE3zmf8/Anq4/AztFzcAoAaNbf7ehN0e/l+Z19zF664qJPPO6WxO92f9ENAOjBAyaaQYGzTQDgynQDAymQDMwmALNwDBhNAOj4o8nRLdzPpJmEYMp0AwME0YzMEwYzcAABs3AAAbNwAgAI7HbeZ1m3c6BcS2J3c7rNOt2DoxrSbzBV6fZDT5g/C9WxN35rtPszvcuYAzsALLP8+3T/3zz9v7RdAmp06zb+QgRY2Cbs90ebodutltbEh5NX6k6zbqd7wtGbw/Z/Z16ezASOxHWadbtfGQwBraU3aHPbDUYib1r6zTrdr4XGEMazg638oE5VREYid3O6zTrdr47GAO7x96q1CcLhoix1a/rdj4mGDunUvv0P1djFNUYup0vdvj9re+v2Md2rUodcFVKt/NBYKy7ELg5lVqXX23Vbx/j4PsYup13dr7tfN+InW9g/CfOSr0VRZ2VAsZq3Ijrdl6nWbdzYLxVb8R1O6/TrNs5MGimGRg00wwMpkAzMJgCzcBgCjQDw4TRDIxCMAjR7ZyQ8fypgSAEGIQAgxBgEAIMQoBBCDAImQQYhJBb8g/rYyJR4gg9+wAAAABJRU5ErkJggg==</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2011-01-17 02:56:18 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2011-01-17 02:56:18 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-10 12:55:11 +1000" MODIFIED_BY="jane clarke">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2011-01-17 02:56:18 +1000" MODIFIED_BY="[Empty name]">
<P>A. Search strategy for MEDLINE (OVID)<BR/>a) Search strategy to locate RCTs<BR/>#1 randomisation controlled trial<BR/>#2 random allocation<BR/>#3 random* allocat*<BR/>#4 RCT<BR/>#5 #1~#4/or</P>
<P>B) Search strategy to locate ectopic pregnancy<BR/>#6 ectopic pregnancy<BR/>#7 ectop* pregnancy<BR/>#8 ectopic pregnan*<BR/>#9 ectop* pregnan*<BR/>#10 eccyesis<BR/>#11 ectopic fetation<BR/>#12 ectopic feta*<BR/>#13 ectop* fetation<BR/>#14 ectop* feta*<BR/>#15 ectopic gestation<BR/>#16 ectop* gestation<BR/>#17 ectopic gestat*<BR/>#18 ectop* gestat*<BR/>#19 extra-uterine pregnancy<BR/>#20 extra-uterine pregnan*<BR/>#21 extra-uter* pregnancy<BR/>#22 extra-uter* pregnan*<BR/>#23 heterotopic pregnancy<BR/>#24 heterotopic pregnan*<BR/>#25 heterotop* pregnancy<BR/>#26 heterotop* pregnan*<BR/>#27 #6~#26/or</P>
<P>c) Search strategy to locate traditional Chinese herbal medicines<BR/>#28 traditional Chinese herbal medicine<BR/>#29 Chinese traditional medicine<BR/>#30 traditional Chinese medic*<BR/>#31 Chinese traditional medic*<BR/>#32 herbal medicine<BR/>#33 herb* medic*<BR/>#34 medic* herb*<BR/>#35 Chinese herbal medicine<BR/>#36 Chinese herb* medic*<BR/>#37 Chinese medic* herb*<BR/>#38 herbal<BR/>#39 herb*<BR/>#40 complementary<BR/>#41 alternative medicine<BR/>#42 comp*<BR/>#43 alter* medic*<BR/>#44 #28~#43/or<BR/>#45 #5 AND #27 AND #44</P>
<P>B. A similar strategy will be for EMBASE<BR/>#1 ectopic<BR/>#2 pregnancy<BR/>#3 ectopic pregnancy<BR/>#4 ectop*<BR/>#5 pregnancy<BR/>#6 ectop* pregnancy<BR/>#7 ectopic<BR/>#8 pregnan*<BR/>#9 ectopic pregnan*<BR/>#10 ectop*<BR/>#11 pregnan*<BR/>#12 ectop* pregnan*<BR/>#13 ectopic<BR/>#14 fetation<BR/>#15 ectopic fetation<BR/>#16 ectop*<BR/>#17 fetation<BR/>#18 ectop* fetation<BR/>#19 ectopic<BR/>#20 feta*<BR/>#21 ectopic feta*<BR/>#22 ectop*<BR/>#23 feta*<BR/>#24 ectop* feta*<BR/>#25 ectopic<BR/>#26 gestation<BR/>#27 ectopic gestation<BR/>#28 ectop*<BR/>#29 gestation<BR/>#30 ectop* gestation<BR/>#31 ectopic<BR/>#32 gestat*<BR/>#33 ectopic gestat*<BR/>#34 ectop*<BR/>#35 gestat*<BR/>#36 ectop* gestat*<BR/>#37 extra-uterine<BR/>#38 pregnancy<BR/>#39 extra-uterine pregnancy<BR/>#40 extra-uter*<BR/>#41 pregnancy<BR/>#42 extra-uter* pregnancy<BR/>#43 extra-uterine<BR/>#44 pregnan*<BR/>#45 extra-uterine pregnan*<BR/>#46 extra-uter*<BR/>#47 pregnan*<BR/>#48 extra-uter* pregnan*<BR/>#49 heterotopic<BR/>#50 pregnancy<BR/>#51 heterotopic pregnancy<BR/>#52 heterotop*<BR/>#53 pregnancy<BR/>#54 heterotop* pregnancy<BR/>#55 heterotopic<BR/>#56 pregnan*<BR/>#57 heterotopic pregnan*<BR/>#58 heterotop*<BR/>#59 pregnan*<BR/>#60 heterotop* pregnan*<BR/>#61 #1~#60/or</P>
<P>The above EMBASE search was restricted by study design as below (combined with 'AND')<BR/>#1 explode 'clinical-trial' / all subheadings<BR/>#2 explode 'controlled-study' / all subheadings<BR/>#3 'randomization-' / all subheadings<BR/>#4 'case-control-study' / all subheadings<BR/>#5 #2 NOT #4<BR/>#6 random* or clin*<BR/>#7 #1~#6/or</P>
<P>C. A search strategy in <I>The Cochrane Library</I>
<BR/>#1 ECCYESIS*: ME<BR/>#2 (((ECTOP* near PREGNAN*) or FETA*) or GESTAT*)<BR/>#3 ( ECTOP* or (EXTRA-UTER* or (HETEROTOP* near PREGNAN*)))<BR/>#4 (#2 or #3)<BR/>#5 (#1 or #4)</P>
<P>D. Search strategy in the Chinese Biomedical Database (CBM)<BR/>#1 ectopic pregnancy<BR/>#2 ectopic fetation<BR/>#3 ectopic gestation<BR/>#4 eccyesis<BR/>#5 extra-uterine pregnancy<BR/>#6 heterotopic pregnancy<BR/>#7 traditional Chinese herbal medicine<BR/>#8 Chinese herbal medicine<BR/>#9 herb* medicine<BR/>#10 medic* herbs<BR/>#11 medic* herb*<BR/>#12 traditional medicine<BR/>#13 (#1~#6/or) and (#7~#12/or)</P>
<P>E. The same search strategy was used in the CNKI, VIP and traditional Chinese herbal medicine Database System.<BR/>All of the search terms were translated to Chinese terms when we</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>